Virulence and Evolutionary Ecology in the Entomopathogen Bacillus thuringiensis by Manktelow, J
Virulence and Evolutionary Ecology in the 




Submitted by Christopher James Manktelow to the University of Exeter  
  as a thesis for the degree of  
Doctor of Philosophy in Biological Sciences 




This thesis is available for Library use on the understanding that it is copyright 





I certify that all material in this thesis which is not my own work has been 
identified and that no material has previously been submitted and approved for 












Bacillus thuringiensis is an entomopathogen in the Bacillus cereus 
species group, and has been used as a biopesticide for over 50 years.  Despite 
extensive use of B. thuringiensis, there remain questions over its specific 
ecology compared to other members of the B. cereus group which poses 
problems for its continued applied use.  Tying entomopathogenic ecology to a 
specific clade within the B. cereus group will limit confusion between B. 
thuringiensis used in agriculture and more harmful strains.  Better 
understanding of B. thuringiensis ecology can also be used to combat 
resistance in pest species through selective passaging. 
The ecology of B. thuringiensis was explored through competitions in 
Plutella xylostella (diamondback moth) larvae, which showed clade 2 B. 
thuringiensis have improved fitness in insects compared to clade 1 strains.  
Additionally, growth rates were compared in vitro, giving different thermal 
profiles for the two clades.  Growth media preference was assessed for B. 
cereus group species with all favouring protein media over soil-based ones. 
Selective passaging explored the effects of relatedness and host 
background on virulence evolution.  For relatedness, B. thuringiensis subsp. 
aizawai was passaged for five rounds in P. xylostella larvae with none, one or 
two bottlenecking events.  These treatments failed to produce any increase in 
virulence.  In the second, B. thuringiensis subsp. entomocidus was passaged 
either in Cry1Ac-resistant, Cry1Ac-susceptible, alternating rounds of each or 
coevolved P. xylostella, with all containing a mutagenesis step with ethyl 
methanesulfonate.  Virulence increased in the resistant and coevolved 
treatments, confirming that resistance is best overcome by passaging in harder-
to-kill hosts. 
The ecological and genetic distinctiveness of clade 2 B. thuringiensis 
suggests the species should be reclassified to solely this clade, which will limit 
safety concerns.  Selective passaging can improve the virulence of strains, 
even if the underlying interactions are unknown; it can also provide insight into 
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Bacillus thuringiensis (Berliner 1911) is a Gram-positive, endospore-
forming motile bacterium and is part of the Bacillus cereus species group in the 
Bacillaceae family (Turnbull 1996, Liu, Lai et al. 2015).  As with another species 
in the B. cereus group – Bacillus anthracis, the causative agent of anthrax 
(Zwick, Joseph et al. 2012) – B. thuringiensis has been distinguished from B. 
cereus sensu stricto through specific virulence factors it produces and 
associated epidemiology.  In particular, B. thuringiensis is characterised by the 
presence of crystalline δ-endotoxins (Cry toxins) within the parasporal body.  
While B. anthracis is a mammalian pathogen (Zwick, Joseph et al. 2012), B. 
thuringiensis infections are limited to invertebrates (Aronson and Shai 2001).  
Entomocidal activity has been demonstrated against a number of insect Orders 
(Aronson and Shai 2001), especially Lepidoptera, Coleoptera and some Diptera 
(de Almeida Melo, Soccol et al. 2016), while some isolates have activity against 
nematodes and gastropods (Rae, Iatsenko et al. 2010, Palma, Munoz et al. 
2014). 
The entomocidal abilities of B. thuringiensis have led to it being adapted 
for use as a biopesticide, with genes for its Cry toxins also inserted into 
transgenic crops.  At least 15 pest species of moth have since evolved 
resistance to particular commercialised toxins (Tabashnik and Carriere 2017) 
and this has meant there are ongoing attempts to produce improved or novel 
strains and toxins to overcome this problem (Park, Abdullah et al. 2009, Deist, 
Rausch et al. 2014, Rausch, Chougule et al. 2016).  As explored here, selection 
experiments may provide a robust way to produce toxins that can overcome 
resistance.  Along with these clear applied aspects of studying B. thuringiensis, 
the large variety of strains and toxins, combined with the availability of resistant 
host populations, make B. thuringiensis a viable candidate for exploring the 
mechanistic aspects of virulence and its associated traits, as well as the 
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evolutionary ecology shaping investment in various virulence factors (Raymond, 
West et al. 2012, Zhou, Slamti et al. 2014). 
Experimental evolution provides one of the most powerful tools for 
examining how ecological factors affect evolution of virulence in B. thuringiensis 
and other pathogens (Kawecki, Lenski et al. 2012, Rafaluk, Jansen et al. 2015).  
In this thesis the effects of within-host relatedness and mutation rates on B. 
thuringiensis virulence evolution are explored through selective passaging.  
Treatments that appear to increase the virulence can then be incorporated into 
future passages with the ultimate aim of identifying a selection protocol for 
reliably producing isolates with restored mortality rates in initially resistant hosts.  
Achieving this will require a clearer understanding of the growth conditions 
favoured by B. thuringiensis, in part because any isolates of interest need to be 
viable in vitro to produce the quantities needed for applied work.  This will also 
give greater clarity over the B. cereus group’s ecology and classification, which 
may be required to avoid future regulatory concerns.  The within-host 
interactions between commercialised B. thuringiensis strains also will be 
characterised to better understand how mixed infections affect strain fitness and 
to inform the design of relatedness treatments in the selective passages. 
 
History of the use of B. thuringiensis  
 
B. thuringiensis was originally isolated from diseased Bombyx mori 
silkworms in Japan in 1901 by Shigetane (Roh, Choi et al. 2007).  It was fully 
described by Berliner in 1911 after being isolated again, in this instance from 
the Mediterranean flour moth Anagasta kuehniella, and given the species name 
thuringiensis after the East German city of Thuringen where the moths were 
captured (Berliner 1911).  As a result of their entomocidal abilities, B. 
thuringiensis strains were subsequently adapted for use in agriculture as 
biopesticides, either through the use of spores or purified toxins.  This value as 
a biocontrol agent was first recognised in France in 1938, with the first 
commercial product launched under the name Sporeine (Lambert and Peferoen 
1992), though this was preceded elsewhere by non-commercial production 
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targeted at curbing the European corn borer moth, Ostrinia nubilalis (Lambert 
and Peferoen 1992).  Subsequently, B. thuringiensis pesticides were registered 
in the United States in 1961 (Sanahuja, Banakar et al. 2011). Despite this long 
period of use B. thuringiensis-based pesticides still only make up 2% of total 
global pesticide use (Adang, Crickmore et al. 2014).  There are several potential 
reasons: weak persistence on the surface of crops (Sanchis, Gohar et al. 1999); 
high costs relative to chemical alternatives but also because of the emergence 
of resistance to common products in some pest species, particularly in South 
East Asia (Gong, Wang et al. 2010, Zhang, Zhang et al. 2016, Tabashnik and 
Carriere 2017). 
Biopesticide use preceded knowledge of precisely how B. thuringiensis 
acted to kill the pests it was employed against – it was not until 1956 that Angus 
discerned that crystalline toxins provided the entomocidal activity and they were 
located within the parasporal body (Angus 1956), having been produced during 
sporulation.  Toxin identification was followed in the 1980s by the discovery that 
these crystal toxins were encoded on genes typically located on plasmids rather 
than in the main bacterial chromosome.  Cloning and characterisation of these 
genes in the reference strain B. thuringiensis subsp. kurstaki HD1 (BGSC 4D1) 
was carried out around this time by Schnepf and Whiteley (1981).  At the same 
time the viability of transferring genes into plants to produce transgenic crops 
was being successfully demonstrated, with virus-resistant tobacco first 
introduced commercially in 1992 (James 1998) and in 1996 the first transgenic 
plant (potato, Solanum tuberosum) containing a B. thuringiensis-sourced toxin 
gene was approved for sale in the USA (James 1998).  As knowledge of genetic 
modification techniques has improved B. thuringiensis genes have been 
incorporated into a growing range of plants to produce more pest-resistant 
transgenic crops, with two thirds of the USA maize planted in 2012 containing 
such genes (Tabashnik, Brevault et al. 2013).  By 2003 80% of biopesticides 
were B. thuringiensis-based (Whalon and Wingerd 2003) and B. thuringiensis-
facilitated products are now used on 75% of arable and forested lands in North 
America (Bailey, Boyetchko et al. 2010).  Increasing use has led to increasing 
resistance – in the last 20 years resistance to B. thuringiensis products has 
emerged in multiple pests, including the diamondback moth, Plutella xylostella 
(Zhang, Zhang et al. 2016, Tabashnik and Carriere 2017). 
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P. xylostella is a member of the lepidopteran family Plutellidae and a 
global pest of cruciferous crops (Miyata, Kawai et al. 1982), with control and 
crop losses together costing approximately $5 billion per annum (Furlong, 
Wright et al. 2013).  They are a constant pest in South East Asia (Gu 2009) 
while they also threaten harvests in more temperate northern regions, where 
colder winters prevent them from becoming established year-round (Honda, 
Miyahara et al. 1992).  The moth’s ancestral range has not yet been pinpointed 
though both Mediterranean and South African origins have been proposed (Kfir 
1998).  P. xylostella, in conjunction with B. thuringiensis, represents an ideal 
study system for both practical considerations and applied reasons.  Under lab 
conditions generation time is two weeks at 24oC and, combined with their small 
size (<1.5cm) and high fecundity, this allows large numbers to be reared with 
little effort.  This means that any bioassays or other in vivo experiments carried 
out using larvae can be done with larger sample sizes across multiple 
treatments.  In the field P. xylostella was the first insect species to show 
resistance to Cry1Ac-based biopesticides with resistance to the DiPel® (Valent 
BioSciences LLC) product appearing in the first half of the 1990s (Tabashnik, 
Cushing et al. 1990, de Almeida Melo, Soccol et al. 2016). 
 
Biology of Cry Toxins 
 
The crystalline toxins underlying the value of B. thuringiensis to 
agriculture can be split into Cry (crystal) and Cyt (cytolytic) toxins and the 
former have been the primary focus of biotechnological applications with B. 
thuringiensis so far (Kim, Roh et al. 2008, Gong, Wang et al. 2010).  Cry toxins 
also provided the basis for identifying B. thuringiensis (Priest, Barker et al. 
2004, Rasko, Altherr et al. 2005) and there are currently over 300 recognised 
Cry toxins in 75 classes, as maintained in the Bacillus thuringiensis toxin 
nomenclature full list of δ-endotoxins (Berry and Crickmore 2017, Crickmore, 
Baum et al. 2018).  To be recognised as a Cry toxin on the database a protein 
must be sufficiently similar to existing Cry toxins and/or be a protein with 
entomocidal activity that can be isolated from crystal inclusions in a B. 
thuringiensis isolate.  This does mean that if a protein is significantly similar to 
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an existing Cry toxin it can also be categorised as one even if its action or target 
are unknown (Crickmore, Baum et al. 2018).  Within the currently defined B. 
thuringiensis species there are hundreds of named strains (Aronson and Shai 
2001) which have mainly been identified and initially grouped together based on 
serotyping, but this is being replaced by genome sequencing and associated 
methods such as multi-locus sequence typing (Maiden, van Rensburg et al. 
2013).  Individual strains may carry multiple different Cry toxins from the same 
or different toxin groups, and these toxins determine which hosts a strain is able 
to successfully infect.  The host range of any particular strain is generally 
restricted to a number of species within an Order, with some exceptions 
spanning Diptera and Lepidoptera (Zheng, Gao et al. 2017).  However, across 
all the toxins and strains, a wide range of host species can be infected.  This 
means that a new B. thuringiensis isolate potentially can be screened against 
various pest species to see which it produces high mortality in, while a specific 
pest can be bioassayed with a large variety of B. thuringiensis strains to find 
one that can be used against it.  This combination of high toxicity, specificity 
and diversity is the core reason that B. thuringiensis has been so highly utilised 
for insect pest control, as it enables individual pest species to be targeted 
without causing mortality in the wider invertebrate fauna (particularly natural 
enemies and pollinators). In addition to the Cyt and characteristic Cry toxins B. 
thuringiensis strains can produce other virulence factors, including over 150 
vegetative insecticidal proteins (Zheng, Gao et al. 2017), which are secreted 
during vegetative growth.  Production of additional virulence factors is regulated 
through quorum sensing, with the transcription factor PlcR controlling 
production of stationary phase virulence factors and Rap controlling sporulation 
(Slamti, Perchat et al. 2014, Zhou, Slamti et al. 2014).  The importance of 
quorum sensing to virulence factor production suggests that virulence may be 
strongly affected by within-host densities and population structure. 
The many currently catalogued Cry toxins can be divided into different 
groups based on their levels of amino acid sequence similarity.  Taking the 
commonly commercialised toxin Cry1Ac as an example, each character in the 
name represents a particular level of amino acid sequence identity.  If two 
toxins have the same characters in the first three ranks (requiring a fourth rank 
to distinguish them) then their sequences are at least 95% identical; differing 
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primary ranks mean a similarity of less than 45% (Crickmore, Zeigler et al. 1998, 
de Maagd, Bravo et al. 2001).  The catalogue currently lists Cry toxins labelled 
from Cry1Aa1 to Cry75Aa3 with the majority being 3-domain Cry toxins (Berry 
and Crickmore 2017, Crickmore, Baum et al. 2018).  By contrast, there are only 
three subgroups of 40 Cyt toxins, and the third only contains a single toxin, 
Cyt3Aa1 (Crickmore, Baum et al. 2018). 
In Cry toxins the majority of groupings share 5 conserved regions, with a 
smaller number of other groups lacking one or more of them.  These regions 
were originally identified by Hofte and Whiteley (1989) and together the five 
appear to correspond to a 3-domain structure so that all toxins with these five 
conserved regions also possess a 3-domain structure.  The first toxin to have its 
structure discerned was Cry3Aa in 1991, via X-ray crystallography (Li, Carroll et 
al. 1991, Berry and Crickmore 2017).  The 3-domain proteins can be split into 
domains I, II and III.  Domain I is thought to primarily play a role in pore 
formation, while domain II has a greater role in specificity and binding 
(particularly through its exposed surface loops) and domain III potentially has 
functions in both binding and insertion of toxins into the host cell membrane 
(Xu, Wang et al. 2014, Berry and Crickmore 2017). 
In the 3-domain proteins the domains can be linked back to the five 
conserved regions, with the first region corresponding to the centre of domain I.  
Regions 2 and 3 are found at the joins of domains I-II and II-III, respectively.  
The final two regions are both in domain III, with 4 in the centre and 5 at the end 
(Schnepf, Crickmore et al. 1998) and the majority of categorised Cry toxins are 
thought to have this 3-domain form (Bravo, Gomez et al. 2013).  However, Cry 
protoxins range from only 369 to 1344 amino acid residues in length, with the 
shorter ones lacking some or all of the five normally conserved regions (Adang, 
Crickmore et al. 2014).  Some of this can be attributed to the varied length of 
the C-terminal extension which is cleaved off in the gut to leave the active toxin 
and is thought to play a role in crystal formation (de Maagd, Bravo et al. 2001). 
Cry toxins were initially classified based on their entomocidal activities, 
i.e. toxins that were active against closely related host species were considered 
to be closely related themselves (Hofte and Whiteley 1989).  Sequence data 
have replaced this functional classification, although sequence similarity can still 
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predict range of host activity to some extent.  Sequence data may include the 
cleaved protoxin region which is unlikely to affect host-binding specificity (Bravo 
1997, de Maagd, Bravo et al. 2001).  Likewise, the three different domains of 
most Cry toxins are not all involved in binding to receptors (Schnepf, Crickmore 
et al. 1998) so it may be necessary to limit the sequence any tree is built from 
before comparisons with older entomocidal-based classifications. Indeed the old 
host-based classification is close to the trees constructed for domains I and II, 
though there are exceptions e.g., Cry9Aa toxins show sequence similarity to 
other Cry9 ones in the cleaved protoxin region and domain III instead (Bravo, 
Gill et al. 2007).  While the similarity between host-based trees and domain II is 
unsurprising given its role in receptor binding, domain I’s similarity may be a 
result of different host groups possessing different gut conditions: lepidopteran-
targeting 3-domain toxins appear to favour arginine over lysine in domain II, but 
not those affecting the more acidic guts of Coleoptera (Grochulski, Masson et 
al. 1995). 
While domains I and II appear to have mainly coevolved, the distinct tree 
generated by domain III may help to explain the great variety of 3-domain Cry 
toxins (Bravo 1997, Bravo, Gill et al. 2007).  There is clear evidence of 
homologous recombination between Cry toxin genes facilitating the swapping of 
domain III (Bosch, Schipper et al. 1994, de Maagd, Weemen-Hendriks et al. 
2000).  This is evident when examining the Cry1C and Cry1E toxins – in each 
group, the I and II domains are almost identical yet some Cry1C domain IIIs are 
far more similar to Cry1E ones than their supposed Cry1C neighbours (Bravo 
1997).  This shuffling of domains increases the number of combinations, giving 
greater toxin variety and activity against more host species.  This has been 
demonstrated in the laboratory, with domain swapping between Cry1Ac and 
Cry1Fa toxins producing ones that are effective against a greater host range 






Mode of Infection 
 
The structure of 3-domain Cry toxins ultimately allows them to trigger the 
breakdown of a host’s midgut lining, allowing B. thuringiensis cells to invade 
and proliferate in the haemolymph.  In lepidopterans the alkaline conditions of 
the pro-gut cause the crystals to dissolve, after which protoxins are cleaved by 
gut enzymes to give active toxin (Hofmann, Luthy et al. 1988, Aronson and Shai 
2001).  Activated 3-domain toxins then bind to receptors on microvilli in 
membranes of cells lining the midgut (de Maagd, Bravo et al. 2001, Bravo, Gill 
et al. 2005).  Binding to the receptors ultimately triggers cell death, though there 
are at least two potential routes for this (de Almeida Melo, Soccol et al. 2016).  
Cell death results in the midgut wall breaking down which allows mixing of gut 
contents, including B. thuringiensis, with the haemolymph where the bacteria 
can proliferate vegetatively.  Host death can result solely from sufficient damage 
to the midgut, as shown by the existence of toxin-only biopesticides and 
transgenic crops.  Mortality is increased with the presence of vegetative cells, 
which can cause septicaemia as they reproduce; other bacteria present in the 
gut becoming pathogenic when given access to the haemocoel might also 
contribute to the success of toxin-only control methods (Raymond, Johnston et 
al. 2009).  While any particular part of the infection process could contribute to 
host specificity, it is thought this is principally achieved through binding to host-
specific receptors (Berry and Crickmore 2017).  Lepidopteran larvae can 
respond to infection with melanisation of infected tissue (Rahman, Roberts et al. 
2004), which results in B. thuringiensis cadavers having a characteristic black 
appearance that is easily distinguishable in laboratory conditions. 
As described, the overall process of B. thuringiensis infection is well 
characterised.  However, the exact way 3-domain Cry toxins trigger cell death is 
not fully resolved.  The better established classic model is that sequential 
binding and pore formation in the plasma membrane lead to osmotic shock and 
cell death (Bravo, Gill et al. 2007, de Almeida Melo, Soccol et al. 2016).  The 
cleaved Cry toxin may bind to cadherin, N-aminopeptidase or other receptors 
which causes a conformational change in the toxin, as well as allowing further 
toxin proteins to bind and form pores (Dorsch, Candas et al. 2002, Jimenez-
Juarez, Munoz-Garay et al. 2008).  Other membrane proteins have also been 
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linked to Cry toxin binding, including ABC type-C reporters (abcc2) (Gahan, 
Pauchet et al. 2010, Baxter, Badenes-Perez et al. 2011, Park, Gonzalez-
Martinez et al. 2014) and alkaline phosphatase (Jurat-Fuentes and Adang 2004, 
Guo, Kang et al. 2015).  The proliferation of pores in the plasma membrane 
causes it to break down and the resulting loss of control over osmotic gradients 
results in cell death (de Almeida Melo, Soccol et al. 2016). 
The alternative mechanism for cell death still has toxins binding to 
surface receptors and generating pores, but includes an additional signalling 
pathway where binding to cell-surface receptors triggers a change in cell 
metabolism which is the ultimate cause of cell death (Zhang, Candas et al. 
2006, de Almeida Melo, Soccol et al. 2016).  This mechanism partly has been 
proposed to explain alternate forms of Cry toxin resistance which have been 
observed.  It is clear that changing membrane receptor shape can produce 
resistance, as toxins can no longer bind to form pores, and this is compatible 
with the classical model of toxin action.  In addition, preventing expression of 
the receptors also generates resistance, while restoring either cadherin or N-
aminopeptidase can be enough to rescue susceptibility (Schwartz, Lu et al. 
1997).  However, there is evidence of resistance occurring without any change 
to surface receptors, possibly implying that pores are still being formed through 
toxin-receptor binding but not ultimately causing cell death and a breakdown in 
midgut epithelium (Vachon, Laprade et al. 2012); while receptor binding does 
confer specificity it cannot necessarily predict susceptibility (Adang, Crickmore 
et al. 2014).  This could mean that resistance has evolved to an alternate trigger 
for cell death, hence the potential requirement for a different pathway.  
However, as cells that are riddled with pores could be expected to undergo 










Against a susceptible host, ingestion of only a few B. thuringiensis 
spores can be sufficient for host death (Cornforth, Matthews et al. 2015).  
However, one of the reasons that B. thuringiensis has not become a panacea 
for agricultural pests is that high selection pressure rapidly leads to resistance 
e.g., through modification or loss of the cadherin-like or abcc2 receptors with 
the latter being the likely mechanism in P. xylostella (Baxter, Zhao et al. 2005, 
Baxter, Badenes-Perez et al. 2011).  B. thuringiensis has been widely deployed 
against P. xylostella, particularly in South East Asia.  Here the climate, as well 
as being favourable for crop growing, allows at least 12 P. xylostella 
generations a year (Koshihara and Yamada 1981).  The short generational turn-
over and large population sizes mean that resistance in P. xylostella can 
emerge rapidly and it was the first species to show resistance to B. thuringiensis 
products in the field (Tabashnik, Cushing et al. 1990). 
While resistance can appear through heritable behaviour such as 
avoiding high levels of B. thuringiensis (Aronson and Shai 2001, Schulenburg 
and Muller 2004), it appears primarily to be a result of shape changes to, or 
deletion of, receptors to which the toxin binds (de Almeida Melo, Soccol et al. 
2016).  Within P. xylostella, Park was able to identify 52 genes that coded for 
cadherins or highly similar proteins, but only absence of the midgut-expressed 
one reduced toxin susceptibility (Park, Herrero et al. 2015).  However, Cry 
toxins can still cause mortality in P. xylostella carrying the same cadherin 
mutations which confer resistance in the bollworms Pectinophora gossypiella 
and Helicoverpa armigera (Morin, Biggs et al. 2003, Xu, Yu et al. 2005, Baxter, 
Badenes-Perez et al. 2011).  Instead, based on genetic mapping it is likely that 
resistance for the Plutella-targeting Cry1Ac toxin is actually linked to the abcc2 
gene (Baxter, Badenes-Perez et al. 2011); transforming Drosophila cells to 
express moth abcc2 receptors but not cadherins also renders them susceptible 
to Cry1Ac (Stevens, Song et al. 2017).  As changes to a receptor’s structure 
could be the result of a single nucleotide polymorphism, large host populations 
and short generations mean that such a mutation is highly likely to occur and 
quickly sweep to fixation once it does.  This appears to be the case in the field, 
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as resistance to Cry toxin-based transgenic crops is far more widespread than it 
was a decade ago (Tabashnik and Carriere 2017).  While resistance 
management techniques like refugia can help limit the emergence of resistance 
(Tabashnik, Gassmann et al. 2008), it is unlikely that only a small pool of 
applicable B. thuringiensis strains and toxins will be sufficient in the future. 
 
Ecology and Phylogeny 
 
The ability of B. thuringiensis to kill susceptible invertebrates through its 
Cry toxins is well established but there is still some debate about whether 
growth in a host is essential to the life-cycle of B. thuringiensis, i.e. if it is an 
obligate pathogen (Jensen, Hansen et al. 2003, Raymond, Wyres et al. 2010).  
This has remained an issue because of the phylogeny of B. thuringiensis and its 
ubiquity in the environment.  As B. thuringiensis can be isolated readily from 
soils and leaves alongside B. cereus, while cadavers are rarely encountered, it 
has been suggested that entomocidal activity is incidental and most vegetative 
B. thuringiensis growth happens in the wider environment (Jensen, Hansen et 
al. 2003, Hendriksen 2016).  However, this has been countered by the fact that 
much of the B. thuringiensis in the soil may be there as spores or associated 
with nematodes (Ruan, Crickmore et al. 2015).  While some strains do possess 
Cry toxins that are nematocidal (Schulte, Makus et al. 2010, Kho, Bellier et al. 
2011) strains may also rely on nematodes to move them through soil and into 
contact with suitable hosts.  This could occur through direct nematode-insect 
contact or by moving spores to plants where they are more likely to be 
consumed by potential hosts (Ruan, Crickmore et al. 2015), as it appears that 
B. thuringiensis spores can be preferentially moved to seedlings from the soil, 
though the mechanism is currently unclear (Monnerat, Soares et al. 2009, 
Raymond, Wyres et al. 2010). 
There is also confusion over whether B. thuringiensis should be 
considered separate from B. cereus sensu stricto.  The morphological 
similarities of B. thuringiensis to B. cereus made it easy to identify the two as 
sister species in a pre-genomic world, with Cry toxin possession a clear marker 
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to separate them.  In turn, serological responses to H-flagellin proteins were 
used to group together different B. thuringiensis isolates (Lecadet, Frachon et 
al. 1999).  There were exceptions to the apparently neat classification of B. 
thuringiensis, with some isolates lacking crystals but still responding to B. 
thuringiensis-specific serotyping (Lecadet, Frachon et al. 1999).  The fact that 
only plasmid-encoded Cry toxins were needed for identification meant that B. 
thuringiensis and B. cereus strains could be otherwise identical at the 
morphological level (Helgason, Okstad et al. 2000, Priest, Barker et al. 2004).  
As Cry plasmids could be gained and lost through horizontal transfer (Meric, 
Mageiros et al. 2018) then the clear distinction between the two species 
appeared to break down. 
The revolution in genome-wide sequencing has fully removed the B. 
thuringiensis-cereus divide as it was previously understood.  Full genome 
sequencing of all available isolates in the B. cereus group showed that B. 
thuringiensis does not form a single clade either as a sister to or within B. 
cereus – instead B. thuringiensis strains are distributed through the B. cereus 
group (Priest, Barker et al. 2004, Didelot, Barker et al. 2009).  Notably, the other 
species thought to be closely related, B. anthracis, maintains its monophyletic 
grouping when scrutinised with genome sequencing.  The rest of the B. cereus 
group splits into clades, starting from work with sequence types based off seven 
alleles (Priest, Barker et al. 2004): Clade 1, containing the B. anthracis sub-
clade and the majority of B. cereus, clade 2 with the majority of B. thuringiensis 
and clade 3 mainly containing Bacillus weihenstephanensis and Bacillus 
mycoides.  As B. thuringiensis strains are found in clade 1 and 2, the existing 
species is polyphyletic so an alternative is required.  There are two solutions, 
with the simplest being to discard B. thuringiensis as a species altogether and 
note which B. cereus strains possess Cry toxins.  The second is to examine 
further the distribution of B. thuringiensis in the B. cereus clades and look for 
other factors that might distinguish them.  If B. thuringiensis is an 
entomopathogen and B. cereus primarily a soil saprophyte (Raymond, Davis et 
al. 2007, Didelot, Barker et al. 2009) it may be that clades’ ability to grow in 
these environments could be linked to separate species.  Maintaining the B. 
thuringiensis species in some form may be useful if this is the case – B. 
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anthracis remains a separate species because its divergence from B. cereus 
lines up with important epidemiological differences. 
From a commercial standpoint, how B. thuringiensis is classified has 
implications for its regulation and use.  Clade 2 contains the currently 
commercialised strains such as kurstaki and aizawai (Zheng, Gao et al. 2017) 
and these could be a starting point for experimental evolution to produce or 
identify novel toxins or strains, as attempted here.  The existing classification of 
B. thuringiensis means it includes strains in clade 1 which have products that 
bind to B. anthracis antigens and others that are closely related to B. cereus 
strains causing emetic food poisoning (Cachat, Barker et al. 2008, Didelot, 
Barker et al. 2009).  In particular, the cereulide toxins that cause emetic food 
poisoning are also plasmid-borne so there are fears in the European Food 
Safety Authority that commercial B. thuringiensis strains could become human 
pathogens through horizontal transfer (EFSA 2016).  However, this ignores the 
fact that the clade 2 strains used on crops are not closely related to the clade 1 
emetic strains.  Clade 2 having a distinct ecology as an obligate insect 
pathogen would also mean there are no opportunities for horizontal exchange of 





Virulence in pathogens generally can be seen as the fitness cost to the 
host of infection, although difficulties in measuring this accurately mean it is 
often reframed as the pathogen-induced mortality rate (Bull 1994).  Earlier work 
considered the extent to which a pathogen’s virulence might change as it 
adapted to a host e.g., myxomatosis (myxoma virus) becoming progressively 
less virulent after its initial release into Australian rabbit populations (Kerr 2012).  
This thinking forms part of the virulence-transmission trade-off theory (Frank 
1996, Levin 1996, Galvani 2003).  For myxomatosis this explained transmission 
increasing at the expense of virulence: if viral mortality takes longer there is 
increased chance of transmission to other hosts, so less virulent strains should 
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become more prevalent over time.  However, the trade-off also suggests that 
pathogens can become more virulent given appropriate conditions.  If a 
pathogen reproduces slowly (low virulence) it may not reach sufficient densities 
for successful transmission e.g., blood pathogen levels might be too low to 
ensure uptake by a vector, or the infection might be cleared by the host immune 
system before transmission occurs (Frank 1996).  Increased virulence would 
therefore be selected for to increase transmission (Frank 1996) e.g., attenuated 
vaccines regaining pathogenicity (Bull 1994).  This trade-off can be seen in B. 
thuringiensis with spore numbers highest in cadavers with an intermediate 
infection length (Raymond, Ellis et al. 2009). 
Transmission potential is not the only factor affecting the virulence of 
pathogens.  There is increasing evidence that mixed-strain infections may be 
the rule rather than the exception (Gilbert, Plebanski et al. 1998, Petney and 
Andrews 1998, Lord, Barnard et al. 1999), even down to the level of varied 
plasmid carriage in the same genotype (Medaney, Ellis et al. 2016).  Mixed-
strain infections can occur either as super- or co-infections (Nowak and May 
1994, May and Nowak 1995): in the former, at any one point there is a dominant 
strain in the infection and any strains subsequently colonising the host either 
replace it or are out-competed, with only one strain transmitted; in co-infections 
multiple strains persist at the same time and potentially all can be transmitted 
(Alizon and van Baalen 2008).  Multiple pathogen genotypes add another factor 
to any virulence-transmission trade-off considerations.  A host is a finite 
resource so the faster a strain grows the more of the host it can utilise at the 
expense of competing strains.  Therefore within-host competition would favour 
fast growing, more virulent strains and increase overall virulence under the 
established trade-off theory of virulence (Nowak and May 1994, Frank 1996, 
Gandon, Jansen et al. 2001).  Single-strain infections would instead favour 
more prudent strains where virulence remains low enough to ensure 
transmission before host death.  When tested there is evidence both for (de 
Roode, Pansini et al. 2005, Bell, De Roode et al. 2006) and against (Turner and 
Chao 1999) more virulent strains being favoured under experimental co-
infections (Alizon and van Baalen 2008).  However, this view of virulence does 




Kin Selection & Public Goods 
 
In the last 25 years there has been ever increasing evidence that 
bacteria are highly social, in the sense that there is communication and pooling 
of resources between coexisting cells (Brown and Johnstone 2001, Griffin, West 
et al. 2004, Harrison, Browning et al. 2006).  Many bacteria secrete extra-
cellular products which are ‘public goods’ – while an individual secretes them, 
any local bacteria may benefit from their action.  This is a clear example of kin 
selection, where such sharing is favoured as long as the recipients share the 
same secretory genes and so have a higher level of relatedness than average 
(Rumbaugh, Trivedi et al. 2012).  Pathogenic bacteria produce many secretory 
products including those for sequestering resources from the host, such as iron-
gathering siderophores, or triggering cell death as Cry toxins do (Griffin, West et 
al. 2004, Deng, Slamti et al. 2015).  Bacteria can also secrete quorum-sensing 
molecules for the purpose of determining population density.  Bacteria that 
share the same quorum-sensing mechanism will be more closely related, 
favouring the secretion of pubic goods and allowing group-level control of their 
production (Leggett, Brown et al. 2014); quorum sensing systems oversee both 
secretion of virulence factors and sporulation in B. thuringiensis (Slamti, Perchat 
et al. 2014).  When this system is considered in a host it is clear that close 
relatedness may favour higher virulence, if virulence relies more on production 
of public goods rather than growth rate (Frank 1996).  When bacteria in a host 
are closely related production of public goods required for growth can be 
maintained; at low relatedness non-relatives will benefit from public goods so 
they are not produced, limiting growth and virulence.  This goes further than 
altruistic public goods as bacteria can also show spiteful behaviour to eliminate 
non-relatives (Gardner, West et al. 2004), most commonly via secreted 
bacteriocins and antibiotics (Riley and Gordon 1999).  Clearly, if bacteria limit 
each other’s growth through spite it will reduce overall virulence, both by initially 
reducing bacterial load and by diverting resources away from growth into anti-
competition measures (Gardner, West et al. 2004). 
The social aspect of Cry toxin production provides a possible explanation 
for why the majority of cry genes are maintained on plasmids rather than in the 
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bacterial chromosome.  If B. thuringiensis is an obligate pathogen, with Cry 
toxins crucial to its life cycle, it might be expected that these genes would be in 
the core genome rather than on elements that could be lost more easily.  
However, if cry genes can easily be transferred to other bacteria it may help 
maintain higher levels of genetic relatedness, preventing Cry-null cheats that 
avoid toxin production costs from emerging.  This social transfer explanation 
can be countered by arguing that cheat plasmids might then be favoured in a 
population that exchanged Cry plasmids.  This may be limited in the case of B. 
thuringiensis and other pathogens, as Leggett, Brown et al. (2014) argue the 
population structuring provided by hosts means that horizontal gene transfer 
rates will affect levels of relatedness in different parts of the genome.  Plasmids 
which are readily transferred will be transferred into neighbours and their 
products will only benefit neighbouring cells that now also carry the plasmid.  
This is supported by work in Escherichia coli showing that genes which were 
more likely to be horizontally transferred were also more likely to encode 
secreted products (Nogueira, Rankin et al. 2009), while larger Cry plasmids 





Resistance to B. thuringiensis products and toxins is now a global 
concern (Jorgensen, Aktipis et al. 2018).  To overcome it a combination of 
effective toxins and prudent management of their use e.g., strategies involving 
refugia, will be needed (Tabashnik, Carriere et al. 2003).  As existing toxins 
become less effective one solution is to find or create new ones.  Novel toxins 
may be identified in strains newly isolated from the environment (Roh, Choi et 
al. 2007) although they may then only be tested for activity against a few pest 
species (van Frankenhuyzen 2009).  Alternatively, as more strains are 
sequenced it is possible to search through them for toxin or toxin-like genes that 
have been overlooked so far (Ye, Zhu et al. 2012).  To generate novel toxins 
site-directed mutagenesis has been used to alter existing ones which have 
limited activity against a pest (Kim, Roh et al. 2008, Deist, Rausch et al. 2014), 
25 
 
or regions of the toxin have been removed to restore activity (Soberon, Pardo-
Lopez et al. 2007).  Altered toxins can then be screened via bioassays to see 
whether entomocidal activity has been increased, eventually producing a toxin 
with restored effectiveness.  If there are multiple Cry toxins that produce low 
levels of mortality in a pest, it may be possible to combine them in a 
transformed strain where their effects synergise to produce sufficiently high 
mortality, perhaps because the toxins target different receptors (Emiliano 
Canton, Zanicthe Reyes et al. 2011, Raymond, Wright et al. 2013).  The same 
idea of mix-and-match can also be applied at the Cry protein domain level.  In 
3-domain Cry proteins, exchanging binding domains of a toxin which is effective 
in one species for one with low mortality in another may produce a toxin which 
is now sufficiently effective in the second species (Deist, Rausch et al. 2014). 
In the above methods any novel toxins generated then need to be 
assayed against the target pests.  Depending on the techniques used and initial 
number of proteins there may be a large library of toxins produced, all needing 
their entomocidal activities determined.  Assaying this many products can be 
labourious and time-consuming, even if it may now be possible to automate 
much of it, and there is no guarantee that any effective toxin will be identified.  
These problems can potentially be circumvented by directed experimental 
evolution.  In its simplest form this means exposing a resistant pest population 
to intermediate doses, recovering spores from pests that die and then growing 
them up to infect further resistant pests.  This should mean that only bacteria 
generating higher mortalities are selected and brought forward for the next 
round of infection.  Ideally, such increases in mortality would result from 
changes to the Cry toxins, though it may be the case that toxin production or 
other virulence factors are upregulated instead.  If resistance appears through 
conformational changes to a toxin receptor to prevent binding (Ayra-Pardo, 
Raymond et al. 2015) a complementary conformational change in the toxin 
could be sufficient to restore entomocidal activity.  Rounds of selection could 
then bring to prominence any sequence variation that restores toxin 
effectiveness.  However, it could be that a restorative mutation is not already 
present within the population, or it might require multiple mutations to reach the 
desired effectiveness.  In either case, there is insufficient variation present and 
waiting for it to emerge may exceed an appropriate timescale. 
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A lack of variation could be solved by combining mutagenesis and 
directed experimental evolution.  Mutagenesis should greatly increase variation 
within a B. thuringiensis population, while combining it with selection limits the 
need to isolate many different bacteria or toxins and bioassay them all.  
Sufficient rounds of selection could result in bacterial lineages that have 
insecticidal activity orders of magnitude greater than the ancestral strain (Ebert 
1998).  Beyond this theoretical basis there are multiple variables that can be 
explored in an attempt to maximise the success of the process e.g., how many 
rounds of selection and mutagenesis are required or how should bacteria be 
recovered and processed between rounds?  Afterwards sequence comparisons 
with the ancestor can determine whether any increase in virulence is the result 
of changes in cry genes or the result of some other change such as up-
regulation of toxin production.  While a strain producing more toxin could be 
useful as a biopesticide, it would be less so when looking for new cry genes to 
trial in transgenic crops. 
A selection protocol as outlined above assumes that any bacteria 
isolated between rounds will be from the lineages of interest, but this is by no 
means a certainty.  As the mutagenesis process creates high variation within 
the infecting population there should effectively be a co-infection within the host.  
Biopesticide applications of B. thuringiensis could also result in mixed 
infections, with sprayed spores being consumed alongside naturally-occurring 
spores already on crops.  Competition experiments show that infecting hosts 
with multiple strains of B. thuringiensis can result in all strains being recovered 
from cadavers, meaning that co-infection generally occurs rather than super-
infection (Raymond, Davis et al. 2007).  Therefore infecting a host with a pool of 
non-clonal bacteria (as with the combination of mutagenesis and selection) also 
results in a co-infection.  Recovery of multiple strains may partly be a product of 
the speed of infection as mortality in P. xylostella second-instar larvae occurs 
within four days of infection. 
Trade-offs have already been raised in regards to mortality versus 
transmission, but there are others to consider.  Cry toxins are public goods and 
require energy that could otherwise be spent on reproduction, so there is a 
selective advantage to losing Cry toxin production when producers are common 
(Raymond, West et al. 2012).  As highlighted this can lead to a ‘tragedy of the 
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commons’ situation where, if there are sufficient cheats, insufficient Cry toxin is 
produced to establish a successful infection.  Even if there are no Cry-null 
cheats, variation in the insecticidal activity of toxins for different clonal groups 
might correspond with variation in haemolymph growth or sporulation rate.  This 
is a potential stumbling block when trying to select for increased entomocidal 
activity.  While toxins alone are sufficient to cause mortality via breakdown of 
the midgut lining, the ensuing septicaemia from bacteria growth in the 
haemocoel also contributes (Johnston and Crickmore 2009).  While cadavers 
may contain clones with high insecticidal activity there may be others present 
which lack effective toxins but are able to sporulate more rapidly, increasing 
their proportion of the population for the next round.  Conversely, while co-
infections are possible, the dynamics of competition between clones within 
cadavers (van Leeuwen, O'Neill et al. 2015) suggests that low relatedness may 
not be a barrier to experimental evolution of increased virulence.  This is 
encouraging as high relatedness may favour the cooperation necessary for 
higher virulence, but in turn it could limit the variation required for selection to 
increase virulence further.  In any case, experiments can address this issue and 




Exploring the outcomes of within host-competition for B. thuringiensis 
strains will aid understanding of the trade-offs between toxin production and 
competitive ability.  While this knowledge should be valuable in its own right it 
will also help to inform conditions when attempting selective passages to 
produce improved entomocidal activity.  Most obviously, there is a wide body of 
existing work suggesting that the level of relatedness between pathogens in a 
host is central to the production of public goods and growth (Brown, Hochberg 
et al. 2002, Griffin, West et al. 2004, Garbutt, Bonsall et al. 2011, Deng, Slamti 
et al. 2015).  As Cry toxins are public goods and high growth rates correspond 
to septicaemia then both principal components of B. thuringiensis entomocidal 
activity should be linked to within-host relatedness.  Levels of relatedness in an 
infection can be varied by infecting with a single clone, multiple clones of the 
28 
 
same strain or multiple distinct strains.  Different strains carry different Cry toxin 
plasmids so mixed infections could also provide an opportunity to shuffle 
plasmids, potentially giving rise to new Cry toxin combinations (Zheng, Gao et 
al. 2017).  Likewise, bringing different Cry toxin genes together may give novel 
domain combinations through recombination and domain shuffling (Bosch, 
Schipper et al. 1994, de Maagd, Weemen-Hendriks et al. 2000).  If mixed 
infections persist as co-infections then the door is open to explore how 
competition during selection can affect attempts to select for high entomocidal 
activity during rounds of experimental evolution.  Levels of relatedness could be 
further controlled by altering the levels of spatial structuring in a host, which is 
most easily achieved by altering the number of spores in an infective dose. 
The effects of relatedness are best explored before adding variables 
such as mutagens to the selection process.  Use of mutagens will increase 
variation within the infection and correspondingly decrease relatedness.  If 
relatedness does interact with artificial selection for greater insecticidal activity, 
then this needs to be considered and accounted for in any subsequent selection 
experiments that also include mutagens. 
Growth experiments with strains from B. cereus group clades 1, 2 and 3 
and competitions between B. thuringiensis strains in clades 1 and 2 will aim to 
highlight the differences in ecology between the clades, including specialisation 
of clade 2 B. thuringiensis as insect pathogens.  Any ecological differences 
identified will reflect the genetic separation of clade 2 from the majority of B. 
cereus strains in clade 1.  This may appear a distinct issue from factors 
affecting the evolution of B. thuringiensis virulence and Cry toxin improvement, 
but the two are interlinked biologically and commercially.  That there is still 
confusion over whether B. thuringiensis is an obligate pathogen or whether B. 
cereus is only a generalist soil saprophyte shows the ecology of this group is 
not fully understood.  It would be unwise to carry out selection experiments 
without a better understanding of which growth conditions are most appropriate 
or how factors such as sporulation might interact with experimental conditions 
and trait targeted for selection.  Confirming the specialisation and separation of 
clade 2 strains may also temper current unease about B. thuringiensis spore 
use on food crops.  
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I: Ecology of Bacillus thuringiensis 
 
Abstract 
Phylogenetic distinctions and taxonomy are extremely important for 
applied microbiology, as names are expected to summarise biological attributes 
and therefore hazard.  The Bacillus cereus group encompasses a wide range of 
environmental and pathogenic isolates, including the aetiological agents of 
anthrax and lethal food poisoning, as well as the entomopathogen Bacillus 
thuringiensis, which is widely exploited in insect pest management.  
Characterising the niches of different members of this group can identify the 
ecological factors that might affect the prevalence of aetiological agents of 
disease.  In addition the extent of the ecological distinctiveness of the different 
members is extremely important in informing the potential hazards involved in 
exploiting member species such as B. thuringiensis. 
Here the hypothesis that B. thuringiensis constitutes a distinctive and 
ecologically specialised group of invertebrate pathogens was tested.  In 
addition, whether B. cereus and the predominantly environmental species 
Bacillus weihenstephanensis are better adapted to exploit soil or plant derived 
nutrients than these putative pathogens was tested.  In contrast to some 
previous work, all species could only grow vigorously in protein-rich media.  
Importantly, phylogenetic clade, in addition to nominal species, was an 
important predictor of growth in insects and of thermal profiles in growth rate 
and productivity, although anthracis clade isolates did not show the expected 
ability to grow at 37°C, which is characteristic of vertebrate pathogens.  
However, these data are consistent with the hypothesis that B. cereus isolates 
have evolved from a necromenic (cadaver-specialised) ancestor. 
Characterising species solely on the basis of secondary metabolism, 
especially when these traits are encoded on mobile elements can mean that 
species names are poor predictors of broad biological traits.  In contrast data-
rich phylogenetic analyses, based on readily available genomes, are more likely 





The Bacillus genus contains Gram-positive, aerobic, spore-forming 
bacteria (Maughan and Van der Auwera 2011, Liu, Lai et al. 2015).  Many 
clinically and economically important bacteria are in the Bacillus cereus species 
group, including: Bacillus cereus sensu stricto (strains of which can cause 
severe emetic food poisoning), Bacillus thuringiensis and Bacillus anthracis 
(anthrax) (Papazisi, Rasko et al. 2011).  There are up to eight further species in 
the group, including Bacillus weihenstephanensis (Papazisi, Rasko et al. 2011, 
Liu, Lai et al. 2015).  Prior to the sequencing age these species were defined 
based on their morphology and biochemistry, as were many other bacteria 
(Gupta and Maiden 2001, Priest, Barker et al. 2004, Papazisi, Rasko et al. 
2011, Zheng, Gao et al. 2017).  In principal B. thuringiensis is defined by its 
production of crystalline delta-endotoxins (Cry toxins) (Aronson and Shai 2001, 
Vilas-Boas, Peruca et al. 2007) and associated mortality in insects, while B. 
anthracis is recognised by its possession of pXO plasmids and associated 
capsule and toxin, and anthrax epidemiology in mammals, among other traits 
(Okinaka, Pearson et al. 2006, Kolsto, Tourasse et al. 2009).  B. 
weihenstephanensis is defined by its psychrotolerance (growth below 7oC but 
not above 43oC) (Soufiane and Cote 2010) while B. cereus is as much defined 
by the absence of these characteristics as it is by any one particular trait. 
As the main identifiers of B. thuringiensis and B. anthracis are plasmid-
borne, arguments have been made that chromosomally these bacteria are 
indistinguishable from B. cereus (Helgason, Okstad et al. 2000).  Indeed curing 
them of their plasmids makes them morphologically identical to B. cereus 
(Helgason, Okstad et al. 2000), although subsequent phylogenetic analyses 
based on DNA sequences rather than band mobilities have not repeated the 
detailed findings of the Helgason paper (Priest, Barker et al. 2004).  The 
question then becomes whether there is anything within the genomes or 
ecology of these species that sufficiently distinguishes them, or if they should all 
be considered the same.  This has led to some disagreement over the identities 
and relatedness of B. cereus group species (Liu, Lai et al. 2015).  However, 
conflating B. cereus and thuringiensis has important implications for food safety 
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regulation because B. thuringiensis is in regular use on food crops while many 
strains of B. cereus can cause food poisoning, with those carrying cereulide 
toxin plasmids potentially being the most severe (Dierick, Van Coillie et al. 
2005, Arnesen, Fagerlund et al. 2008). 
What defines a species is not only a concern within Bacillus, but 
throughout the prokaryote phyla (Rossello-Mora 2003).  In eukaryotes Mayr’s 
biological species concept is sufficiently robust to demark species and is based 
on there being barriers to genetic exchange between organisms in different 
species (Mayr 1944, Cohan 2002).  This was constructed with sexual 
reproduction in mind, but can be adapted to fit a hypothetical bacterial species.  
In a fully clonal population any single lineage could be construed as a species 
as there is complete reproductive isolation.  However, the increasing volume of 
sequence data has made apparent that the majority of bacteria do exchange 
genetic material, whether directly or not (Ochman, Lawrence et al. 2000, 
Ochman, Lerat et al. 2005).  This gives a way of labelling bacterial species in 
line with the biological concept, as one could argue that bacteria can only 
exchange genetic material with sufficiently close relatives i.e. within the same 
species.  The B. cereus group shows reasonably high levels of recombination – 
more than Gram-positive Staphylococcus aureus, although recombination 
contributes less genetic change than point mutations but has a greater effect on 
the genome (Didelot, Barker et al. 2009).  These recombination events appear 
to be mainly intra-clade with incorporation of material from outside the group 
rarer except in clade 1 (Didelot, Barker et al. 2009).  Sequence data also show 
that genetic distance between exchangers can vary greatly across bacteria 
(Didelot and Maiden 2010), so this cannot be a universal method for splitting 
bacterial species as is. 
In general, bacterial species are now defined on overall genetic similarity.  
This started with DNA-DNA hybridisation in the 1960s, with >70% similarity 
placing isolates in the same species (Richter and Rossello-Mora 2009, Peak, 
Duncan et al. 2011).  More efficient modern techniques have used comparisons 
in silico, focusing on the similarity of single, highly conserved genes, such as 
16S rRNA (>97%) (Cohan 2002) or comparing across whole genomes via 
average nucleotide identity (ANI; with >95% corresponding to the >70% required 
by DNA-DNA hybridisation) (Richter and Rossello-Mora 2009, Chan, Halachev 
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et al. 2012).  Sticking rigidly to these barriers may not be a viable solution either 
– returning to Bacillus, the currently defined species within the B. cereus group 
cannot always be separated along these lines.  Early sequencing efforts 
suggested that together they share at least 99% 16S rRNA sequence similarity 
(Ash, Farrow et al. 1991, Bavykin, Mikhailovich et al. 2008) which would group 
them together.  However, subsequent efforts using the more comprehensive 
techniques like ANI give sufficient separation between B. cereus group clades 
for them to be maintained as distinct species: <92% ANI between isolates of 
clades 1 and 2, but >95% within clade 2  (Zheng, Gao et al. 2017). 
The methodologies using a wider amount of sequence information agree 
on their revised broad phylogenetic structure of the B. cereus species group 
(figure 1.1):  B. anthracis strains fall neatly into their own clonal grouping, as an 
offshoot of a larger B. cereus sensu stricto-heavy clade (clade 1 or ‘anthracis’ 
group); this leaves a clade containing the majority of B. thuringiensis isolates 
(clade 2 or ‘thuringiensis’ group) and a primarily B. weihenstephanensis clade 
(clade 3 or ‘weihenstephanensis’) (Priest, Barker et al. 2004, Didelot, Barker et 
al. 2009, Zheng, Gao et al. 2017).  Note that these three clades are sexually 
isolated to a degree (Didelot, Barker et al. 2009).  The main difficulty principally 
comes from some strains (as currently labelled) not falling into the 
appropriate/expected clades e.g., some B. thuringiensis strains group with the 
majority of B. cereus strains in clade 1 (figure 1.1) (Didelot, Barker et al. 2009).  
This disorder has partly led to safety concerns being raised about B. 
thuringiensis, both in the past (Bavykin, Mikhailovich et al. 2008) and recently 
by the European Food Safety Authority (EFSA 2016).  This is primarily because 
some Cry toxin-possessing strains in clade 1 are closely related to enteric B. 
cereus strains that can cause emetic food poisoning and may themselves be 
capable of causing enteric diarrhoea (EFSA 2016), while strains carrying Cry 
toxins isolated from burn wound infections and bacteraemia have also raised 
concerns (Damgaard, Granum et al. 1997, Han, Xie et al. 2006, Kuroki, 
Kawakami et al. 2009).  Returning to sequence-based phylogeny of the B. 
cereus group, these fears appear misguided as all the highly insecticidal strains 
of B. thuringiensis (i.e. the ones used for agricultural pest control) are found in 
clade 2, making them genetically distant from the potentially troubling strains 




Figure 1.1: Clade relationships within the B. cereus species group.  B. 
thuringiensis strains are highlighted in green, showing that while the majority 
are in clade 2, some are found in clade 1 (the anthracis group). 
 
As an alternative to the strict divisions expected by the biological species 
concept and the problems distinct names appear to have caused, Cohan 
proposed the idea of ‘ecotypes’ for prokaryotes (Cohan 2002).  These ecotypes 
consist of populations of bacteria that, while they might not meet DNA-DNA 
hybridisation requirements, do occupy distinct niches.  Even if the clades within 
the B. cereus group were not sufficiently far enough apart, then their different 
niches (e.g., B. thuringiensis being a specialised insect pathogen) should be 
enough to separate them as distinct ecotypes.  Others have also proposed that 
phenotype still inform species when hybridisation limits are not fully met (Logan, 
Berge et al. 2009).  However, the status of B. thuringiensis as an obligate 
pathogen has also been questioned in the past (Broderick, Raffa et al. 2006) – 
in part from supposed lack of differentiation from B. cereus (Helgason, Okstad 
et al. 2000).  However, as mentioned improved sequence comparison 
techniques across more data are now providing clearer support for distinct 
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clades (Priest, Barker et al. 2004, Didelot, Barker et al. 2009, Raymond, Wyres 
et al. 2010).  Any genetic differences between clades that do exist should be as 
a result of the requirements of their different ecologies, as only around 80% of 
chromosomal genes occur in both (Hendriksen 2016). 
 Whether or not an ecotype-based solution is appropriate to solve the 
classification of B. thuringiensis and B. cereus, there is still disagreement over 
what constitutes the principal niche of B. cereus.  If B. cereus can be found in a 
wide variety of possible niches (pathogen, commensal, symbiote, saprophyte or 
necrotroph) (Jensen, Hansen et al. 2003, Hendriksen 2016), then the 
entomocidal role of B. thuringiensis could more easily be seen as just another 
niche.  In this instance B. thuringiensis would only be another ecotype and 
possibly no more worthy of individual species designation than any other.  
Genome comparisons show a distinct clade 2 containing the majority (and most 
highly insecticidal) of the B. thuringiensis strains (Zheng, Gao et al. 2017) while 
other clades in the B. cereus group can be broadly linked to particular habitats 
based on their most likely source of isolation (Raymond, Wyres et al. 2010).  
While many of the B. cereus strains in clade 1 carry genes permitting a 
pathogenic lifestyle (such as emetic cereulides) and can be isolated from 
infections (Ehling-Schulz, Fricker et al. 2004, Arnesen, Fagerlund et al. 2008), 
the majority of other B. cereus group strains are isolated from soil (Raymond, 
Wyres et al. 2010).  Following this there is growing evidence that the source of 
isolation will predict the clade of the strain.  It could be that human pathogenic 
strains of B. cereus are on the first steps of the path taken by B. thuringiensis 
and B. anthracis which is supported by the clonal grouping of most emetic 
strains (Didelot, Barker et al. 2009).  Association with a particular virulence 
factor opens up a pathogenic niche in a host and over time specialisation leads 
to a distinct pathogenic clade (Daffonchio, Raddadi et al. 2006) – the highly 
clonal nature of B. anthracis might suggest that it is less far down this route than 
clade 2 B. thuringiensis (Priest, Barker et al. 2004).  Loguercio and Argolo-Filho 
(2015) suggest that human action, through the proliferation of agriculture and 
associated crops, may have favoured the emergence of entomocidal B. 
thuringiensis. 
 B. thuringiensis can be easily isolated from soil (Nicholson 2002), which 
could support it being able to grow there and has previously been raised as a 
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point against its status as an obligate pathogen.  However, this overlooks a 
defining feature of Bacillus – they can form highly resistant endospores 
(Alcaraz, Moreno-Hagelsieb et al. 2010, Liu, Lai et al. 2015).  It is therefore 
unsurprising that B. thuringiensis can be isolated from soil even if it does not 
proliferate there; this presents another aspect of its ecology that could be 
explored.  B. thuringiensis in the soil needs to be ingested by an insect to 
successfully reproduce, but any host is most likely herbivorous as most are 
lepidopteran or coleopteran larvae.  It would therefore be highly advantageous 
to B. thuringiensis if it could be selectively recruited from soil to leaves via 
plants.  In turn this scenario could be selected for in plants as it would provide 
an additional defence against insect herbivory and the potential for some level 
of symbiosis (Smith and Couche 1991, Elliot, Sabelis et al. 2000, Aronson and 
Shai 2001).  Comparisons between B. thuringiensis, B. cereus and B. 
weihenstephanensis in greenhouse experiments with cabbage have shown that 
B. thuringiensis is selectively recruited to leaves at a higher rate than the others, 
though all three can be recruited (Raymond, Wyres et al. 2010). 
If B. thuringiensis is a specialised insect pathogen then it should also 
possess a suite of genes that better facilitate this lifestyle, compared to B. 
cereus.  The obvious example would be the Cry toxins, along with other 
virulence factors such as vegetative insecticidal proteins.  However, these 
characteristics contributed to the existing classification knot because of their 
propensity for being plasmid-borne and so potentially lost or transferred through 
the group (Ceuppens, Boon et al. 2013, Liu, Lai et al. 2015).  Cry toxins break 
down the midgut epithelium allowing bacteria to enter the haemocoel.  There 
must therefore be other genes that have been selected to allow/increase 
vegetative growth in the haemolymph, through sequestering and processing the 
available metabolites while also defending against or avoiding the host immune 
system (Fedhila, Daou et al. 2006) e.g., genes involved in kurstakin production, 
a peptide required for cadaver growth (Dubois, Faegri et al. 2012).  Conversely, 
strains currently labelled B. thuringiensis in clade 1 may have only recently 
acquired their Cry toxins, with the rest of their genes the same as in sister B. 
cereus strains.  This would means they are less able to grow in an insect host. 
A previous argument against possession of any insect-specific gene 
suite was that much of the mortality from B. thuringiensis infections was actually 
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a result of other gut bacteria becoming pathogenic once Cry toxins allowed 
access to the haemolymph (Broderick, Raffa et al. 2006).  This was purportedly 
shown by feeding gypsy moth (Lymantria dispar) larvae an antibiotic mixture to 
clear the gut and then unsuccessfully producing mortality with B. thuringiensis 
(Broderick, Raffa et al. 2006).  However, this ignored the fact that antibiotics 
persist in larval tissue after feeding, preventing subsequent B. thuringiensis 
growth and inhibiting pathogenicity (Raymond, Johnston et al. 2009); B. 
thuringiensis is also capable of producing septicaemia alone after direct 
injection into the haemocoel (Johnston and Crickmore 2009).  If Cry toxins were 
the sole contributors to B. thuringiensis pathogenicity this might instead suggest 
that B. thuringiensis would do as well when grown in non-insect conditions more 
common to the rest of the B. cereus species group (Hendriksen 2016). 
Adaptation to within-insect growth can be explored experimentally by 
comparing in vivo growth between clade 1 and 2 strains, with the expectation 
that clade 2 strains will be fitter.  However, this is complicated by the fact that 
different strains will potentially have different Cry toxin suites – any apparent 
fitness differences might only be a result of whether or not an infection can be 
established, rather than actual differences in haemolymph growth.  This can be 
mitigated by carrying out all infections alongside a common competitor B. 
thuringiensis strain that has highly effective toxins against the host 
(diamondback moth, Plutella xylostella).  Doing so ensures that all treatment 
strains can successfully access the haemolymph and means that relative fitness 
of strains can be used to assess their adaptation to growth in insect hosts.  The 
degree of host specialisation should go hand in hand with different temperature 
preferences across the B. cereus species group.  If B. thuringiensis is an insect 
pathogen, B. cereus primarily necromenic and B. weihenstephanensis is soil-
based then different temperature growth profiles should be expected for each 
clade.  Guinebretière, Thompson et al. (2008) have already argued that 
“modification of temperature tolerance” has helped shape the evolution of the B. 






B. cereus growth comparisons across potential niche-simulating media 
Three B. cereus, five Cry-null B. thuringiensis and seven B. 
weihenstephanensis strains (table 1.a) were streaked from -80oC stocks, single 
colonies picked and grown overnight in 5ml 2% LB at 30oC with 150rpm shaking.  
The B. thuringiensis strains used were Cry-null strains to give a fair growth 
comparison with B. cereus and B. weihenstephanensis strains that do not have 
the potential metabolic handicap of toxin production.  Overnight cultures were 
then diluted to 10-3 in saline (0.85% NaCl), and 10µl added to 200µl of growth 
medium in three wells of a 96-well plate for each strain, with well order 
randomised.  Six different media were used, with one plate for each.  Plates 
were incubated in a plate reader (Thermo Fisher Scientific Inc. Varioskan Flash) 
at 26oC for 24 hours with OD600 readings taken every 2mins with shaking before 
each reading. 
Bacillus species Strain / isolate Source 
B. cereus B. cereus type-strain ATCC 11778 
B. cereus (wild-type isolate) BGSC 6A4 
B. cereus enterotoxic NCTC 11145 
B. thuringiensis israelensis Cry- BGSC 4Q7 
B. thuringiensis sotto Cry- BGSC 4E5 
B. thuringiensis kurstaki Cry- BGSC 4D7 
B. thuringiensis thuringiensis Cry- BGSC 4A12 
B. thuringiensis kurstaki Cry- BGSC 4D22 
B. weihenstephanensis ST 353 Raymond 
B. weihenstephanensis ST 417 Raymond 
B. weihenstephanensis (wild-type isolate) BGSC 6A50 
B. weihenstephanensis (wild-type isolate) BGSC 6A21 
B. weihenstephanensis vazensis BGSC 4CE1 
B. weihenstephanensis navarrensis BGSC 4BM1 
B. weihenstephanensis (wild-type isolate) BGSC 6A46 
 
Table 1.a: Bacillus species and strains used in media growth experiment.  B. 
weihenstephanensis strains vazensis and navarrensis are listed as B. 
thuringiensis on the BGSC but should be reclassified (Soufiane and Cote 2010); 
non-catalogued strains from Raymond, Wyres et al. (2010) 
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Brain heart infusion (BHI; Honeywell International Inc. Fluka) was used 
as it is a protein rich medium and so represents a controlled artificial simulation 
of cadaver.  SESOM (soil-extracted soluble organic matter) is a soil-simulating 
medium (Vilain, Luo et al. 2006) while TREM (tomato root extract medium) 
artificially replicates the nutrients around plant roots (Meyer and Abdallah 1978, 
Lugtenberg, Kravchenko et al. 1999).  SESOM and TREM were produced in 
both base and sugar-enriched forms, and a control version of SESOM was also 
used with the same buffer and sugar enrichment, but no soil – MOPS (3-(N-
morpholino)propanesulfonic acid) (Vilain, Luo et al. 2006).  These media were 
used as artificial representations of the three proposed niches for B. cereus: 
cadavers, the soil and plant roots, with Vmax and productivity calculated from the 
resulting 24 hour growth data.  MOPS medium was used to contrast with 
SESOM media, as the only difference was mixing with soil in SESOM.  The 
MOPS, SESOM and TREM media were produced as follows: 
• MOPS enriched: 100mg glucose, 1mg casein hydrolysate and 1mg 
yeast extract added to 500ml of 10mM pH7 3-(N-morpholino) 
propanesulfonic acid 
• SESOM base: 100g commercial loam-based topsoil (Asda Stores Ltd.) 
mixed in 500ml of 10mM pH7 MOPS via shaking for one hour at 200rpm 
and filter sterilised with 0.2µm filters 
• SESOM enriched: 100mg glucose, 1mg casein hydrolysate and 1mg 
yeast extract added to 1l SESOM base 
• TREM base: 6g K2HPO4, 3g KH2PO4 and 1g (NH4)2SO4 dissolved in 1l 
H2O and autoclaved, then 1ml of filter-sterilised 20% MgSO4 added 
followed by 2.5ml of filter-sterilised stock trace elements solution (0.61g 
MnSO4, 0.1g ZnSO4.7H2O, 1.27g H3BO3, 0.4g Na2MoO4.2H2O, 0.04g 
CuSO4 and 13.5g Fe2 EDTA in 1l H2O) 
• TREM enriched: 50ml of filter-sterilised “root exudate” solution (1g citric 
acid, 0.5g succinic acid, 0.02g malic acid, 0.01g glucose, 0.02g fructose, 






Production of B. thuringiensis spores and marked strains  
A marked B. thuringiensis clone was produced for use as the standard 
competitor in all competition experiments.  B. thuringiensis subsp. kurstaki 7.1.o 
was transformed with the plasmid pHT315 carrying DsRed and tetR for 
tetracycline resistance (Zhou, Slamti et al. 2014).  To produce electrocompetent 
cells for transformation the strain was cultured overnight at 30oC with 150rpm 
shaking in 2% LB broth.  5ml of overnight culture was then added to 500ml pre-
warmed 2% LB in a conical flask and incubated for four hours at 30oC with 
150rpm shaking.  After four hours, 67ml of 50% glycine was added to give 3% in 
the culture, and the culture incubated for an additional hour.  Culture was 
transferred to eight 50ml pre-chilled Falcon tubes and these left on ice for 
5mins.  Tubes were centrifuged at 3,200g and 4oC for 12mins.  Tubes were put 
on ice while supernatant was poured off.  Cell pellets were gently re-suspended 
with 10ml ice-cold buffer ‘F’ (272mM sucrose, 0.5 mM MgCl2, 0.5mM K2HPO4 
and 0.5mM KH2PO4 at pH 7.2) (Peng, Luo et al. 2009).  This was repeated two 
further times, with final resuspension in 500µl of buffer ‘F’ and transferred to a 
pre-chilled Eppendorf.  100µl of electrocompetent cells were added to a pre-
chilled 0.1cm3 cuvette with 2µl plasmid DNA and electroporated at 1.8kV 
(MicroPulser, Bio-Rad Laboratories Inc.).  The cells were then transferred to 
1ml of pre-warmed 2% LB and incubated at 30oC for one hour.  After one hour, 
100µl of culture was spread onto a 10µg/ml tetracycline 2% LB agar plate and 
900µl onto another and incubated at 30oC overnight.  Colonies produced were 
re-streaked on tetracycline plates and viewed under UV light to confirm plasmid 
uptake, and the resulting strain named Btk pHT315-DsRed-tetR. 
 B. thuringiensis strains from clade 2 (n = 11) and clade 1 (n = 6) (table 
1.b) were assessed in thermal profiling and competition experiment.  To 
produce spores each strain was cultured on B. cereus-selective agar (Oxoid 
Ltd.) at 30oC for six days.  After this, spores for each strain were suspended in 
700µl saline, centrifuged at 6,200g for 2mins and then the supernatant 
removed.  This was repeated three times then spores were re-suspended in 1ml 
saline with 0.05% Triton X surfactant.  All dilutions were carried out in saline with 
Triton surfactant, unless stated otherwise.  
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Clade Strain / isolate Source 
1 finitimus BGSC 4B2 
1 kyushuensis BGSC 4U1 
1 monterrey BGSC 4AJ1 
1 pulsiensis BGSC 4CC1 
1 roskildiensis BGSC 4BG1 
1 sotto NRRL B-18679 
2 alesti BGSC 4C3 
2 darmstadiensis BGSC 4M3 
2 entomocidus BGSC 4I4 
2 israelensis BGSC 4Q1 
2 jegathesan NRRL B-23141 
2 kumamtoensis BGSC 4W1 
2 kurstaki 7.1.o Raymond 
2 morrisoni BGSC 4AA1 
2 sotto BGSC 4E3 
2 tenebrionis BGSC 4AA1 
2 thuringiensis BGSC 4A3 
2 thuringiensis BGSC 4A5 
 
Table 1.b: Bacillus thuringiensis subsp. used in competition temperature growth 
experiments.  Strains are split by clade based on analyses in Meric, Mageiros et 
al. (2018); kurstaki 7.1.o from Raymond, Wyres et al. (2010). 
 
Thermal profiling 
The growth rates of the 17 strains were assessed across a temperature 
range.  The strains were grown overnight in 5ml 2% LB at 30oC with 150rpm 
shaking and then diluted 1,000-fold.  10µl of each strain culture was added to 
three wells of 200µl 2% LB in a 96-well plate with wells randomly ordered on 
each plate for 10 plates.  Preliminary work in just LB showed that strains would 
not grow at 50oC and had limited growth at 10oC.  OD600 readings were taken 
every 2mins and plates shaken before each reading.  Plates were grown for 24 
hours at 14, 17, 20, 23, 26, 29, 32, 35 and 38oC in both 2% LB and 2% BHI with 
OD600 readings taken every 2mins and plates shaken before each reading.  




B. thuringiensis competition experiments 
Spore preparations were enumerated by diluting, plating and counting on 
2% LB agar plates after overnight incubation at 30oC.  Spores were diluted to a 
final concentration of 600cfu/µl in sterile H2O.  Btk pHT315-DsRed-tetR was 
used as a standard competitor and to ensure that bacteria can pass into the 
haemocoel of larvae even if the treatment strain lacked effective toxins for the 
experimental host. Btk pHT315-DsRed-tetR spore suspensions were diluted to 
200cfu/µl.  Final suspensions were re-checked before mixing to produce a 
300:100 ratio of experimental strains to Btk pHT315-DsRed-tetR. 
 
In vivo competition 
Plutella xylostella larvae (VLSS population – Cry1Ac-susceptible) were 
raised from surface-sterilised eggs on sterile insect diet until late second-instar 
(Zhou, Alphey et al. 2018).  Eggs were sterilised for 30s in 10% bleach solution, 
then drained and twice washed with sterile H2O, then dried for 15mins in a 
laminar flow hood.  Diet was 90g of dry mix (44.3g wheatgerm, 18.4g casein, 
0.1g inositol, 1.5g sodium propionate, 5.9g Wesson salts, 1.5g sorbic acid, 0.9g 
cholesterol, 1.5g methyl-4-hydroxybenzoate, 0.3g choline chloride, 3g locust 
bean gum, 1.6 cellulose, 1.6g fructose and 9.4g agar) with 420ml demineralised 
water.  After autoclaving, 2g of Vanderzant vitamin mix and 1.8g ascorbic acid 
were each dissolved in 30ml sterile H2O, filter-sterilised and added to cooled 
autoclaved diet.  Diet was poured into 12oz plastic pots (Vegware Ltd.) to 15mm 
depth for insect rearing or 50mm Petris to 5mm depth for experiments and 
allowed to set in a laminar flow hood. Quarters of diet in eight 50mm Petri 
dishes were coated with 100µl of a competition treatment and dried in a laminar 
flow hood.  Ten late second-instar larvae were added to each Petri for 80 per 
treatment.  The Petri dishes were then incubated at 22oC for five days.  After, 
48 cadavers from each treatment were transferred to sterile 1ml microtubes and 
10µl of sterile H2O added to each.  The microtubes were sealed and incubated 
at 30oC for seven days to ensure sporulation.  690µl sterile H2O and sterile 
5mm steel ball bearings were then added to microtubes to lyse cadavers via a 
tissue lyser (Qiagen N.V.), shaking at 1,350rpm for 4.5mins.  The tubes were 
then pasteurised in a 65oC water bath for 25mins and afterwards diluted in 10-
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fold series to 10-6, and 10-3 to 10-6 dilutions plated out on plain and 10µg/ml 
tetracycline 2% LB agar plates for colony counts. 
 
In vitro competition  
These used the same 3:1 treatment mixtures as the in vivo competitions.  
Here, 10µl of each mixture was added to eight wells of 1ml HCO sporulation 
medium in 24-well plates.  HCO sporulation medium was adapted from Lecadet, 
Blondel et al. (1980) and made by adding 7g casein hydrolysate and 6.8g 
KH2PO4 to 1l demineralised H2O, adjusting pH to 7.2 with 2M NaOH and 
autoclaving.  After cooling, 1ml 20% MgSO4.7H2O, 1ml 2
% Fe2(SO4)3, 2.2ml 1
% 
ZnSO4.H2O, 2.2ml 1
% CaCl2.2H2O, 440µl 0.5
% MnSO4.4H2O, 15ml of 20
% 
glucose (from sterile stocks) and two tablets of Polymyxin B were added 
(50,000 IU per tablet, Oxoid Ltd.).  The plates were sealed and incubated at 
30oC with 150rpm shaking for four days to ensure sporulation.  Spores were 
then enumerated by diluting plating and culture plating on LB agar without 
antibiotics and on plates containing 10µg/ml tetracycline. 
 
Statistical analysis 
All bacterial growth experiment (thermal profile and media comparisons) 
were initially analysed in the same manner using RStudio 1.1.456 (based on R 
3.2.5) (R Core Team 2016, RStudio Team 2016).  OD600 data from 24 hour 
growth had growth curve models fitted individually for every plate well, using 4-
parameter logistic models for growth (Crawley 2013).  For wells that would not 
fit this (e.g., those with no/limited growth) a linear model was used.  Fitted 
models provided Vmax (the maximum growth rate) and productivity values for 
each well.  Overall growth curve plots for each clade or species were produced 
by fitting secondary 4-parameter logistic models for all wells of a given set of 
conditions.  Vmax was the maximum slope of the fitted curve.  Production was 
calculated by integrating the model and subtracting the initial media OD600 
value; the initial media value was taken as the first fitted value.  Vmax and 
productivity were analysed via generalised linear models (GLMs). 
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For competitions, cfu/µl values were used to calculate Malthusian 
fitnesses for competitor and treatment strains and these were combined to 
produce relative fitness for the treatment strain in each competition as follows, 
then loge transformed and analysed using GLMs:   













B. cereus group growth comparisons across potential niche-simulating media 
(figure 1.2) 
 Whether different nominal species within the B. cereus species group 
would have enhanced growth (figure 1.3) or productivity (figure 1.4) on media 
that would reflect specialization on protein-rich resources (hosts or cadavers), 
plant-derived nutrients and soil-derived nutrients was tested.  Comparison 
across media showed vastly enhanced growth rates and productivity in protein-
rich BHI compared to soil nutrient (SESOM) and plant nutrient (TREM) artificial 
media.  B. cereus showed significantly faster growth in the protein-rich BHI, but 
this was not reflected in the soil and root media.  Both species and growth 
media had strong main effects on Vmax (F2, 629 = 29.3, p < 6.56x10
-13; F6, 629 = 
497 p < 2x10-16).  Additionally, the media treatment used could be simplified 
down to either BHI or not without losing any explanatory power.  There was also 
a significant interaction effect between species and whether or not the growth 
medium was BHI (F2, 644 = 45.6, p < 2x10
-16) and such an interaction implies that 
there is some degree of specialisation in the species for or against particular 
media, with B. cereus more strongly favouring BHI.  For productivity, only 
whether or not the medium was BHI had a significant effect (F1, 648 = 2940, p < 




Figure 1.2: OD600 24 hour growth of of B. cereus, B. thuringiensis and B. 
weihenstephanensis strains (table 1.a) in protein-based (BHI), soil-simulating 
(SESOM) and plant root exudate-simulating media (TREM).  The lower graph 
excludes BHI protein media to clarify differences between the others. 
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Figure 1.3: Vmax growth rate (OD600 increase per hour) of B. cereus, B. 
thuringiensis and B. weihenstephanensis strains (table 1.a) in protein-based 
media (BHI), soil-simulating media (SESOM) and plant root exudate-simulating 
media (TREM).  The lower graph shows the same data magnified.  NS = not 
significant, *** = p < 0.001. 
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Figure 1.4: Productivity (cumulative OD600 over 24 hours) of B. cereus, B. 
thuringiensis and B. weihenstephanensis strains (table 1.a) in protein-based 
media (BHI), soil-simulating media (SESOM) and plant root exudate-simulating 
media (TREM).  The lower graph shows the same data magnified.  NS = not 
significant, *** = p < 0.001. 
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Thermal profiling of B. thuringiensis clades (figure 1.5) 
The two clades of B. thuringiensis show distinct growth preferences 
across the temperature range and two growth media used.  The growth 
experiment in LB and BHI at 14 to 38oC with 3oC intervals was analysed fully by 
fitting models at the clade level in each medium (tables 1.c and 1.d). 
For productivity (figure 1.6, table 1.c) the effect of temperature on each 
clade could be fitted for graphs using a cubic, and a general additive model with 
6 d.f. for smoothing was used to compare the two clades in each medium.  In 
both media, clade 2 had lower productivity than clade 1 (BHI: F1, 532 = 7.53, p = 
6.27 x 10-3; LB: F1, 529 = 24.4, p = 1.07 x 10
-6), as can be seen in figure 1.6 from 
the lower curves and data points of clade 2. 
For Vmax (figure 1.7, table 1.d) only linear models provided an accurate fit 
for each clade, though when compared they showed that Vmax was not affected 
by clade in either media (BHI: F1, 536 = 2.69, p = 0.102; LB: F1, 533 = 2.10, p = 
0.148).  However, there was an interaction between clade and temperature in 
LB (F1, 533 = 31.2, p = 3.64 x 10
-8), which reflects the alternate slope gradient 
signs for the two clades.  The negative relationship between temperature and 
Vmax for clade 1 does not reflect the pattern seen in productivity; while linear 
models may fit the Vmax data here, they will not reflect growth rates across 





Figure 1.5: 24 hour growth in terms of OD600 of B. thuringiensis strains (table 




Figure 1.6: Productivity (in terms of cumulative OD600 over 24 hours) of B. 
thuringiensis strains (table 1.b) across a temperature range, grouped by clade, 
in BHI and LB media. 
Media Clade Model R2 F p 
BHI 1 Cubic 0.547 74.4 (3, 185 d.f.) < 2.2 x 10-16 
BHI 2 Cubic 0.593 168 (3, 347 d.f.) < 2.2 x 10-16 
LB 1 Cubic 0.496 59.9 (3, 183 d.f.) < 2.2 x 10-16 
LB 2 Cubic 0.567 151 (3, 346 d.f.) < 2.2 x 10-16 
 
Table 1.c: Graph fits for B. thuringiensis clade 1 and 2 productivities across 





Figure 1.7: Vmax growth rates (in terms of OD600 increase per hour) of B. 
thuringiensis strains (table 1.b) across temperature range, grouped by clade, in 
BHI and LB media. 
Media Clade Model R2 F p 
BHI 1 Linear 0.001 0.192 (1, 187 d.f.) 0.662 
BHI 2 Linear 0.119 47.2 (1, 349 d.f.) 3.02 x 10-11 
LB 1 Linear 0.085 17.3 (1, 185 d.f.) 5.00 x 10-5 
LB 2 Linear 0.042 15.2 (1, 348 d.f.) 1.14 x 10-4 
 
Table 1.d: Model fits for B. thuringiensis clade 1 and 2 Vmax across 





B. thuringiensis in vivo competitions (figure 1.8) 
All larvae died in every treatment.  Colony counts on the 2% 10µg/ml 
tetracycline LB agar plates gave cfu/µl for the Btk pHT315-DsRed-tetR 
competitor.  These values were subtracted from those obtained from plain 2% 
LB plates to give cfu/ml values for the clade 1 and 2 treatment strains, from 
which Malthusian and relative fitness were calculated.  If a negative cfu/µl value 
was obtained this was taken as zero. 
 
Figure 1.8:  Graph showing the loge relative fitness of B. thuringiensis strains 
(table 1.b) in competitions in vivo against DsRed- and tetR-tagged B. 
thuringiensis subsp. kurstaki competitor in Cry1Ac-susceptible P. xylostella 
larvae.  All relative fitnesses are from 3:1 competitions, with data points as 




Relative fitnesses were grouped according to treatment strain clade and 
loge transformed to account for the asymmetric nature of relative fitness data 
(as it is bound by 0).  ANOVA of strain loge relative fitnesses by clade showed 
that clade 2 strains had a significantly higher relative fitness than clade 1 strains 
(F1, 647 = 59.9, p = 3.77 x 10
-14) – clade 2 strains had an overall mean loge 
relative fitness of 0.510 compared to 0.223 in clade 1. 
One of the treatment strains used was an untransformed wildtype of Btk 
pHT315-DsRed-tetR.  As expected, the kurstaki isolate did not have a loge 
relative fitness significantly different from 0 (i.e. equally as fit as Btk pHT315-
DsRed-tetR; F16, 647 = 13.0, t = -0.255, p = 0.799).  This also shows that the 
marker plasmid inserted into the standard competitor does not noticeably affect 
its fitness under these experimental conditions. 
 
B. thuringiensis in vitro competitions (table 1.e) 
Overall, clade 2 B. thuringiensis strains were less fit in HCO sporulation 
broth than their clade 1 counterparts.  The in vitro competitions could not be 
analysed via relative fitness, as in eight of the competitions only one of the two 
strains could be recovered on plates after incubation.  In competitions where 
only Btk pHT315-DsRed-tetR could be recovered the cultures were noticeably 
red in colour after incubation.  Relative fitness is meaningless with only a single 
strain present, so competitions were assessed solely on which of the treatment 
or competitor strains was more common or the only survivor when plated out.  
The more common/surviving strain was therefore taken to be the fitter of the two 
competitors, as shown in table 1.e.  These data produced a contingency table of 
count data and analysis by Fisher’s exact test showed that clade 1 strains were 
significantly more likely to persist in sporulation media at the expense of Btk 
pHT315-DsRed-tetR than clade 2 strains were (n = 152; odds ratio = 8.28, p = 
7.14x10-8).  This supports the hypothesis that clade 1 strains are fitter than 
clade 2 strains in vitro in HCO sporulation broth.  In contrast to the in vivo 
competitions Btk pHT315-DsRed-tetR was less fit than its untransformed 




Fitter than competitor 
in vitro 
Less fit than competitor 
in vitro 
Strain  Clade Strain  Clade 
 pulsiensis 1  sotto B-18679 1 
 kyushuensis 1  alesti 2 
 roskildiensis 1  tenebrionis 2 
 finitimus 1  kurstaki 7.1.o 2 
 monterrey 1  jegathesan 2 
 israelensis 2  morrisoni 2 
 kumamtoensis 2  darmstadiensis 2 
 sotto 4E3 2  thuringiensis 4A3 2 
 thuringiensis 4A5 2     
 
Table 1.e:  Fitness of B. thuringiensis strains (table 1.b) by clade when 
competed against the Btk pHT315-DsRed-tetR competitor in vitro in HCO 
sporulation media.  Relative fitness values could not be obtained in 
competitions where only one strain persisted to the end.  Fitter strains either 
gave higher relative fitness values than the competitor, or persisted at the 
expense of the competitor, with the opposite the case for less fit strains. All 





The three Bacillus cereus-group species all grew significantly faster with 
significantly higher production in Brain and Heart infusion.  Within the presumed 
B. cereus and thuringiensis species the phylogenetic clade of strains 
significantly affected overall in vivo growth in P. xylostella, with clade 2 strains 
being relatively fitter, along with their temperature-dependent growth rate and 
productivity. Unexpectedly, anthracis clade strains showed decreased ability to 
grow at 37°C, despite this being the characteristic growth temperature of 
vertebrate pathogens.  Overall these data also support the hypothesis that B. 
cereus isolates evolved from necromenic (cadaver-specialised) ancestors. 
 
The comparisons in growth across distinct media types show that the B. 
cereus group require protein, which is unsurprising as they carry many protease 
genes but few for processing carbohydrates, particularly when compared to soil-
dwelling Bacillus subtilis (Rasko, Altherr et al. 2005, Han, Xie et al. 2006, 
Alcaraz, Moreno-Hagelsieb et al. 2010).  Enriching soil-simulating media with 
sugars did not significantly improve growth and there was no clear difference 
between SESOM and TREM.  These findings contrast those by Vilain, Luo et al. 
(2006) that showed clear differentiation between successful growth in SESOM 
and no growth in MOPS.  This previous study also showed growth in base 
SESOM and no lag phase with vegetative cells in enriched SESOM while there 
is in LB.  This was not found here – there was no growth after 24 hours in 
unenriched SESOM.  The enriched SESOM produced very limited growth, but 
this was best modelled as a shallow (s-shaped) 4-parameter growth curve, 
implying there is a lag phase.  Overall this shows that soil or plant nutrient 
simulating media whether simulating just soil (SESOM) or the root-soil interface 
(TREM) do not provide favourable environments for growth.  Previous 
experiments have also suggested this, with B. thuringiensis cells only able to 
sporulate but not grow when added to soil (Yara, Kunimi et al. 1997). 
There are differences between Bacillus species, with B. 
weihenstephanensis growing best and B. thuringiensis worst in both MOPS and 
SESOM enriched media, while B. cereus grew best in BHI.  It is not surprising 
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that B. weihenstephanensis grew most in soil media as it has been 
characterised by its psychrotolerance and isolation solely from soil, plant 
material and food (Lechner, Mayr et al. 1998, Sorokin, Candelon et al. 2006, 
Raymond, Wyres et al. 2010) although its poorer growth in TREM appears to 
run counter to a possible association with plant roots (Dutta, Rani et al. 2013, 
Vidal-Quist, Rogers et al. 2013).  In contrast, B. thuringiensis does not appear 
to reproduce in soil (Vilas-Boas, Vilas-Boas et al. 2000). BHI is produced from 
bovine and porcine organs, and so represents a protein rich resource such an 
invertebrate or vertebrate host or carcass.  As B. cereus can be isolated from 
mammals (Arnesen, Fagerlund et al. 2008), this improved growth relative to B. 
weihenstephanensis is not surprising.  In line with this B. anthracis is more 
specialised as a mammalian pathogen and shows an increased growth rate 
compared to B. cereus across multiple strains in BHI (De Siano, Padhi et al. 
2006).  Overall then, this study found no support for the general hypothesis that 
B. cereus is a soil saprophyte (Jensen, Hansen et al. 2003, Priest, Barker et al. 
2004, Vilain, Luo et al. 2006) although individual isolates may of course vary in 
their propensity to grow in different media; while some differences were found, 
the magnitude of effect sizes tended to be small. 
The thermal profile of different species or clades can also be informative 
as to niche.  If clade 1 bacteria are mammalian pathogens, then these strains 
would be expected to grow efficiently at 37°C.  The fact that growth of both 
clade 1 and clade 2 B. thuringiensis tends to decline as temperatures exceed 
29°C suggested that mammals are not key hosts for these strains.  Previous 
work has shown that there are two relatively deep branches in clade 1 
(Guinebretiere, Thompson et al. 2008).  There appears to be different thermal 
profiles across these two sub-clades, those more closely related to B. anthracis 
grow across a higher temperature range (15-45°C), consistent with the ability to 
infect mammals, while those in the other sub-branch (equivalent to PanC 
genetic group 2) have a lower temperature profile (10-40°C) consistent with the 
majority of the isolates in this study.  Guinebretière also confirms the 
psychrotrophic nature of B. weihenstephanensis, with its ability to grow at low 
temperatures and separation in clade 3 supporting a distinct niche for it as well 
(Guinebretiere, Thompson et al. 2008). 
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This feeds back to the differences in temperature preference of clades 1 
and 2.  If B. cereus is found in/around mammalian cadavers, it may be that 
these cadavers reach different temperatures to insect ones.  A rat is roughly 104 
times larger than a Plutella larva and so may retain sufficient heat from 
decomposition that its temperature remains above ambient.  If clade 1 B. 
thuringiensis strains are B. cereus strains that have recently acquired Cry 
plasmids they may be better adapted to growth in mammalian cadavers, 
reflected by their poorer relative fitness in insects and differing optimal 
temperatures.  The different temperature profiles favoured by B. cereus sensu 
stricto and B. anthracis could be indicative of a necromenic lifestyle for B. 
cereus.  This means that it colonises mammalian cadavers rather than creating 
them from live hosts, which may explain why it lacks the 37oC favoured growth 
temperature of B. anthracis.  Additionally, some ‘virulence factors’ in B. cereus 
such as cereulide may originally have been antimicrobials (Tempelaars, 
Rodrigues et al. 2011), perhaps for limiting competition in cadavers, but have 
subsequently permitted opportunistic or accidental pathogenicity in humans. 
The temperature growth experiments focussing on just the clade 1 and 2 
B. thuringiensis strains also showed differences in favoured growth conditions 
between the selected strains.  However, it is difficult to directly relate the two 
clades’ differences in Vmax and production to the ecological roles that they may 
occupy.  B. thuringiensis spores can be isolated from soil globally (Martin and 
Travers 1989, Bizzarri and Bishop 2008, Ruan, Crickmore et al. 2015), so the 
differing responses might simply reflect where strains have been isolated.  
However, the supported hypothesis here is that clade 2 B. thuringiensis are 
obligate pathogens with in-soil growth not significant to the life cycle.  If B. 
thuringiensis is a specialised insect pathogen then this still does not necessarily 
explain temperature growth differences.  Insects are endothermic and small so 
internal temperature is likely similar to ambient temperature, so again the 
geographic range of B. thuringiensis might account for differing growth rates.  
However, the results obtained would require the two clades to have distinct 
ranges, which is not the case, although the ratio of B. cereus to thuringiensis 
isolated from soil can vary by climate (Hendriksen 2016).  It is therefore difficult 
to give a satisfying conclusion why strains in the two clades might favour 
different temperatures based solely on growth curve data, beyond the point that 
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different temperature preferences should reflect adaptation to different niches.  
Across the whole B. cereus group distinct clades within do appear to favour 
different temperature ranges, most obviously the psychrotrophic B. 
weihenstephanensis (Guinebretiere, Thompson et al. 2008). 
The competition experiments better highlight the hypothesised 
differences between the clade 1 and 2 B. thuringiensis strains.  Clade 2 strains 
have higher relative fitness on average in vivo while the reverse is true in vitro.  
If fitness relative to Btk pHT315-DsRed-tetR is an accurate representation of 
absolute fitness, then it is clear that clade 2 B. thuringiensis strains are better 
able to grow and sporulate in an insect host than clade 1 strains and poorer at 
this in a non-insect environment.  There are a few possible explanations for this 
result: the clade 2 strains grow faster outright, they are better able to supress 
competitors or they can avoid any immune response.  If suppression were the 
cause then this should be the same in vitro as bacteriocins would still limit 
competition (Riley and Gordon 1999), but this was not the case.  It could be 
argued that in vitro clade 2 strains lack access to nutrients required for 
bacteriocin production and so can no longer suppress the faster growing 
competitor.  Either way, making better use of growth medium resources for 
other products is just as clear an indicator of adaptation to that environment as 
absolute growth is.  The same argument can be made if immune escape is the 
reason for the improved competitive ability in vivo – having an advantage 
dependent on avoiding specific host responses would also be a clear indication 
of adaptation to that host.  While P. xylostella larvae were used throughout the 
in vivo work, they are unlikely to be natural hosts of all strains used.  Toxins 
from kurstaki, aizawai and berliner strains have all been employed against 
lepidopteran pests successfully (Iqbal, Verkerk et al. 1996), but israelensis 
carries toxins that make it effective against dipterans, in particular mosquitoes 
(Ankarloo, Caugant et al. 2000).  This suggests that if strains were competed in 
their preferred host species then fitness differences compared to clade 1 might 
be greater. 
The improved growth and separation of clade 2 from the rest of the B. 
cereus group strongly support the hypothesis that Cry toxins and the 
entomopathogen lifestyle emerged together and diversified as putative B. 
thuringiensis came into contact with more insect species.  If B. thuringiensis 
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were only an opportunistic pathogen, then Cry toxins should have some 
function in environments other than the insect gut (Brown, Cornforth et al. 2012) 
such as aiding plant colonisation, but this is not the case (Bizzarri and Bishop 
2008).  However, while some toxins have been identified that bind to non-insect 
cells and some have no currently identified insecticidal activity (Mizuki, Park et 
al. 2000, Ruan, Crickmore et al. 2015), there is no general secondary function, 
which further supports specialisation by B. thuringiensis.  This formative 
association with Cry toxins then allowed for adaptation elsewhere in the 
genome to an entomopathogen lifestyle and necrotrophic exploitation of 
resulting cadavers (Dubois, Faegri et al. 2012).  Clade 1 strains appear to lack 
such adaptations and so may have acquired Cry toxins only recently as it is 
clear they can be transferred from B. thuringiensis to cereus (Ceuppens, Boon 
et al. 2013, Palma, Munoz et al. 2014).  Some of the confusion over the 
abundance of B. thuringiensis in soil could be because of its associations with 
nematodes, which can be hosts or provide access to insects and are plentiful in 
soil (Loguercio and Argolo-Filho 2015, Ruan, Crickmore et al. 2015).  B. 
thuringiensis shows specialisation even within herbivorous insects – while 
lepidopterans and coleopterans are common hosts along with some dipterans, 
there are few toxins that target hemipterans (Chougule and Bonning 2012, 
Palma, Munoz et al. 2014).  This is unlikely to be because of a lack of searching 
as hemipterans are also important crop pests; instead B. thuringiensis may not 
be sufficiently exposed to hemipterans to evolve toxins against them.  While 
lepidopteran larvae consume leaf tissue carrying spores, hemipterans instead 
pierce to access phloem sap, bypassing spores on the leaf.  Plants may recruit 
B. thuringiensis to defend against such herbivory (Elliot, Sabelis et al. 2000, 
Bizzarri and Bishop 2008); an experiment was attempted to explore any 
differences in this between the two clades (in the manner of Raymond, Wyres et 
al. (2010)), but this failed.  The lack of bug-targeting toxins has meant 
expanding use of B. thuringiensis-based transgenic crops has increased 
problems with hemipteran pests, such as mirid outbreaks in China (Lu, Wu et al. 
2010, Chougule and Bonning 2012). 
Realigning B. thuringiensis to solely clade 2 to reflect its distinct ecology 
should also remove confusion over links between clade 1 strains of B. 
thuringiensis and more harmful strains.  B. thuringiensis subsp. monterrey is 
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more closely related to B. anthracis than to other clade 1 strains used here and 
produces a capsule than binds to B. anthracis antigens (Cachat, Barker et al. 
2008).  This may appear to be of little concern as monterrey is harmless to 
humans while B. anthracis is clearly not, but there are also related harmful B. 
cereus strains in clade 1 involved in food poisonings, particularly those carrying 
cereulide toxins.  These links have fuelled the European Food Safety Authority’s 
concerns about B. thuringiensis on food crops as a safe product for human 
consumption, as in their view commercialised strains from clade 2 could 
possess human virulence factors like their ‘close’ relatives (EFSA 2016). 
The apparent safety of B. thuringiensis matters because it is such an 
important part of agriculture and may become more so with food production 
needing to increase at least 70% by 2050 (Godfray, Beddington et al. 2010).  
Already, B. thuringiensis or its genes are used on three quarters of North 
American arable land (Bailey, Boyetchko et al. 2010).  Spore-based 
biopesticides provide a defence against specific pests without harming other 
species, which is more of a concern than ever – e.g., neonicotinoids and bees 
(Henry, Beguin et al. 2012) – and allows for fewer other insecticides to the 
benefits of natural predators (Lu, Wu et al. 2012).  Their provenance also 
means they can be used on organic produce, which have more limited options 
for precise pest control.  This safety argument does not directly impact 
transgenic crops (which are far more important agriculturally than B. 
thuringiensis biopesticides) but any discussions about the safety of B. 
thuringiensis could alter public perception of anything linked, further harming 
support for transgenic crops.  If resources are committed towards engineering 
improved strains and Cry toxins then this needs to be done knowing that they 
will not become hostage to potential new regulation (Maughan and Van der 
Auwera 2011).  B. thuringiensis has been used and therefore consumed since 
the mid-20th century (Lambert and Peferoen 1992, Sanahuja, Banakar et al. 
2011) and yet the only potential black mark against it has been a recent food 
poisoning incident in Germany that gave the EFSA cold feet (EFSA 2016, 
Raymond and Federici 2017).  However, this case was more likely caused by B. 
cereus also isolated from the contaminated food (Raymond and Federici 2017).  
The EFSA support their wariness by arguing that all B. thuringiensis and cereus 
are equally closely related so the former could easily become a human 
61 
 
pathogen, as it is already highly related to one.  As shown here however, the 
clade 2 strains of B. thuringiensis used as biopesticides have clearly adapted to 
a distinct niche and are genetically separate from the more dangerous forms of 
B. cereus.  As B. thuringiensis has adapted to an entomopathogenic lifestyle 
opportunities for recombination with B. cereus will have fallen, greatly limiting 
the likelihood of human virulence factors such as cereulide genes passing 
between them (Didelot and Maiden 2010). 
The genetic and ecological distinction between clade 2 and the rest of 
the B. cereus family appears sufficient to maintain use of the B. thuringiensis 
species name, provided it is realigned to only clade 2.  Sequence data make it 
clear that B. thuringiensis cannot persist just as a name for bacteria that 
possess Cry toxins within the B. cereus group, and that plasmids as a whole 
should not be relied on for Bacillus taxonomy (Liu, Lai et al. 2015).  The 
supposed value in the existing system is that it identifies insect pathogens 
(Priest, Barker et al. 2004), except that all of the commercially viable 
biopesticide strains are already located in clade 2 and as shown here clade 1 
strains are not as well adapted to growth within insect hosts (Zheng, Peng et al. 
2013).  It would therefore be better to align the name with the single clade that 
does contain clear, successful entomopathogen strains and that appears to be 
the origin of this lifestyle.  This distinction between the clades already exists 
informally with clade 2 being referred to as the thuringiensis group and clade 1 
the anthracis group as it also contains the B. anthracis sub-clade (Sorokin, 
Candelon et al. 2006, Raymond, Wyres et al. 2010, Zheng, Gao et al. 2017).  
An approach that combines both phylogenetic and ecological or phenotypic 
information to determine species could be used throughout the prokaryotes.  
The work here has shown that defining solely by phenotype can lead to 
disordered relationships.  However splitting species solely on the basis of a 
particular level of genetic distance seems foolish – ultimately, species are 
defined and catalogued because it is beneficial to us to do so; not considering 
phenotypic differences in bacterial species would waste much of this benefit. 
The combination of distinct genetic grouping and correspondingly distinct 
niche supports the previously suggested rearrangement of the B. cereus 
species group so that B. thuringiensis is limited to clade 2 and B. cereus 
excludes these strains, independent of possession or lack of Cry toxins.  As 
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discussed, this would provide a clearer picture to regulators, but more 
importantly it would represent the reality of the group, unlike the current 
classification.  The existing one was built using identification methods that have 
been superseded by sequencing, and an argument for maintaining it was that it 
simplified regulation of new products.  The current concerns of the EFSA have 
removed this benefit of the existing system, so there is little reason not to take 
advantage of improved knowledge of the B. cereus species group by updating 
its classifications.  
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 Competition between co-infecting strains is known to strongly affect the 
virulence of infections.  Classical virulence theory states that strain competition 
should result in a race to consume the most resources, increasing virulence to 
the host.  However, the role of public goods in infections suggests that high 
virulence would be favoured by cooperation rather than antagonism.  
Competition is then expected to be highest between distantly related strains 
with a corresponding decrease in cooperation.  Shared public goods include 
many virulence factors, like the crystal (Cry) endotoxins of the entomopathogen 
Bacillus thuringiensis.  B. thuringiensis infections are established from the insect 
midgut so spore distribution may affect infectivity.  Increased infectivity may 
correspond to improved competitive ability, although the public nature of Cry 
toxins could also allow less infective strains access to the haemolymph. 
The insecticidal activity of three well-characterised B. thuringiensis 
subsp. (aizawai, entomocidus and kurstaki) was confirmed in Cry1Ac-resistant 
and -susceptible Plutella xylostella larvae, pre- and post-transformation with 
marker plasmids.  As expected, the strains had differing activities, with aizawai 
the most lethal to resistant larvae and kurstaki to susceptible larvae.  In order to 
test the hypotheses that virulence predicts competitive ability and infection 
composition is influenced by midgut spatial structuring, competitions were 
carried out in resistant larvae with B. thuringiensis subsp. aizawai or kurstaki 
against entomocidus; these were done at multiple densities and frequencies. 
 Gut spatial structuring does not appear to affect infection composition for 
B. thuringiensis in P. xylostella.  However, B. thuringiensis fitness outcomes in 
co-infections appear to be generally frequency dependent within-host, as has 
been shown previously.  Since increased infectivity does not provide a 
competitive advantage within-host, selection for increased virulence must rely 
fully on between-host competition, i.e. selection at larger spatial scales, while 





Competition has always been at the centre of ideas regarding how 
natural selection operates.  Conflict over resources is readily apparent down to 
a microscopic level, including with bacteria, where antibiotics are the best 
known example of antagonistic competition (Linares, Gustafsson et al. 2006).  
Many infections may consist of multiple strains of a particular pathogen (Gilbert, 
Plebanski et al. 1998, Lord, Barnard et al. 1999, Read and Taylor 2001, Alizon 
and van Baalen 2008), as clearly has been shown with malarial infections (de 
Roode, Pansini et al. 2005, Bell, De Roode et al. 2006). In mixed infections 
competition is expected between strains and may strongly affect infection 
intensity and outcome, whether they take the form of super- or co-infections.  
For the former, one strain completely outcompetes and replaces the other so 
that only it remains in the host to be transmitted (Alizon and van Baalen 2008).  
In co-infections multiple genotypes persist or invade simultaneously, although 
the conditions for long-term coexistence can be quite restrictive (Alizon and van 
Baalen 2008).  Under classical models of virulence, competitive ability is linked 
to the harm done to a host, so that mixed infections may select for an increase 
in virulence (in terms of “disease-induced mortality of the host”) (Frank 1996, 
Gandon, Jansen et al. 2001, Day 2002).  This has been demonstrated 
experimentally in some cases (Ebert and Mangin 1997, Davies, Fairbrother et 
al. 2002, de Roode, Pansini et al. 2005) although Bell, De Roode et al. (2006) 
suggest that there is no “logical necessity” for virulence and competitive ability 
to be linked. 
In contrast, when virulence is cooperative and depends upon the 
secretion of public goods e.g., siderophores or the crystalline δ-endotoxins of 
Bacillus thuringiensis, competition within-host in mixed infections will decrease 
relatedness and promote conflict and/or cheating (Massey, Buckling et al. 
2004).  Thus mixed infections are predicted to favour cheaters and select for 
lower investment in virulence factors (Brown, Hochberg et al. 2002).  
Experimentally, decreasing relatedness appears to favour reduced investment 




In ecological terms, competition between strains that produce 
antagonistic compounds (antibiotics, bacteriocins) can also reduce virulence 
(Massey, Buckling et al. 2004) and there is plenty of experimental evidence 
showing a decrease in virulence as more strains infect the host (Turner and 
Chao 1999, Brown and Johnstone 2001, Gower and Webster 2005, Harrison, 
Browning et al. 2006).  Unlike antibiotics, which are principally employed 
against more distantly-related organisms, bacteriocins are targeted more at 
conspecifics or other closely related bacteria (Riley and Wertz 2002).  While an 
antibiotic producer may be protected from it through lack of the specific pathway 
targeted, bacteriocins require specific antidotes e.g., Escherichia coli producing 
colicins and manufacturing corresponding immunity proteins (Riley and Gordon 
1999).  The antidote gene is typically linked to the bacteriocin one so that 
another immune bacterium is likely to share both genes, making it more closely 
related than the surrounding susceptible population (Riley and Wertz 2002, 
Garbutt, Bonsall et al. 2011).  Producing bacteriocins is costly (Dobson, Cotter 
et al. 2012) so increased antagonistic interactions are likely to come at the cost 
of reduced investment in growth or virulence. 
The dominant, and obligate, virulence factors of B. thuringiensis are the 
crystalline δ-endotoxins (Cry toxins) and these are known to behave as public 
goods within the insect midgut (Raymond, West et al. 2012).  Cry toxin 
production also has high metabolic costs (Agaisse and Lereclus 1995) which 
gives a clear opportunity for exploitation by cheats.  However, unlike many 
public goods that are secreted during vegetative growth and provide near-
immediate benefit, Cry toxins produced at the end of one infectious cycle during 
sporulation (Deng, Peng et al. 2014, Deng, Slamti et al. 2015) are not active 
until ingestion by the next host.  Furthermore, Cry toxins require no carriage of a 
receptor molecule or similar – once released and activated in the insect midgut 
their action is independent of the bacteria.  Instead they cause perforations in 
the gut epithelial cells’ microvilli (Bravo, Gill et al. 2005), giving B. thuringiensis 
access to haemolymph nutrients (Schnepf, Crickmore et al. 1998).  The 
separate action means that Cry toxins do not control access to perforations – 
entry to the haemolymph is unrestricted (Raymond, Davis et al. 2007).  A 
consequence of this is that cheat B. thuringiensis that produce no Cry toxins 
could still pass into the haemocoel.  As with cheats in other systems the Cry-
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null strains would then be expected to either outgrow their honest counterparts 
or sporulate faster without the burden of toxin production (Raymond, Davis et al. 
2007).  The possibility of cheats may help to explain why Cry toxin genes 
remain on plasmids rather than integrated into the chromosome, as horizontal 
transfer could restore them to Cry-null strains (Nogueira, Rankin et al. 2009, Mc 
Ginty, Rankin et al. 2011, Leggett, Brown et al. 2014). 
Given the high cost of Cry toxin production, mixed infections between 
Cry null cheats and toxin producers should give a strong competitive advantage 
to toxin cheats (Raymond, Davis et al. 2007, Raymond, West et al. 2012).  
However, there are a great breadth of Cry toxins and B. thuringiensis strains 
(Aronson and Shai 2001), each with a limited host range against which they are 
effective (de Maagd, Bravo et al. 2001).  The outcome of competitive 
interactions between two strains with similar levels of investment in different Cry 
toxins, but very different infectivity in a host, is harder to predict.  If competing 
strains are investing in antagonists such as bacteriocins the most common 
strain may have a competitive advantage and produce positive frequency 
dependent selection (Levin 1988, Gardner, West et al. 2004).  Antagonism 
aside, social evolution theory can predict the conditions favouring investment in 
public goods.  Spatial structure in populations, for instance, is known to be 
fundamental for the operation of kin selection (Taylor 1992, Griffin, West et al. 
2004).  For example, when competition is purely local organisms will be 
competing with their relatives, undermining the benefits of cooperation.  Put 
another way, the existence of spatially distinct groups allows the operation of 
global group level competition and so that investment in traits that benefit group 
can pay dividends (Frank 1998).  Virulence factors do not necessarily move 
freely through hosts.  Indeed spatial structure in the insect midgut is believed to 
account for the low fitness of null quorum sensing (QS) mutants of B. 
thuringiensis (Zhou, Slamti et al. 2014), although QS signals and QS-regulated 
traits behave as public goods in other experimental systems (Brown and 
Johnstone 2001, Diggle, Griffin et al. 2007). 
Therefore it could be predicted that conditions favouring spatial structure 
in the midgut (figure 2.1) might provide an increased selective advantage to 
more infective strains, i.e. strains producing Cry toxins which more effectively 
perforate the midgut of their host.  For instance, relatively few spores can be 
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sufficient to cause mortality in a susceptible host (Cornforth, Matthews et al. 
2015); the fewer spores ingested then the fewer toxins will be released into the 
midgut with correspondingly fewer perforations in the epithelium.  Spatial 
variation in toxin concentration is therefore more likely to occur if toxin levels are 
low and if toxins are released by relatively few spores.  As well as low absolute 
density, a low frequency of spores in a mixed infection might also lead to local 
release of toxins and provide an advantage to a more infectious strain.  Notably, 
some Cry toxins appear to be bound to the spore surface and may trigger spore 
germination through binding to midgut receptors (Du and Nickerson 1996); if 
this also triggers pore formation it could limit epithelial breakdown to a spore’s 
immediate area when there are fewer solubilised toxins. 
This issue has important fundamental and applied implications.  First, 
how does selection for increased infectivity operate when virulence is based on 
public goods?  Is it entirely dependent on group-level competition, i.e. 
differences in infectivity between near clonal infections in different hosts or 
populations of hosts; or does within host competition play a role in selection for 
infectivity at some level?  The answer to this fundamental question has 
important implications for how one might design artificial selection regimes that 
seek to increase the infectivity of social pathogens such as B. thuringiensis, the 
focus of a substantial part of this thesis.  Should some degree of within-host 





Figure 2.1: Comparison between high spatial structure (top) and low spatial 
structure (bottom) in the midgut.  With high spatial structure (low spore density), 
toxins that can bind and perforate the midgut may only be in the vicinity of 
associated B. thuringiensis spores.  With low spatial structure (high spore 
density) toxins are distributed throughout the midgut, allowing all spores access 
to the haemolymph. 
 
While B. thuringiensis populations show strong spatial structuring on 
plants (Collier, Elliot et al. 2005, Raymond, West et al. 2012) the distribution of 
spores throughout the environment suggests mixed infections might be 
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somewhat common, although less frequent than clonal infections.  The ability of 
B. thuringiensis strains to produce bacteriocins supports the occurrence of 
intraspecific within-host competition (Cherif, Rezgui et al. 2008, Raymond, 
Johnston et al. 2010) and within-host competition is likely to affect other aspects 
of the biology of this important biocontrol organism. Although the rarity of B. 
thuringiensis epizootics in nature makes observing competition directly in the 
field difficult (Porcar and Caballero 2000), experimental mixed infections can be 
established easily (Raymond, Davis et al. 2007, Raymond, Wright et al. 2013).  
The work here tested experimentally whether more infectious strains in mixed 
infections have an increased selective advantage in conditions favouring spatial 
structure within the gut (low dose, low frequency).  Since infectivity of strains 
varies with insect genotype, whether the relative fitness of stains in 
standardised mixes varies in insects with differing susceptibility to a critical 
commercialised Cry toxin was also tested. 
Initial work was done to assess the insecticidal activity of commonly 
available, well characterised strains in Cry1Ac-susceptible and -resistant 
Plutella xylostella larvae populations.  B. thuringiensis strains kurstaki, 
entomocidus and aizawai have all been used for insect control e.g., XenTari® 
biopesticide containing aizawai ABTS-1857 (Valent BioSciences LLC).  B. 
thuringiensis subsp. kurstaki has been used as a biopesticide principally 
because its Cry1Ac toxin causes high levels of mortality in a number of 
lepidopteran pest species (Tabashnik, Carriere et al. 2003).  As resistance to 
Cry1Ac has emerged, aizawai has also been used as its Cry1C toxins still 
produce sufficient mortality in many of these populations (Liu, Tabashnik et al. 
2001).  However entomocidus, which also lacks Cry1Ac but carries Cry1C 
toxins (Crickmore, Baum et al. 2018), has found less widespread use as a 
commercial biopesticide.  Bioassays of these strains in Cry1Ac-resistant and -
susceptible P. xylostella were carried out to confirm they each cause different 
levels of mortality in these insect populations.  Based on previous work kurstaki 
was expected to produce the highest virulence in Cry1Ac-susceptible larvae 
and aizawai the highest in Cry1Ac-resistant ones.  This had the unexpected 
effect of identifying the aizawai isolate used initially as a contaminant in this 
formulation.  In order to confirm the identity of new isolates from XenTari® as 
aizawai a protocol based around restriction fragment length polymorphisms 
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(RFLP) was developed in order to distinguish between serotypes.  Once 
correctly identified, aizawai, kurstaki and entomocidus were all transformed with 
marker plasmids.  Initial competitions were predicted to show that the two types 
of marker plasmid do not impose differing fitness costs. 
As discussed above, varying the levels of spatial structuring in the gut 
should help to highlight potential links between infectivity and competitive ability.  
Strains were expected to show positive frequency dependence, as higher 
relatedness during growth in the haemolymph should favour increased public 
goods production to aid growth.  In particular, it was expected that as spatial 
structure increased (through lower density and frequency), the relative fitness of 
the more infective strain should increase. 
In addition to the commercially available strains, competition experiments 
also investigated two experimentally evolved kurstaki mutants produced in 
previous experiments (as part of the same overall project) by Dimitriu, 
Crickmore et al. (unpub. data).  These had been generated from kurstaki 7.1.o 
wild-type strain put through selective passaging for higher virulence in Cry1Ac-
resistant P. xylostella larvae.  The two evolved mutants showed higher mortality 
in Cry1Ac-resistant larvae but did not persist in subsequent selection rounds.  It 
is therefore likely that the altered or increased toxin production necessary to 
overcome resistance here carries a strong fitness cost.  When competed 
directly with their kurstaki ancestor outside of a selection protocol they were 
therefore expected to be less fit across all spore density and frequency 
treatments. 
 Beyond the immediate aims of the work here, the information gained will 
also inform protocol designs for subsequent selection experiments to evolve 
more virulent strains – in particular how the different strains perform under 
competition here may affect their use.  Mixed infections could allow for 
increased horizontal transfer and recombination of cry genes, which appears to 
be the process that has produced such a diversity of Cry toxins (Vilas-Boas, 
Vilas-Boas et al. 1998, de Maagd, Bravo et al. 2001).  However, if the strain 
targeted for improvement is a poor competitor it may be difficult to facilitate 





Producing marked strains 
Three well-characterised B. thuringiensis strains from three serotypes 
were used in this study (table 2.a): kurstaki 7.1.o, aizawai and entomocidus.  
Each was initially transformed to give two marked versions, one with plasmid 
pHT315 carrying gfp and eryR for erythromycin resistance and one with 
pHT315 carrying DsRed and tetR for tetracycline resistance (Zhou, Slamti et al. 
2014).  To produce electrocompetent cells for transformation the strains were 
cultured overnight at 30oC with 150rpm shaking in 2% LB broth.  5ml of 
overnight culture was then added to 500ml pre-warmed 2% LB in a conical flask 
and incubated for four hours at 30oC with 150rpm shaking.  After four hours, 
67ml of 50% glycine was added to give 3% in culture and the culture incubated 
for an additional hour.  Culture was transferred to eight 50ml pre-chilled Falcon 
tubes and these left on ice for 5mins.  Tubes were centrifuged at 3,200g and 
4oC for 12mins.  Tubes were kept on ice while supernatant was poured off.  Cell 
pellets were gently re-suspended with 10ml ice-cold buffer ‘F’ (272mM sucrose, 
0.5mM MgCl2, 0.5mM K2HPO4 and 0.5mM KH2PO4 at pH 7.2) (Peng, Luo et al. 
2009).  This was repeated two further times, with final resuspension in 500µl of 
buffer ‘F’ and transferred to a pre-chilled Eppendorf.  100µl of electrocompetent 
cells were added to a pre-chilled 0.1cm3 cuvette with 2µl plasmid DNA and 
electroporated at 1.8kV (MicroPulser, Bio-Rad Laboratories Inc.).  The cells 
were then transferred to 1ml of pre-warmed 2% LB and incubated at 30oC for 
one hour.  After one hour, 100µl of culture was spread onto a 2% LB agar plate 
containing the appropriate selective antibiotic and 900µl onto another and 
plates incubated at 30oC overnight.  Colonies were re-streaked on selective 







Bacillus species Strain / isolate Source 
B. thuringiensis kurstaki 7.1.o Raymond 
B. thuringiensis kurstaki 7.1.o C1 mutant Dimitriu 
B. thuringiensis kurstaki 7.1.o C2 mutant Dimitriu 
B. thuringiensis aizawai (contaminant) BGSC 4J4 
B. thuringiensis aizawai X1 (confirmed) XenTari® 
B. thuringiensis aizawai X6 (contaminant) XenTari® 
B. thuringiensis entomocidus BGSC 4I4 
 
Table 2.a: B. thuringiensis strains used during competition experiments.  C1 
and C2 from Dimitriu, Crickmore et al. (unpub. data) – mutants derived from 
kurstaki 7.1.o (Raymond, Wyres et al. 2010) via separate passage experiments; 
X1 was isolated from XenTari® (Valent BioSciences LLC) product and 
confirmed as aizawai via RFLP of hag flagellin gene. 
 
Initial bioassays 
Each strain used was streaked on plain 2% LB agar plates and incubated 
overnight at 30oC, then a colony of each spread on Bacillus cereus-selective 
agar (Oxoid Ltd.) and incubated for six days at 30oC to produce spores.  Spores 
of each marked strain were suspended in 700µl saline (0.85% NaCl), centrifuged 
at 6,200g for 2mins and supernatant removed.  This was repeated three times 
then spores re-suspended in 1ml saline with 0.05% Triton X surfactant.  Spores 
of each marked strain were diluted to 10-6, and 10-6 dilutions plated out on 
20µg/ml tetracycline or erythromycin 2% LB agar plates to check counts.  
Inocula were then made from the dilutions as specified in each of the individual 
bioassays below.  This was also done with the original untransformed, wild-type 
strains. 
Experiments used diamondback moth, Plutella xylostella, larvae that 
were either susceptible (VLSS population) or resistant (FR population) to 
Cry1Ac toxin (Zhou, Alphey et al. 2018).  Insects were raised from surface-
sterilised eggs on sterile insect diet until late second-instar.  Eggs were 
sterilised for 30s in 10% bleach solution, then drained and twice washed with 
sterile H2O then dried for 15mins in a laminar flow hood.  Diet was 90g of dry 
mix (44.3g wheatgerm, 18.4g casein, 0.1g inositol, 1.5g Sodium propionate, 
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5.9g Wesson salts, 1.5g sorbic acid, 0.9g cholesterol, 1.5g methyl-4-
hydroxybenzoate, 0.3g choline chloride, 3g locust bean gum, 1.6 cellulose, 1.6g 
fructose and 9.4g agar) with 420ml demineralised water.  After autoclaving, 2g 
of Vanderzant vitamin mixture for insects and 1.8g ascorbic acid were each 
dissolved in 30ml sterile H2O, sterilised via 0.2µm cellulose filter and added to 
the cooled autoclaved diet mix.  Diet was poured into 12oz plastic pots 
(Vegware Ltd.) to a depth of 15mm for insect rearing or into 50mm Petris to a 
depth of 5mm for experiments and allowed to set in a laminar flow hood.  
Individual quarters of sterile diet in five 50mm Petri dishes were coated with 
100µl of spore inoculant and dried in a laminar flow hood.  Ten larvae were 
added to each Petri dish, giving 50 larvae per strain dilution.  In all bioassays a 
control was also used with only sterile H2O added to diet.  Insects fed on 
inoculated diet at 22oC for five days.  After five days the assay was scored for 
the number of live larvae and melanised cadavers to give mortality for each 
strain (transformed and wild-type) across all doses. 
Preliminary work showed that the available stock isolate of aizawai was 
unable to kill Cry1Ac-resistant larvae any more effectively than kurstaki.  
Therefore a bioassay on resistant larvae was carried out using kurstaki, the 
ineffective aizawai and spores grown from XenTari® commercial product (Valent 
BioSciences LLC) which is marketed as containing aizawai.  Spore suspensions 
of 37, 111, 333, 1,000, 3,000 and 9,000cfu/µl were used with aizawai and 
XenTari®, and 111, 333, 1,000, 3,000, 9,000 and 27,000cfu/µl for kurstaki. 
 A second bioassay was then carried out in both resistant and susceptible 
larvae, using kurstaki, entomocidus and two isolates from XenTari® picked from 
individual colonies, named X1 and X6.  This was done over the same ranges as 
before, with all strains at 37-9,000cfu/µl except kurstaki at 111-27,000cfu/µl. 
A final bioassay was carried out using wild-type and DsRed- and gfp-
transformed versions of both kurstaki and X1 in both resistant and susceptible 
larvae.  Again, X1 was used at 37-9,000cfu/µl and kurstaki at 111-27,000cfu/µl.  
This was done to assess the effects of transformation and additional plasmid 
carriage on mortality, and to confirm that any difference in mortality between X1 




RFLP confirmation of aizawai  
Isolates from XenTari® commercial spore mix suspected of being B. 
thuringiensis aizawai were grown overnight on 2% LB agar at 30oC, then a 
colony picked and used to inoculate 5ml 2% LB for overnight growth at 30oC with 
150rpm shaking.  70µl of culture and 70µl of 10mM Tris pH 8.0 were boiled for 
10mins then centrifuged at 2,000g for 4.5mins.  Supernatant was then used in 
PCR to amplify the B. thuringiensis hag gene for flagellin, with the primers 
Bthag-F1 (5’-AGTACATGCGCCAAAACCAAG) and Bthag-R2 (5’-
TAACTCAAATGGCTTATTGT) (Xu and Cote 2006).  The PCR program used 
had 5mins initial denaturing at 94oC then 30 cycles of 15s at 95oC, 30s at 56oC 
and 60s at 72oC with an additional final extension at 72oC for 5mins. PCR 
products were then digested separately with TaqαI (65oC) and EcoRV (37oC) 
restriction enzymes (New England Biolabs Inc.) for one hour and deactivated by 
incubation at 80oC for 20mins.  The restriction products were run in 1.5% 
agarose gel at 100V for 45mins against a non-restricted sample and 2-log 
ladder.  The number of distinct restriction fragments and their lengths were 
compared against expected patterns from kurstaki 7.1.o and aizawai restrictions 
in silico using Geneious® R8 (Biomatters Ltd.). 
 
In vivo competitions to investigate spatial structuring 
Competition experiments with the gfp-tagged kurstaki and aizawai X1 
tested whether these bacteria showed density or frequency dependent fitness 
against DsRed-tagged entomocidus in Cry1Ac-resistant larvae.  Since 
entomocidus is substantially more infective than kurstaki in this genetic 
background (see Results, figure 2.3), low frequency and low doses were 
expected to favour this strain in competition with kurstaki.  In contrast, aizawai 
and entomocidus impose similar mortality and differences in infectivity would 
not be expected to drive frequency or density dependent fitness in this 
interaction. 
Spore suspensions for each strain were counted via diluting in series and 
plating out on selective 2% LB agar plates and then adjusted to 27,000cfu/µl.  
Spores were combined in 5:5, 9:1 and 1:9 ratios, keeping the 27,000cfu/µl 
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overall concentrations.  These mixes were also used to produce 10-fold and 
100-fold dilutions in the same ratios.  Larvae were inoculated as with the single-
strain bioassays, with the number of larvae used adjusted based on bioassay 
mortalities to give an expected minimum of 48 cadavers per treatment. 
After five days, up to 48 cadavers were collected for each treatment and 
placed into sterile 1ml microtubes with 10µl sterile H2O, sealed and then 
incubated at 30oC for five days to ensure sporulation.  After five days 690µl 
sterile H2O was added with a sterilised 5mm stainless steel ball bearing.  Tubes 
were shaken for 4.5mins at 1,350rpm in a tissue lyser (Qiagen N.V.), and then 
pasteurised at 65oC for 25mins in a water bath.  Samples were diluted to 10-4 
and dilutions 10-1 to 10-4 plated out onto erythromycin and tetracycline 20µg/ml 
2% LB agar plates.  Plates were incubated overnight at 30oC and then colonies 
counted.  Competitions were also carried out only in 50:50 ratios at 27,000cfu/µl 
between all three strains with both gfp- and DsRed-tagged versions in Cry1Ac-
resistant and -susceptible larvae in the same manner. 
Competitions using the evolved strains of kurstaki (labelled C1 and C2 
and also carrying pHT315-gfp-eryR) were carried out under the same protocol, 
using the same ratios and total spore concentrations.  The same competition 
protocol was also carried out between combinations of transformed strains, but 
all at 50:50 ratios and 27,000cfu/µl to avoid problems with insufficient mortality. 
For all competitions colony counts on the 2% 20µg/ml tetracycline LB 
agar plates gave cfu/µl for the DsRed-tetR-transformed competitor and those on 
2% 20µg/ml erythromycin gave cfu/µl for the gfp-eryR-transformed one.   
 
Statistical analysis 
For bioassay analysis larvae were recorded as either alive or dead, 
allowing mortality to be analysed via GLMs with binomial errors, as per 
Raymond, Wright et al. (2013).  To account for over-dispersion with a standard 
binomial distribution a quasibinomial one was then used.  This was tested using 
the F-statistic at the overall level against a significance level of p < 0.01, given 
the noisiness of bioassay data, and using the t-statistic for within-treatment 
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tests.  Bioassay mortality data were analysed in RStudio 1.1.456 (based on R 
3.2.5; R Core Team 2016, RStudio Team 2016). 
For competitions, final spore cfu/µl values were used to calculate 
Malthusian fitnesses for both competitor strains, which were then used to 
calculate relative fitness as follows (Lenski, Rose et al. 1991): 
















Preliminary work suggested that the stock isolate labelled as B. 
thuringiensis aizawai did not kill more Cry1Ac-resistant larvae than kurstaki.  
This runs counter to the expected insecticidal activity of aizawai as unlike 
kurstaki it should possess Cry1Ca toxins that permit mortality in the FR Cry1Ac-
resistant larval population used (Crickmore, Baum et al. 2018). 
 
The first full bioassay (figure 2.2) using XenTari® spores along with 
kurstaki and defective aizawai confirmed that XenTari® produced significantly 
higher mortality in FR larvae than either of the other two strains.  Spore doses 
were loge transformed and the mortality data analysed via GLM with 
quasibinomial errors, as with all subsequent bioassays.  The different strains 
produced significantly different mortalities (F2, 26 = 23.2, p = 2.48 x 10
-6) along 






Figure 2.2: Bioassay mortalities of B. thuringiensis strains kurstaki and aizawai 
with XenTari® product in Cry1Ac-resistant P. xylostella larvae. 
 
Plating out the XenTari® and picking colonies produced isolates, two of 
which (X1 and X6) were used in the larger second bioassay (figure 2.3) in 
Cry1Ac-resistant and susceptible larvae alongside kurstaki and entomocidus.  
This bioassay confirmed that the X1 isolate produced higher mortality in the 
Cry1Ac-resisant larvae, while the X6 isolate gave low mortalities at all spore 
levels (F3, 43 = 42.3, p = 3.07 x 10
-11).  As expected, the larval type also strongly 






Figure 2.3: Bioassay mortalities of B. thuringiensis strains kurstaki and 
entomocidus with XenTari® product isolates X1 and X6 in Cry1Ac-resistant and 
-susceptible P. xylostella larvae. 
 
Identifying aizawai via RFLP (figure 2.4) 
The identity of isolate X1 as aizawai was confirmed via RFLP analysis of 
the hag gene for B. thuringiensis flagellin in X1 and kurstaki 7.1.o.  Initial PCR 
using Bthag-F1 and -R2 primers produced PCR products between 700 and 
800bp in length based on comparison with 2-log ladder.  Based on existing 
sequence data, kurstaki 7.1.o is expected to give a product of 753bp with Bthag 
primers and aizawai 723bp.  Restriction with EcoRV of X1 produced a single 
fragment the same length as the original PCR product as predicted.  The 
restriction with TaqαI was expected to produce three fragments but only two 
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could clearly be resolved, perhaps because the third fragment was only 
expected to be 66bp.  The kurstaki restriction with EcoRV was expected to 
produce three fragments, but again the third fragment was not clearly visible, 
while the TaqαI restriction produced two as expected.  Subsequent repeating of 
RFLP on X1 after transformation with DsRed and gfp plasmids confirmed the 
same pattern with the short EcoRV 66bp fragment partially visible.  Using RFLP 
based on the B. thuringiensis hag gene appears to be a simple way of 
distinguishing between previously sequenced strains of B. thuringiensis, 
provided that convenient distinguishing restriction sites are available.  RFLP 
also suggested that the supposed aizawai isolate initially bioassayed was 
contaminated with kurstaki. 
 
 
Figure 2.4: RFLP demonstration, here with entomocidus (Ent) and aizawai X1 
(Xen1), showing distinct band patterns for each strain with the restriction 
enzymes TaqI and EcoRV.  This also confirmed that contamination did not 
occur during transformation with marker plasmids (RFP and GFP) through 






Bioassays with transformed strains (figure 2.5) 
B. thuringiensis strains kurstaki 7.1.o, entomocidus and aizawai X1 were 
all successfully transformed with the DsRed-tetR- and gfp-eryR-carrying 
pHT315 plasmids.  Bioassays in both Cry1Ac-resistant and -susceptible larvae 
with aizawai X1 showed that it still maintained its increased mortality in Cry1Ac-
resistant larvae compared to kurstaki (F1, 54 = 36.8, p = 3.76 x 10
-7) and that 
there was no significant difference between original wild-types and the 
transformed strains (F2, 52 = 1.76, p = 0.185). 
 
 
Figure 2.5: Bioassay mortalities of B. thuringiensis strains kurstaki and aizawai 
X1 in Cry1Ac-resistant and -susceptible P. xylostella larvae.  Mortalities are split 




Effect of marker pHT315 plasmids 
Strains carrying the DsRed-tetR- and gfp-eryR pHT315 plasmids did not 
have significantly different relative fitnesses in vivo (F1, 253 = 5.34, p = 0.0217).  
Costs of the plasmids versus untransformed wild-types were not considered as 
experiments only used transformed strains. 
 
Full competitions in vivo; kurstaki and aizawai versus entomocidus (figure 2.6) 
In the kurstaki versus entomocidus competitions, neither the 
competitions at 270cfu/µl total nor the ones at 99:1 kurstaki to entomocidus in 
Cry1Ac-resistant larvae produced sufficient mortality to proceed with calculating 
relative fitness.  For this reason these treatments also were not used in the 
aizawai X1 versus entomocidus competitions. The number of larvae used 
initially meant that it was not considered practical to repeat the competition 
experiments with a large enough number of larvae to produce sufficient 
cadavers. 
There was no evidence for density dependent fitness in these 
experiments.  Overall concentration of the competition mixture used did not 
affect the relative fitness of the strains in either competition and could be 
excluded from the model (F1, 278 = 1.12 p = 0.291), as was the case with all 
interaction terms including it. 
Overall, proportion affected entomocidus relative fitness (F1, 279 = 12.8, p 
= 4.01 x 10-4), and in particular there was a strong interaction between 
proportion and strain (F1, 279 = 35.1, p = 9.37 x 10
-9); this fitness being 
unchanging in the kurstaki versus entomocidus competition but negative 
frequency dependent in the aizawai X1 versus entomocidus one.  The 
competing strain itself also significantly affected the relative fitness of 
entomocidus (F1, 279 = 39.1, p = 1.51 x 10
-9), which again is unsurprising as the 
change in slope mentioned means that entomocidus is fitter when rare against 





Figure 2.6: Relative fitness of B. thuringiensis entomocidus for competitions 
against kurstaki and aizawai X1 in Cry1Ac-resistant P. xylostella larvae.  
Relative fitness is shown at two different total spore densities (2,700 and 27,000 
cfu/µl) for three frequencies of entomocidus relative to the competitor, where a 
0.1 proportion of entomocidus corresponds to a 10:90 ratio of entomocidus to 
competitor. 
 
50:50 competitions in both host backgrounds (figure 2.7) 
Data were split by the two competitor strains (aizawai X1 and kurstaki) to 
compare across host genotype.  For both sets of competitor, fitness overall did 
not differ between Cry1Ac-susceptible and –resistant larvae (F1, 143 = 0.177, p = 
0.186; F1, 111 = 0.123, p = 0.727).  As well as not having significantly different 
effects on fitness (described previously) there was no reason to expect an 
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interaction effect between the pHT315 marker plasmids and host background.  
In the entomocidus competitions the strain had slightly lower relative fitness 




Figure 2.7: Relative fitness of B. thuringiensis strains entomocidus, kurstaki 
and aizawai X1 in competitions against each other in Cry1Ac-resistant and -
susceptible P. xylostella larvae.  All relative fitnesses are from 50:50 
competitions at 27,000cfu/µl. 
 
C1 and C2 kurstaki mutants 
The C1 and C2 mutants produced significantly fewer spores both in vivo 
and in vitro than their kurstaki ancestor when initial and final spore counts were 
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combined to give Malthusian fitnesses (figure 2.8).  Overall strain type was 
significant (F2, 275 = 57.4, p < 2.2 x 10
-16), and a Tukey HSD post-hoc test 
confirmed that both the mutants were less fit than their kurstaki ancestor.  
Simplifying the model down to just kurstaki and mutants could not be justified as 
the two show differing fitness levels in both growth media, with C2 fitter in both.  
In the competitions against the kurstaki ancestor (figure 2.9) sufficient cadavers 
could only be collected for competitions with C2.  There was a clear difference 
in the fitness of the C2 mutant depending on whether it was in susceptible or 
resistant larvae and its proportion.  This is reflected by the significance of the 
interaction terms involved, between strain and proportion (F1, 403 = 64.1, p = 
1.29 x 10-14) and larvae and proportion (F1, 402 = 78.9, p < 2.20 x 10
-16).  Strain 
and proportion were significant (F1, 406 = 6.87, p = 0.009; F1, 405 = 186, p < 2.20 x 
10-16) but larval background alone was not (F1, 404 = 4.50, p = 0.0345). 
 
 
Figure 2.8: Malthusian fitness of B. thuringiensis kurstaki C1 and C2 mutants 
compared to their wild-type kurstaki ancestor in HCO sporulation medium and 




Figure 2.9: Relative fitness of B. thuringiensis kurstaki C2 mutant in competition 
against its wild-type kurstaki ancestor in Cry1Ac-resistant and -susceptible P. 
xylostella larvae.  Relative fitness is shown at two different total spore densities 
(2,700 and 27,000 cfu/µl) for three frequencies of C2 relative to its ancestor, 





In line with both preliminary work and existing data, B. thuringiensis 
aizawai had the highest mortality in Cry1Ac-resistant P. xylostella larvae and 
kurstaki in Cry1Ac-susceptible ones.  Spatial structuring in larval guts at the 
levels generated here does not significantly affect B. thuringiensis infection 
composition in P. xylostella larvae.  However, the fitness of these B. 
thuringiensis strains in co-infections shows frequency dependence within the 
host.  As there does not appear to be a within-host competitive advantage 
conferred by the increased infectivity of a strain, between-host competition 
should instead be used when selecting for increased virulence, as co-infections 
do not select for increased virulence in this system. 
 
 Competition between pathogens relying on virulence factors which are 
public goods and act at a distance is largely unexplored.  Here, the principal 
hypothesis that increased infectivity can improve the relative fitness of 
competing strains in hosts was not supported, even when conditions were 
created which were expected to increase spatial structure within infections. 
Nevertheless, host genotype did affect the outcome of some competition 
experiments.  As the host P. xylostella genotypes should differ only in their 
resistance or susceptibility to the Cry1Ac toxin (potentially via loss of abcc2 
receptors) (Baxter, Zhao et al. 2005, Baxter, Badenes-Perez et al. 2011) the C1 
and C2 results suggest that interactions between distantly-acting toxins and 
receptors can affect relative fitness of invading social pathogens, though this 
was not found to be the case with the non-passaged strains.  Negative 
frequency dependent fitness was also observed in interactions between 
mutants or different serotypes, which for entomocidus versus aizawai was 
consistent with social exploitation of virulence factors between strains that differ 
in competitive ability. 
Bioassays confirmed that the aizawai, entomocidus and kurstaki strains 
used produce differing mortality levels in the Cry1Ac-resistant and susceptible 
hosts.  The aizawai and entomocidus strains overcome Cry1Ac resistance in 
the larvae through possession of Cry toxins which kurstaki lacks e.g., Cry1C 
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(Crickmore, Baum et al. 2018); in turn possession of Cry1Ac gives kurstaki very 
high mortality rates in the Cry1Ac-susceptible larvae.  Additionally, transforming 
the strains with marker plasmids carrying fluorescence genes and antibiotic 
resistance traits did not affect their virulence.  The different marker plasmids 
used also had indistinguishable effects on bacterial relative fitness, confirming 
that the methods used to distinguish competing strains did not have undue 
effects on the outcome of experiments and that the experimental set-up was 
appropriate for testing the key hypotheses. 
 The 50:50 competitions in larvae at 27,000cfu/µl spore doses should limit 
any spatial structuring in the insect midgut, with both strains at high density and 
equal frequency.  Lack of structuring should mean that differences in colonies 
counted at the end of the competition should reflect strain competition during 
growth and sporulation in the haemolymph, rather than just which strain could 
access the haemolymph.  The results from the 50:50 competitions suggest that 
the aizawai and kurstaki strains used here have similar fitness levels within 
hosts.  However, the entomocidus tended to be less fit on average than either 
aizawai or kurstaki.  Recent genomic analyses confirm that aizawai and kurstaki 
serotypes are very closely related, while entomocidus (BGSC 4I4) is placed on 
a nearby but separate branch of clade 2 (Zheng, Gao et al. 2017, Meric, 
Mageiros et al. 2018).  In general entomocidus is more closely related to a 
range of typical Cry-null Bacillus cereus isolates than kurstaki and aizawai (Liu, 
Lai et al. 2015) and is very closely related to the B. cereus type strain (ATCC 
14579) with which it shares the entomocidus serotype (Carlson, Johansen et al. 
1996, Xu and Cote 2006).  It is therefore plausible that entomocidus is less of 
an invertebrate specialist than the B. thuringiensis strains more closely related 
to kurstaki (Raymond and Bonsall 2013, Meric, Mageiros et al. 2018) and the 
fitness data here support this interpretation. 
The entomocidus strain used also showed negative frequency dependent 
fitness in competition with aizawai.  Since these stains have similar infectivity it 
is less likely that this frequency dependence is driven by differences in the 
ability to infect and kill hosts.  Various mechanisms can drive negative 
frequency dependence (Ross-Gillespie, Gardner et al. 2007, Healey, Axelrod et 
al. 2016), many of which involve social interactions (Rainey and Rainey 2003, 
Dugatkin, Perlin et al. 2005).  For example, significant spatial structuring or a 
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link between overall cooperation and total population growth can lead to 
negative frequency dependence for social cheats (Ross-Gillespie, Gardner et 
al. 2007).  In B. thuringiensis there is significant spatial structure within the gut 
in terms of different foci of invasion, and this is sufficient to drive negative 
frequency dependent fitness of quorum-regulated (PlcR-dependent) virulence 
mutants (Zhou, Slamti et al. 2014).  These virulence factors are believed to be 
expressed in the gut just prior to invasion of the haemolymph and in P. 
xylostella increase the invasiveness of B. thuringiensis infections (Zhou, Slamti 
et al. 2014). While B. thuringiensis produces crystal endotoxins during 
sporulation for a subsequent infection (Aronson and Shai 2001), the bacteria 
also produce other virulence factors during vegetative growth in the 
haemolymph including the vegetative insecticidal proteins (vips) (Estruch, 
Warren et al. 1996, Ruan, Crickmore et al. 2015).  These other virulence factors 
provide another avenue for cheats to outcompete strains which alone give 
higher insect mortalities.  However, unlike the Cry toxins which allow access to 
the haemolymph and so are the difference between growth or no growth, vips 
and other virulence factors may be more likely to modulate growth rates in the 
haemolymph (Fedhila, Daou et al. 2006), where the majority of vegetative 
growth is thought to occur.  Virulence factors may only cause host damage as a 
secondary effect to aiding bacterial growth e.g., the cereulide toxins in some B. 
cereus are principally antimicrobial but have the side effect of causing vomiting 
and food poisoning in humans.  Virulence factors secreted during vegetative 
growth in the haemocoel may have originally evolved to gather nutrients or limit 
competitors but have the side effect of further damaging the host.  They may 
also be directly employed against the host to release further nutrients or combat 
the efforts of the host immune system.  Even if strains do produce a full suite of 
Cry toxins they could still cheat by cutting production elsewhere which could still 
have an effect on mortality when in a single strain infection. It follows that 
vegetatively produced virulence factors, which increase invasiveness or local 
reproduction, could account for the negative frequency dependence seen here 
and also why fitness does not correspond to spore-associated virulence factors.  
Since aizawai is fitter than entomocidus, and therefore potentially more 
invasive, the frequency dependent fitness in these competition experiments 
could be related to exploitation of vegetative virulence factors produced at a 
higher rate by aizawai. 
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The negative frequency dependence shown by the C2 mutant is slightly 
harder to explain.  This mutant has a lower fitness than its wild type kurstaki 
ancestor in 50:50 competitions in both insect genetic backgrounds.  In the C2 
mutant the most significant change to the genome is the deletion of a 328kb 
region, potentially a pathogenicity island (Hacker and Kaper 2000).  It could be 
that the loss of such a region forces the mutant to rely more on co-infecting 
strains for a particular aspect of infection biology.  Such a split has been found 
in the B. thuringiensis strain LM1212, with some bacteria sporulating without 
toxins and others producing toxin crystals but failing to sporulate (Deng, Slamti 
et al. 2015).  However, C2 cannot be said to be an effective cheater since it has 
low fitness in competition.  Moreover, C2 has lower productivity in live infections 
as well as in vitro. A link between investment in virulence factors and population 
growth can help drive frequency dependence, but only because additional 
opportunities for growth increase the fitness differences between cheaters and 
producers (Ross-Gillespie, Gardner et al. 2007), and this is not the case in this 
study.  Frequency dependence might explain why subsequent attempts to get 
C2 to invade an ancestor population from rare through passage rounds (as 
must have happened during the original selection experiments that produced it) 
were unsuccessful irrespective of the number of C2 bacteria introduced. 
Separate from cheats, strains may carry different Cry toxins that vary in 
cost or produce differing toxin quantities.  Cry toxin inclusions in B. thuringiensis 
spores can take up over a quarter of total volume (Agaisse and Lereclus 1995), 
representing a heavy energetic investment as proved by the emergence of Cry-
null cheats (Raymond, West et al. 2012).  If growth rates in the haemocoel do 
differ there a number of possibilities for this.  It could simply be a race to gather 
resources and convert them into spores, with one strain either requiring less 
energy or possessing more efficient resource-gathering mechanisms.  Strains 
will also employ bacteriocins with their energetic cost being sufficiently offset by 
the reduction in competitors.  Finally, a particular strain may be better able to 
evade any immune response at an acceptable metabolic cost (Brown, Inglis et 
al. 2009, Garbutt, Bonsall et al. 2011), with melanisation the principal response 
in P. xylostella (Cerenius, Lee et al. 2008). 
Host background clearly affected the fitness of the C2 mutant with 
negative frequency dependence being much stronger in the Cry1Ac-susceptible 
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background.  Using relative fitness values gives a clear indication of which 
strain is fitter in a host as their calculation accounts for any differences in host 
quality.  However, the values do not give any insight into the underlying causes 
of the fitness differences e.g., is it because a strain grows faster outright 
(Rafaluk, Jansen et al. 2015) or produces more bacteriocins (Garbutt, Bonsall et 
al. 2011), though increasing antagonistic competition may be the more likely 
reason (Raymond, Davis et al. 2007).  Growing strains individually allows for 
comparisons in basic growth rate via Malthusian fitness and it is clear for the C1 
and C2 mutants that they produce viable spores at a slower rate than their 
kurstaki ancestor both in vivo and in vitro.  This could account for a lower 
relative fitness across all competitions, but does not explain the frequency 
dependent fitness pattern as discussed above.  Decreased spatial structure, in 
terms of mixing of genotypes or diffusion of virulence factors could explain the 
weaker frequency dependence in the Cry1Ac-resistant background; however 
this does not fit with our expectation of the slower and less effective 
disintegration of the midgut in these insects.  As for the cause of C1 and C2’s 
loss of growth, it could be a direct consequence of their increased insecticidal 
activity, a consequence of the loss of particular genes or even a change in the 
rate of sporulation.  If the improved mortality is simply a result of more toxin 
being produced per spore then the extra energy put towards this would be 
expected to cause a corresponding decrease in growth and/or sporulation rates 
as toxin production is known to be highly metabolically costly (Agaisse and 
Lereclus 1995, Deng, Slamti et al. 2015). 
If Cry spores were unevenly distributed in the midgut then it was 
hypothesised that only those with high infectivity would colonise the 
haemolymph.  Therefore the lack of varying fitness in the entomocidus versus 
kurstaki competition suggests toxins and spores do mix through the gut 
independently.  The second competition between entomocidus and aizawai also 
does not suggest any spatial structuring, appearing to show that the fitness of 
entomocidus is negative frequency dependent rather than a result of the 
increasing midgut epithelial breakdown provided by aizawai toxins.  There are 
also the other virulence factors released by B. thuringiensis during germination 
in the midgut.  While the solubility of Cry toxins may give them a more even 
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distribution, other factors could still be limited in how far they spread, such as 
the PlcR-dependent ones previously mentioned (Zhou, Slamti et al. 2014). 
The apparent lack of any spatial structuring is not the only result from the 
competitions.  As discussed in reference to the C1 and C2 mutants, growth rate 
alone is unlikely to account for any differences in fitness.  However, considering 
growth rate in the context of public goods may explain the pattern, with non-
producers gaining an advantage when rare (Turner and Chao 1999, Brown, 
Hochberg et al. 2002).  The spatial structuring of clones would then make a 
difference in public goods-secreting communities.  It appears that the frequency 
dependent fitness of strains, in particular here entomocidus, is important with 
patch structure of growing bacteria in the haemolymph mattering more in 
deciding spore production. 
Together, growth rate and competitive ability of B. thuringiensis strains in 
vivo should reflect adaptation to a host.  Outright growth, even in vivo, will not 
necessarily be a good predictor of fitness and spore production in co-infections, 
because of the varied effects of bacteriocins, virulence factors and other 
secreted products.  These also contribute to the negative frequency 
dependence seen in the competitions, mostly likely in the form of public goods 
cheats which succeed when rare.  The kurstaki and aizawai strains used are 
assumed to be well adapted to their lepidopteran hosts, including their 
competitive ability in-host, while entomocidus appears to favour growth mixed 
with these ‘fitter’ strains.  Their competitive abilities and relative fitness matter in 
the wider context of the thesis work to improve B. thuringiensis insecticidal 
ability against initially resistant hosts.  For example, while entomocidus can 
produce relatively high mortality when infected alone as shown here, its 
negative frequency dependent fitness suggests it could be a poor strain to use 
in experiments focusing on high levels of within-host relatedness. 
Beyond demonstrating the effects of frequency dependence and 
absence of gut spatial structuring on B. thuringiensis co-infections this work was 
in part carried out to inform the experimental conditions used in subsequent 
selection experiments and experimental evolution.  Selection of non-
microscopic organisms allows enough time between generations that any 
individual can have its attributes measured with only certain selected individuals 
93 
 
permitted to reproduce.  Selecting for higher host mortality in B. thuringiensis is 
instead done at the host level, with many rounds of bacterial proliferation 
occurring within.  There will be a risk that within-host selection pressures 
counter host-level selection, causing strains with potentially desirable traits to 
be replaced before they can be isolated.  Increasing toxin production is one 
mechanism for increased virulence, but the metabolic costs this brings might 
favour cheating with other public goods.  As with the C2 mutant this could lead 
to negative frequency dependence which may limit persistence through the 
experiment.  These considerations mean that selection experiments will require 
careful planning of selection protocols to produce highly insecticidal, stable B. 
thuringiensis isolates. 
The B. thuringiensis strains targeted for improvement via selection 
should ideally be those already used in agriculture.  There is existing regulation 
for these strains, while their effectiveness against different pest species is 
already established.  Generating improved virulence in these strains through 
selection may not mean that they necessarily remain as viable before.  The 
experiments with the kurstaki C2 mutant appear to show that increasing 
insecticidal activity can come at the cost of growth rate, which is likely linked to 
the negative frequency dependence it also showed.  However, there is no 
certainty that such a trade-off would occur every time.  If virulence were 
increased through a toxin conformational change giving improved binding to 
midgut receptors there is no reason why this would necessarily carry a 
metabolic penalty.  In any case, C2 still reached sufficient densities to cause a 
detectable spike in host mortality, allowing it to be isolated. 
Finally, it is worth remembering that if a protocol can produce an isolate 
with high insecticidal activity the isolate’s poor competitive ability may not 
necessarily matter.  B. thuringiensis is now primarily used as a source for Cry 
toxins to engineer into transgenic crops (Tabashnik, Brevault et al. 2013).  
Provided the increase in insecticidal ability is linked to changes in the toxin itself 
rather than upregulation of toxin production, the relevant cry gene can be 
removed from the strain, making the strain’s lack of within-host competitive 







III: Selective Passaging of Bacillus thuringiensis while 
Controlling for Within-host Relatedness 
 
Abstract 
 Experimental evolution is well established as a method for exploring 
evolutionary dynamics, including the selective pressures that might affect a 
pathogen’s virulence.  At the same time it is being used in biotechnology to 
produce more efficient enzymes for commercial use.  Bacillus thuringiensis is 
well known in biotechnology for its stock of insecticidal crystal (Cry) δ-
endotoxins which are widely incorporated into pest-resistant crops, along with 
using the bacterium itself as a biopesticide.  In recent years resistance has 
emerged in pests including Plutella xylostella moths.  Experimental evolution of 
B. thuringiensis in its hosts provides a promising avenue for overcoming 
resistance and maintaining the necessary supply of effective toxins.  Social 
theories of virulence suggest that increased relatedness within infections should 
promote cooperation, limiting the appearance of virulence factor cheats.  From 
this it is predicted that increasing levels of within-host relatedness in 
experimental evolution will result in increased levels of virulence. 
 An assessment of the impact of within-host relatedness on the virulence 
evolution of B. thuringiensis was attempted.  B. thuringiensis subsp. aizawai 
was selectively passaged through Cry1Ac-susceptible P. xylostella under four 
relatedness treatments: a control passage, a single bottleneck passage, a two 
bottleneck passage and a coinfection alongside B. thuringiensis subsp. 
entomocidus.  Initial results suggested that the high within-host relatedness 
provided by bottlenecking favoured the evolution of more virulent strains.  
However, after accounting for concerns with the HCO sporulation medium used 
between in vivo passages to increase spore numbers, there was no apparent 
change in virulence for any treatment compared to the ancestor.  The lack of a 
positive result suggests that under the current selective passage protocol 
within-host relatedness has no effect on virulence.  Moreover, poor response to 
selection may have resulted from limitations in the supply of mutations, an issue 





Experimental evolution uses controlled conditions on an evolving 
population to explore the underlying evolutionary processes and test predictions 
about them (Rose and Garland 2009, Kawecki, Lenski et al. 2012, Rafaluk, 
Jansen et al. 2015).  The technique can be a powerful tool to investigate how 
particular genotypes and phenotypes have arisen and the factors that might 
shape them subsequently (Elena and Lenski 2003).  Experimental evolution 
was being utilised even as evolutionary theory appeared, with a contemporary 
of Darwin producing thermophilic protozoa (Dallinger 1878). Experimental 
evolution is most effective in organisms with short generation times and small 
sizes, which allow for large populations (Elena and Lenski 2003).  Along these 
lines, experiments in Drosophila or bacteria are common e.g., Lenski’s 
Escherichia coli long-term evolution experiment or Morgan’s early work with 
Drosophila (Lenski, Rose et al. 1991, Elena and Lenski 2003, Blount, Borland et 
al. 2008, Burke, Dunham et al. 2010); simpler organisms can also be more 
easily characterised phenotypically and have their underlying genotypes and 
mutations identified.  The increasing availability of next generation sequencing 
techniques for identification is likely to have contributed to the increasing use of 
experimental evolution (Van den Bergh, Swings et al. 2018).  Short generations 
and large populations increase the likelihood that phenotypes or genotypes of 
interest are present or will arise within a practical timeframe (Elena and Lenski 
2003).  The former can decrease the absolute time that is then required for a 
genotype to spread through the population, though increasing the size of the 
experimental population will act in opposition.  If the aim is to bring specific 
variation to fixation then the opposing benefits and costs of population size can 
be mitigated via introducing direct selection, greatly increasing the chance of 
phenotype fixation provided there is sufficient heritability (Ebert and Bull 2003). 
Virulence defines the pathogenic lifestyle and understanding its evolution 
has clear applied benefits, most obviously in medicine and agriculture 
(Casadevall and Pirofski 2001, Pirofski and Casadevall 2012).  There are 
examples of pathogens becoming more or less virulent as they continue to 
adapt to hosts; both can be seen in the myxoma virus, with initial attenuation 
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after its release into Australian rabbits, followed more recently by the 
appearance of novel, highly virulent strains (Kerr 2012, Kerr, Cattadori et al. 
2017).  The same increases and decreases have also been produced through 
experimental evolution in multiple different systems (Harrison, Browning et al. 
2006, Ebert 2008, Racey, Inglis et al. 2010, Masri, Branca et al. 2015, Rafaluk, 
Jansen et al. 2015).  Identifying the underlying principles that direct these 
changes should allow for better risk assessment and control of emerging 
zoonotic diseases or improvement in the efficacy of biocontrol.  From the end of 
the 19th century much theoretical work has been done on virulence (Smith 1904, 
Alizon, Hurford et al. 2009), leading to hypotheses such as virulence-
transmission trade-off (Anderson and May 1982).  Better understanding of the 
systems at work (such as the role of cooperation) has led to refined models, but 
these still may not neatly describe all actual results (Alizon, Hurford et al. 2009).  
Models that look to predict the evolution of virulence can then be tested through 
experimental evolution, even if definitions of virulence in theoretical and 
experimental work may not fully overlap (Cressler, McLeod et al. 2016). 
 Experimental evolution with pathogens can take the form of serial 
passage experiments, either in vitro or in vivo, with some of the earliest carried 
out by Pasteur (Mendelsohn 2002, Rafaluk, Jansen et al. 2015) for work on the 
rabies virus.  In vivo these can be coevolution experiments, or hosts can be 
taken from the same population for each round, which can be either naïve or 
have previous experience of the pathogen (one-sided selection) (Rafaluk, 
Jansen et al. 2015).  Hosts are infected with the pathogen(s) of interest and 
then at the desired point in the infection cycle they are collected from the initial 
host and used to infect a new susceptible one.  In passage experiments the 
need to apply pathogen selection and/or experimental constraints from working 
with potentially hazardous organisms mean that transmission is often facilitated 
by the experimenter (Rafaluk, Jansen et al. 2015).  This removes selection 
pressures that may have been acting on the pathogen to maintain effective 
transmission (Day 2001).  The idea of a transmission-virulence trade-off, 
derived from theoretical models, is well established in epidemiology and is 
separate to any effects of multi-strain infections (Alizon and Michalakis 2011).  
In its basic form, a pathogen needs to reproduce sufficiently to ensure there are 
enough infectious forms to infect new hosts.  Reproducing comes at a cost to 
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the host though, with the end result potentially being host death.  Clearly then, if 
the pathogen reproduces too rapidly it may risk killing its current host before 
transmission to new susceptible ones occurs (Frank 1996).  This principal has 
some strong experimental support (Messenger, Molineux et al. 1999, Jensen, 
Little et al. 2006, de Roode, Yates et al. 2008, Alizon, Hurford et al. 2009, 
Doumayrou, Avellan et al. 2013).  Serial passaging can remove this trade-off so 
that there should be no limit on how quickly a pathogen can reproduce and 
correspondingly no limit to how virulent it should become.  However for obligate 
killers such as B. thuringiensis, trade-offs for rapid killing usually occur in terms 
of reduced production of infectious particles, especially if early death curtails 
host growth (Ben-Ami, Mouton et al. 2008, Raymond, Ellis et al. 2009). 
 Transmission is commonly thought to rely on either a vector between 
hosts or on an infected host being in close proximity to susceptible ones.  
Bacillus thuringiensis does not appear to require these mechanisms, instead 
using spores that can persist near-indefinitely in the environment under 
favourable conditions – spores can be found at high levels in soil globally 
(Martin and Travers 1989, Bizzarri and Bishop 2008, Ruan, Crickmore et al. 
2015).  However, there is evidence that spores can be recruited from the soil to 
leaves by plants (Raymond, Wyres et al. 2010) and of phoresis with nematodes 
in soil (Loguercio and Argolo-Filho 2015, Ruan, Crickmore et al. 2015).  While 
there appears to be no direct trade-off between transmission and virulence for 
B. thuringiensis, as it does not require a live host for transmission, there still 
may be trade-offs between vegetative growth rate and quantity or quality of 
spores – less robust spores may not persist in the environment sufficiently long 
for a host to ingest them.  Cry toxin production also occurs during spore 
formation (Hendriksen 2016) and could be involved in similar trade-offs, with 
more virulent strains producing fewer spores or toxins (Raymond, Ellis et al. 
2009).  Trade-offs between growth and spore/toxin production may also lead to 
cheats and selfish loss of toxin production (Turner and Chao 2003, Raymond, 
West et al. 2012, Deng, Slamti et al. 2015). 
There is clear evidence that the virulence-transmission trade-off can be 
realised in serial passages with end-point strains producing higher mortality 
than ancestors in hosts, though increasing virulence appears to be favoured in 
novel hosts versus attenuation in former hosts (Ebert 1998).  This evolution 
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through passage also implies that any initial infection contains variation, or that 
variation is rapidly generated during the infection (Alizon, de Roode et al. 2013).  
If this is the case for B. thuringiensis then it may provide a viable method for 
producing more virulent strains that could be commercialised – either directly, or 
by taking cry genes for use in transgenic crops.  This could be employed either 
to overcome emerging resistance in pests such as Plutella xylostella (Zhang, 
Zhang et al. 2016, Tabashnik and Carriere 2017) or potentially to adapt a strain 
to novel pest species.  If passages are to be used for commercial means then 
then they must be shown to be an efficient and effective way of improving 
virulence in the passage host.  It is therefore prescient to investigate factors 
within a passage experiment that might favour the evolution of increased 
virulence.  This is important beyond the application as it may also provide 
further support to particular theoretical views on the evolution of virulence. 
For selective passaging to work, there must be variation present in the 
initial populations.  In the case of B. thuringiensis, the aim is to select for an 
increased mortality phenotype with the expectation that this reflects change in 
underlying toxin genotypes.  Variation in 3-domain Cry toxin peptide sequences 
should result in conformational changes to toxins when cleaved and activated in 
the insect midgut. This should affect their binding affinity to receptors on cells 
lining the gut (Park, Herrero et al. 2015, de Almeida Melo, Soccol et al. 2016).  
Improved binding could cause greater pore formation in the membranes of gut 
lining cells, resulting in more cell death and increased breakdown of the lining – 
though this assumes binding is the rate-limiting step in pore formation.  This is 
both sufficient to cause mortality alone and increases the number of bacteria 
that can pass into the haemocoel, causing septicaemia (Raymond, Johnston et 
al. 2009). 
The majority of Cry toxins are 3-domain (though certain toxins may lack 
one or more) (Aronson and Shai 2001, Xu, Wang et al. 2014) and it appears 
that the high diversity of these toxins has been generated partly through domain 
swapping in corresponding genes (Bosch, Schipper et al. 1994, Zheng, Gao et 
al. 2017).  Such recombination in mixed infections has already been shown as 
central to the existing diversity of Cry toxins and within-host conjugation rates 
can be very high (Vilas-Boas, Vilas-Boas et al. 1998, de Maagd, Bravo et al. 
2001).  Domain swapping could be further facilitated by the ease with which cry 
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genes can be exchanged between strains (bringing them into contact with novel 
partners to exchange domains with).  Horizontal gene transfer rates are high in 
Bacillus (Didelot, Barker et al. 2009) and cry genes are primarily plasmid-borne 
(Meric, Mageiros et al. 2018).  Considering this in terms of increasing virulence 
through selective passaging, it may mean that using multiple strains in the same 
passage will increase domain shuffling or horizontal gene transfer in general.  
Shuffling could be of both plasmids (and toxin genes they carry) between 
bacteria and domain regions between genes, increasing toxin variation for 
selection to act on. 
Allowing for co-infections between two (or more) strains in an infection 
can affect the overall observed virulence through competition (Frank 1996).  
Virulence models that take into account public goods (as Cry toxins are) show 
that as relatedness in an infection decreases, investment in virulence should 
also decrease (Brown 1999, Brown, Hochberg et al. 2002, Garbutt, Bonsall et 
al. 2011).  Bacteria stop cooperating and instead divert energy to spiteful 
behaviour, such as the release of bacteriocins, rather than growth.  While this 
could be explored with two distinct strains, their differing toxin suites may 
confound any potential observed changes.  As the stated aim here is to 
increase virulence then relatedness of the pathogen population should be kept 
high through the course of the passage, to prevent the emergence of Cry-null 
mutants or other cheats (Deng, Slamti et al. 2015).  The selective nature of the 
passage does not aid in controlling relatedness, as selection only occurs 
between (alive and dead) hosts rather than within-host.  The only way to control 
relatedness within-host is to restrict the founding population, though this will not 
prevent clonal interference between emerging mutants.  Restriction already 
appears to occur at the start of an infection, as most spores in the gut will pass 
through without proliferating in the haemolymph (Zhou, Slamti et al. 2014, van 
Leeuwen, O'Neill et al. 2015) and in hosts with high susceptibility to a particular 
toxin-strain combination, ingesting only a few spores may be sufficient to cause 
host death (Cornforth, Matthews et al. 2015).  In silico work also predicts that 
ingesting small spore numbers should select for more virulent strains (Strauss, 
Crain et al. 2016).  However, this is less useful in an experimental system, 
particularly when an aim of the passaging is to increase the virulence of strains 
that currently need to be ingested in larger quantities to be effective.  Instead, 
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after recovering spores from cadavers, taking a single colony and then growing 
the infective dose up from this for the next round may be sufficient. 
Bottlenecking to give a smaller founding population will ensure that high 
levels of relatedness are maintained (Frank 1996), with shared ancestry also 
giving similar relatedness over all alleles (Rumbaugh, Trivedi et al. 2012).  
However, the expected higher virulence of the infection is because of 
circumstances that favour maintenance of cooperation rather than any novel 
evolutionary change.  Retaining high levels of relatedness will purge cheats 
from the population as well as genetic variation in general.  In any public goods 
situation cheats are expected to invade a population of producers as 
relatedness falls (Brown, Hochberg et al. 2002, Garbutt, Bonsall et al. 2011), 
reinforcing the need for bottlenecking here.  Purging cheats though is just an 
alternate way of saying that variation is being removed from the population, 
even if it undesirable variation in this case.  This means that there needs to be a 
balance between maintaining relatedness but still allowing variation in pathogen 
virulence to persist so that higher virulence can then be selected for.  Work by 
Garbutt, Bonsall et al. (2011) showed that mixed infections of B. thuringiensis 
produced isolates that were better at suppressing competitors but gave lower 
mortality.  In serial passaging this appears best achieved by varying the rate of 
bottlenecking across treatments in search of an optimal level. 
Previous work has already shown that for a given passage treatment 
cadavers from a particular treatment should not have all the spores they 
produce pooled together into a single group for the next round.  Instead, sub-
lineages should be maintained through the passage, as explained in the 
methods.  Doing so produced more virulent clones and already confirms that 
relatedness can affect passage outcome (Dimitriu, Crickmore et al. unpub. 
data).  This may also be because increased structuring in the overall B. 
thuringiensis population can better explore the landscape of mutations that 
would increase virulence (Nahum, Godfrey-Smith et al. 2015).  Bottlenecking 
should allow for further fine control of the levels of relatedness. 
B. thuringiensis has been successful as a biopesticide and tool for 
producing transgenic crops (Tabashnik, Brevault et al. 2013) because its Cry 
toxins have narrow target ranges but high diversity across these ranges 
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(Schnepf, Crickmore et al. 1998).  High mortalities place strong selective 
pressure on evolving resistance, as seen by resistant populations of P. 
xylostella emerging in the field (particularly South East Asia) to all commonly 
used B. thuringiensis toxins (Iqbal, Verkerk et al. 1996, Gong, Wang et al. 2010, 
Zhang, Zhang et al. 2016).  While robust agricultural and pest management 
practices may reduce the accumulation of resistance and limit the turnover of 
toxins (Gould 1998, Tabashnik, Brevault et al. 2013), novel ones to overcome 
resistance will still be required.  Resistance to Cry toxins may be a result of 
changes in binding affinity with receptors in the midgut (Ayra-Pardo, Raymond 
et al. 2015), although multiple resistance genes have been identified even 
within the same population of P. xylostella (Gonzalez-Cabrera, Herrero et al. 
2001).  However, the exact mode of resistance that needs to be overcome 
should not matter when selecting for virulence at the host level. 
The work carried out here will attempt to increase the effectiveness of B. 
thuringiensis subsp. aizawai in Cry1Ac-susceptible P. xylostella larvae through 
varying the level of relatedness in selective passages.  The aizawai strain is 
principally used commercially because it produces higher mortality in pests 
such as P. xylostella that have become resistant to kurstaki and its Cry1Ac 
toxin, or can provide effective control of pests that are not particularly 
susceptible to the Cry1A toxins e.g., Spodoptera (Polanczyk, da Silva et al. 
2000).  However, aizawai toxicity in Cry1Ac-susceptible P. xylostella is much 
less than that of commercially exploited B. thuringiensis kurstaki strains 
(Chapter II, figure 2.3).  These passages will attempt to raise its effectiveness 
against Cry1Ac-susceptible larvae; within-host relatedness can be controlled by 
isolating a single colony from the previous round and growing it up to the 
infective dose.  The expectation is that the treatments with more bottlenecking 
will produce more virulent lineages at the passage end.  An additional treatment 
will greatly increase the variation in-host by coinfecting B. thuringiensis subsp. 
entomocidus alongside aizawai.  While this could increase the material 
available for horizontal transfer, it could also favour the emergence of 





B. thuringiensis subsp. aizawai and entomocidus marker plasmid transformation 
B. thuringiensis subsp. aizawai X1 isolated from XenTari® (Valent 
BioSciences LLC; Chapter II) spore product was transformed with plasmid 
pHT315 carrying gfp and eryR for erythromycin resistance and B. thuringiensis 
subsp. entomocidus (BGSC 4I4) transformed with pHT315 carrying DsRed and 
tetR for tetracycline resistance (Zhou, Slamti et al. 2014), using the methods 
described in Chapter I. Colonies grown after transformation were re-streaked on 
selective antibiotic plates and viewed under UV light to confirm plasmid uptake, 
giving Bta pHT315-gfp-eryR and Bte pHT315-DsRed-tetR. 
 
Initial spore production 
A single clone of Bta pHT315-gfp-eryR was isolated and used to 
inoculate 40 1ml wells of HCO sporulation medium (Lecadet, Blondel et al. 
1980) in 24-well plates.  The 24-well plates were sealed with tape and 
incubated for six days at 30oC with 150rpm shaking.  After incubation, wells 
were pooled into four 15ml Falcon tubes and centrifuged at 3,200g for 6mins.  
The supernatant was discarded and pellets re-suspended in 500µl saline (0.85% 
NaCl) with 0.05% Triton X surfactant and pooled into two Eppendorfs.  Pooled 
spores were pasteurised at 65oC for 25mins in a heat block.  Spores were 
diluted in series to 10-7 with saline with 0.05% Triton X surfactant and plated out 
on 20µg/ml erythromycin 2% LB agar plates and incubated overnight at 30oC to 
confirm spore counts.  The Bta pHT315-gfp-eryR spores were diluted to 
20cfu/µl, which was expected to give approximately 30% mortality based on 
existing bioassay data, and plated out again to confirm cfu/µl. 
 
Selection treatments & selective passaging (figure 3.1) 
Cry1Ac-susceptible Plutella xylostella larvae (VLSS population) were 
divided into four treatments: control treatment, two treatments with population 
bottlenecks (either after second and fourth passage rounds or only after third) 
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and coinfection treatment where aizawai was infected alongside Bte pHT315-
DsRed-tetR.  The treatment with two bottlenecks should maintain the highest 
within-host relatedness, so the hypothesis is that it will produce the greatest 
increase in virulence.  For the co-infection treatment, aizawai and entomocidus 
spores were mixed in ratio 4:1 while maintaining a constant aizawai spore 
density of 20cfu/µl.  For each treatment there were four replicates, each with 10 
subpopulations of larvae per passage round.  For the first passage round a 
quarter of sterile diet in 50mm Petri dish was coated with 100µl of spore 
suspension and allowed to dry, then 12 late second-instar larvae added per 
subpopulation.  This meant 120 larvae per replicate and 480 larvae in each 
treatment round.  Subpopulations were incubated at 24oC, and cadavers 
counted every day.  When mortality reached approximately 25% (usually after 
three days) in subpopulations, cadavers in the five subpopulations with the 
highest (or earliest if tied) mortality were collected into a 1.5ml Eppendorf using 
a sterile toothpick and 10µl saline added.  Cadavers were then incubated at 
30oC for three days.  50µl of saline was added and the cadavers mashed in 
Eppendorfs using sterile toothpicks.  50µl was then transferred into 1ml of HCO 
sporulation media with 20µg/ml erythromycin in a 24-well plate, with one well 
per subpopulation.  Plates were sealed with tape and incubated for six days at 
30oC with 150rpm shaking. 
After incubation, each well had 2x200µl of culture transferred to wells in a 
96-well PCR plate (for inoculating the next passage round) and a third 200µl to 
another PCR plate (for freezing).  Plates were centrifuged at 3,200g for 15mins 
and 180µl of supernatant removed.  Spores for the next passage round were re-
suspended in 80µl saline, and those for freezing were re-suspended in 100µl of 
saline.  The PCR plates for the next round were pasteurised at 65oC for 25mins 
in a thermocycler and stored at 10oC until use; spores for freezing were stored 
at -20oC.  To produce inocula for the next passage round, the spore stocks 
were diluted in series using saline down to 10-3 and plated out onto selective 
plates to give colony counts.  These counts were then used to adjust dilutions to 
give the desired inocula.  For the co-infection treatment, the erythromycin added 
to the HCO sporulation media selected out any Bte pHT315-DsRed-tetR that 
had persisted through the infection, and so these were added to the inocula 




Figure 3.1: Selective passage protocol – core steps between infection rounds. 
1 In a treatment replicate, the five subpopulations with the highest mortality 
are selected and cadavers from each moved to an Eppendorf. 
Cadavers, with 10µl saline added, are incubated for three days at 30oC. 
50µl of saline added and cadavers mashed using sterile toothpicks. 
2 50µl inoculated into 1ml HCO with 20µg/ml erythromycin and incubated 
at 30oC for six days. 
3 2 x 200µl moved into PCR plate wells and centrifuged at 3,200g for 
15mins. 
Spores re-suspended in 80µl saline, diluted in series and plated for 




After the fifth round, for each treatment replicate, spores from the 
subpopulation with the highest mortality in the fifth round were diluted to 40 and 
20cfu/µl; higher dilutions could not be used because of the number of spores 
collected.  These were bioassayed against Cry1Ac-susceptible larvae alongside 
the ancestor, with 60 larvae per treatment dilution.  Spore inocula were added 
to quarters of sterile diet in 50mm Petris, with 100µl of inoculate per quarter, 
and then 12 late second-instar larvae added per Petri.  These were incubated at 
24oC for five days and then mortality scored.  Spores collected from 
subpopulations were also grown up in HCO (as described above) to produce 
further spores for a repeat bioassay at higher cfu/µl.  This bioassay was carried 
out in the same manner as the previous one, but with spore dilutions at 500, 
100 and 20 cfu/µl. 
However, complications over spore viability (as covered in Results) 
meant additional bioassays were needed.  Rather than being based on spore 
counts, they were based solely on dilution factors from spore stocks grown up in 
HCO from those collected from subpopulations after the final passage round.  
All spores were diluted in a 3-fold series from a 750x dilution to 182,250x 
dilution, and these used in further bioassays against Cry1Ac-susceptible larvae 
as previously described.  Actual cfu/µl counts were then also taken for these 
dilutions.   
Finally, spore production in the aizawai X1 ancestor and passaged 
lineages was also assessed.  10µl of each were inoculated into 5ml 2% LB and 
incubated overnight at 30oC with 150rpm shaking.  Overnight cultures were 
diluted 10-3-fold and 10µl of each inoculated into 1ml HCO in 24-well plates.  
These were sealed and incubated for four days at 30oC with 150rpm shaking.  
Culture samples were taken at two, three and four days and 10µl of each 
sample was also plated out onto 20µg/ml erythromycin 2% LB agar and colonies 
counted.  Samples were also taken at the same points and then pasteurised at 
65oC for 25mins and then stained and plated out in the same manner. 
This was then repeated with growth in both HCO (Lecadet, Blondel et al. 
1980) and improved HCO adapted from Lecadet (Chapter I Methodology; with 
filter-sterilised salts added after initial autoclaving), with 10µl samples taken at 
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two and three days from both media and then pasteurised at 65oC for 25mins.  
Pasteurised and unpasteurised samples were stained on glass slides with 
Giemsa stain and then endospores and cells counted under a confocal 
microscope at 400x magnification. 
 
Statistical analysis 
For bioassay analysis larvae were recorded as either alive or dead, 
allowing mortality to be considered in terms of GLMs with binomial errors.  To 
account for over-dispersion with a standard binomial distribution a 
quasibinomial one was then used.  This was tested using the F-statistic at the 
overall level against a significance level of p < 0.01, given the noisiness of 
bioassay data, and using the t-statistic for within-treatment tests.  Bioassay 
mortality data were analysed in RStudio 1.1.456 (based on R 3.2.5; R Core 






 Preliminary work showed both that an antibiotic was needed during the 
HCO growth step to prevent contamination, and erythromycin at 20µg/ml was 
more effective at preventing it than tetracycline when combined with the 
corresponding resistance marker in transformed aizawai X1.  During passaging 
not all replicates for each treatment could be continued through all five rounds 
to the end.  This was primarily because of problems during the HCO growth 
step.  Of the four treatments used in the passages, only the single bottleneck 
treatment had all four replicates pass through all five passage rounds.  Three 
replicates reached the end for the two bottleneck treatment, two for the no 
bottleneck one and only a single replicate for the co-infection passage.  This 
was because the wells in these replicates failed to produce any spores after a 
particular round and so could not be continued. 
 The replicates that did continue through to the end of the passage each 
had all the spores produced from their final subpopulations pooled together and 
bioassayed.  This clearly showed (figure 3.2) that overall passage treatment 
was highly significant (F4, 16 = 48.9, p = 9.02 x 10
-9), though only the two 
bottleneck treatment produced lineages that gave significantly higher mortality 
than the ancestor (t16 = 6.126, p = 1.46 x 10
-5), appearing to confirm the initial 
prediction that high relatedness matters to virulence.  However, a repeat 
bioassay (figure 3.3), while still showing treatment as significant overall (F4, 27 = 
13.8, p = 2.94 x 10-6), now had only the single bottleneck treatment as 
producing a significantly different mortality (t27 = 3.01, p = 5.66 x10
-3) and this 
was now lower than the ancestor.  It was also apparent when preparing spores 
for the bioassays that the visible quantities of spores in Eppendorfs did not 
correspond to plate counts they produced when diluted down to produce 
inocula, with the plate counts being lower than expected.  This meant the result 
above could not be taken at face value.  Replicates that appeared to have low 
spore counts would be diluted far less to reach inoculation levels, and so in fact 





Figure 3.2: Bioassay mortalities of one lineage per passage treatment replicate 







Figure 3.3: Bioassay mortalities of one lineage per passage treatment replicate 
in Cry1Ac-susceptible P. xylostella larvae against the wild-type aizawai X1 
ancestor.  This was a repeat of the bioassay carried out in figure 3.2. 
 
 To confirm this a third bioassay was carried out, except rather than using 
absolute counts replicate pool spores were all diluted by the same factors, and 
then counts also taken from these dilutions.  In this bioassay, whether 
measuring against dilution factor (figure 3.4) or spore count (figure 3.5) there 
was no difference in host mortality for the passage treatments compared to the 
ancestor (for dilutions: F4, 64 = 1.91, p = 0.121; for spore counts: F4, 51 = 0.601, p 
= 0.663).  It therefore seems likely that any differences in the initial bioassay are 
a result of differences in sporulation and the viability of spores produced.  The 
lack of any difference in mortality between replicate pools meant that no 
individual isolates were subsequently assessed.  Likewise, given the concerns 
over the mortalities produced at the end it was not considered worthwhile to 





Figure 3.4: Bioassay mortalities of one lineage per passage treatment replicate 
in Cry1Ac-susceptible P. xylostella larvae against the wild-type aizawai X1 
ancestor.  The x-axis uses dilution levels for spores, rather than spore numbers 





Figure 3.5: Bioassay mortalities of one lineage per passage treatment replicate 
in Cry1Ac-susceptible P. xylostella larvae against the wild-type aizawai X1 
ancestor.  This uses the same data as figure 3.4, but using cfu/µl counts taken 
from the dilutions. 
 
 Testing the sporulation rates of the ancestor and passaged strains in the 
same HCO formulation (figure 3.6) showed that after four days the ancestor 
produced more viable spores than any of the treatment strains (F4, 54 = 6.15, p = 
3.73 x 10-4).  When vegetative cell and spore counts were compared under 
microscope with Giemsa staining there was no overall effect of passage 
treatment on sporulation rates (F4, 230 = 3.38, p = 0.0104), though the single 
bottleneck and entomocidus coinfection treatments did have lower rates than 
the ancestor (t228 = 3.05, p = 2.53 x 10
-3; t228 = 3.07, p = 2.37 x10
-3).  
Unsurprisingly, there was a higher proportion of spores in samples after 
pasteurisation (F1, 228 = 12.2, p = 5.62 x 10
-4) though not by as much as 
expected, possibly because vegetative cells killed by pasteurisation were still 
visible and so counted.  HCO sporulation medium type also mattered, though 
these counts suggest that the original Lecadet version produced a higher 
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proportion of spores (F1, 229 = 24.6, p = 1.41 x10




Figure 3.6: Sporulation rates of passage treatments against aizawai X1 
ancestor.  Plate counts were taken from HCO cultures after 2, 3 and 4 days 
incubation at 30oC, before and after pasteurisation.  Pasteurisation survival 





Figure 3.7: Sporulation rates of passage treatments against aizawai X1 
ancestor.  Vegetative cells and spores were counted under microscope with 
Giemsa staining. Counts were taken from HCO cultures (Lecadet, Blondel et 
al.’s (1980) original protocol or the improved protocol with filter-sterilised salts 
added after autoclaving) after 2 and 3 days incubation at 30oC, before and after 
pasteurisation. 





Strong population bottlenecking appeared to favour the evolution of more 
virulent strains, through a reduction in within-host relatedness.  However, after 
conducting further bioassays accounting for sporulation rates caused by the 
since-changed HCO sporulation medium, no passage treatment produced 
isolates with significantly different virulences compared to the B. thuringiensis 
aizawai ancestor.  It therefore appears that under the passage protocol used 
here virulence is not significantly affected by within-host relatedness; this 
neutral outcome may have resulted from a lack of available variation, which will 
be addressed in Chapter IV. 
 
For the selective passage treatments to vary within-host relatedness it 
was expected that the treatment which maintained the highest level of 
relatedness would produce B. thuringiensis subsp. aizawai X1 lineages with the 
highest mortality in Cry1Ac-susceptible P. xylostella larvae.  Initially it appeared 
this was the case, with the two bottleneck treatment producing isolates that 
gave approximately five times higher mortality than the ancestor at the same 
dose.  Producing these mortality results after only five passage rounds would 
have been a promising success.  However, subsequent work with the passaged 
lineages strongly suggested that any apparently significant results were affected 
by sporulation success in HCO and spore viability.  This likely also explains the 
problems with losing replicates through the course of the passage because of 
insufficient spores being produced.  Once these were accounted for, it appears 
that controlling within-host relatedness limits the ability to select for improved 
virulence, a potential concern noted in the introduction. 
 There appear to be two possible explanations for the actual results.  The 
first is that passaging had no effect on aizawai, and this appears to be the case 
for its insecticidal abilities.  The loss of replicates during sporulation could be 
down to insufficient bacteria being carried over from cadavers, although this 
appears unlikely as only a few spores should be need to inoculate the HCO and 
spore densities in cadavers should easily be sufficient for this (Raymond, Ellis 
et al. 2009).  It is also unlikely that larvae otherwise dead were misidentified as 
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B. thuringiensis cadavers, as these are easily distinguishable.  An alternative is 
that the passage selection protocol actually selects for something else and this 
overrides the aim of selecting for increased host mortality, although it has been 
suggested that in coevolution systems biotic selection pressures should 
override abiotic ones (Scanlan, Hall et al. 2015). 
 The most likely other target of (unintended) selection is sporulation.  The 
bacteria spend five days of each passage round growing in HCO sporulation 
media, which is longer than they spend in live hosts.  After growth in HCO the 
spores are pasteurised which should kill any vegetative cells so there is strong 
selective pressure to sporulate sufficiently quickly.  Any particular lineage in the 
HCO that does not will be killed during pasteurisation and not infect the next 
round of hosts nor persist through the passage.  Sporulation and Cry toxin 
production are tied together, with B. thuringiensis strains producing the majority 
of their Cry toxins during sporulation (Aronson and Shai 2001, Deng, Peng et al. 
2014): triggering of cry genes linked to sporulation is controlled at multiple 
levels including through transcription by the chromosomal sporulation-specific 
sigma factors SigK or SigE (Deng, Peng et al. 2014).  Increasing investment in 
one of sporulation or toxin production may come at the other’s expense, 
particularly given the huge investment in producing Cry toxins which may make 
up 25% of a spore’s weight (Agaisse and Lereclus 1995).  This is perhaps 
illustrated by a strain of B. thuringiensis that has two forms for a division of 
labour, one a spore-former without toxins and the other a crystal producer that 
subsequently lyses to release them (Deng, Slamti et al. 2015).  Increasing toxin 
production could be one way mortality is increased through selection, so also 
potentially selecting for faster sporulation would appear to counter to this.  
Pasteurising after five days should allow sufficient time for this pressure to be 
minor – the aizawai ancestor appeared to show more than 95% sporulation after 
four days.  However, this would not necessarily prevent particular cheats from 
arising in the HCO that grow and sporulate even faster to make up a greater 
proportion of the spores collected for the next passage round. 
 Whatever additional selection pressures the HCO growth stage 
introduces, it seems difficult to exclude it from the passaging protocol.  
Preliminary work showed there were insufficient spores available to produce 
required doses and mortality for the next passage round if spores were taken 
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directly from cadavers.  While the larvae used were raised under sterile 
conditions and passages also set up under them, it was also apparent that 
antibiotic screening was needed to prevent contamination.  Both of these could 
be achieved by growing up collected spores in HCO, while there is no obvious 
method that would negate this step and its additional selective pressures on 
sporulation.  Using strains that do not require a large infective dose to negate 
the HCO step would be reductive – a strain that requires a small dose already 
will cause high mortality and not need improving through selective passaging. 
 While increasingly rapid sporulation is perhaps the expected outcome of 
using an additional growth step it does not appear that this was the main 
problem with the passage, as sporulation rates appear higher in the aizawai X1 
ancestor (figure 3.6).  HCO is an established sporulation medium for B. 
thuringiensis (Lecadet, Blondel et al. 1980) and, despite the sporulation rates 
observed under microscope (figure 3.7), comparing these passages and 
subsequent in-lab work strongly suggested that the Lecadet protocol used here 
might affect its viability.  In particular, the Fe2(SO4)3 added before autoclaving 
did not always remain in solution; adding it and MgSO4.7H2O as filter sterilised 
solutions after autoclaving appeared to improve the viability of spores.  While 
HCO needs to be nutrient poor for starvation to trigger sporulation in Bacillus 
(Narula, Kuchina et al. 2015), the apparent lack of iron cations may have 
hindered successful sporulation, as adding trace iron sulphate to brewer’s yeast 
extract appears to greatly improve B. thuringiensis sporulation rates in it 
(Saksinchai, Suphantharika et al. 2001).  Again, it might be expected that the 
strains passaged through this HCO would adapt to it, but they all had lower 
sporulation rates than the ancestor.  It is likely that the competing selective 
pressures of sporulation and host mortality produced this outcome, though it is 
difficult to unpick exactly why this particular result was produced, or how (if at 
all) the different levels of relatedness imposed by the passage treatments factor 
in to it.  It also may be the case that Cry toxins attached to the surface of spores 
may aid in initial germination (Du and Nickerson 1996), so non-ideal sporulation 
conditions could potentially affect germination through disruption of this 
mechanism. 
 Despite the discovered concerns over the HCO sporulation medium 
used, it seems unlikely based on these results that changing the medium would 
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drastically affect the mortality of lineages at the passage end.  It is not certain 
how effective trying to control for apparent poor sporulation was, but the results 
from the secondary bioassays based on dilutions rather than absolute counts 
suggest that there was no change in mortality.  As discussed, sporulation and 
Cry toxin production are linked but the inability to sporulate or return to 
vegetative growth does not appear to have affected overall toxin production 
here.  If toxin production was directly linked to viable spore production then the 
initial bioassay would not have suggested such a high mortality in the double-
bottleneck treatment.  The small number of viable spores meant it was hardly 
diluted for bioassays, so if there were large volumes of toxin this would not have 
been diluted, giving the increased mortality levels observed.  In any case there 
are many other mechanisms through which mortality could be increased 
depending on the underlying mode of resistance, such as conformational 
changes to Cry toxins to restore binding efficiency to defective binding sites, or 
increased production of any other virulence factors a strain might possess such 
as vegetative insecticidal proteins. 
 As covered, relatedness should favour higher virulence but it will also 
limit the availability of variation for selection to act on.  Strong bottlenecking may 
also allow genetic drift rather than selection to drive evolution, which could 
decrease fitness relative to the desired outcome (Silander, Tenaillon et al. 
2007).  Variation across the experiment could be improved by increasing the 
numbers used (or mutation rates, discussed below) – more passage rounds or 
more larvae used each round, either by increasing the number of replicates or 
subpopulations within the replicates.  However, increasing the number of larvae 
or passages used without error is not practical for a single experimenter, though 
automation of experimental evolution is increasing principally to enable larger-
scale experiments (Van den Bergh, Swings et al. 2018).  Previous selective 
passages as part of the same overall project suggest that lineages with higher 
mortalities can be produced within the number of passage rounds used here 
(Dimitriu, Crickmore et al. unpub. data).  Also, this is partly an attempt to find 
efficient means of overcoming resistance and increasing the number of passage 
rounds (and time taken) would dilute this aim.  This leaves variation as the most 
practical avenue to explore further.  The passages here did include a co-
infection treatment with aizawai and entomocidus that would have increased 
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variation relative to other treatments, but there may still have been limited 
within-strain variation so the net effect of having two strains may have been 
limited.  Additionally, B. thuringiensis strains produce bacteriocins which could 
be employed against each other (Raymond, Johnston et al. 2010, Garbutt, 
Bonsall et al. 2011).  Antibiotic screening meant only aizawai was recovered 
after each passage round; this may have selected for aizawai that were good 
competitors e.g., through increased bacteriocin production, so they could be 
collected for the next round.  This also fits with theoretical views that lower 
relatedness should lead to a breakdown in cooperation and lower virulence 
(Strauss, Crain et al. 2016).  It was hoped the increased opportunities for 
horizontal exchange between strains with different toxin suites would offset this, 
but this does not appear to be the case, at least under the experimental 
conditions employed here. 
 Infecting with a larger dose would increase the variation within-host but 
this is of limited practical value.  The strains used here were from clonal stocks 
so initial variation should be minimal.  It is desirable that this remains the case 
as it means any isolates can be compared directly back to the ancestor, both in 
bioassays and then potentially via sequencing if lineages of note are identified.  
Also, the starting dose is strongly constrained by the need to produce 
intermediate mortality in the hosts.  If all or none of the hosts die in most of the 
subpopulations of a replicate then it is impossible to apply selection when 
collecting spores.  Therefore variation needs to be increased for a given 
population (inoculate) size rather than just increasing overall population size. 
 If population size cannot be altered, variation can instead be raised by 
increasing the rate of mutation, which can be achieved potentially either 
internally or externally.  As few as 1-2% of mutations in bacteria are thought to 
be beneficial, with strongly beneficial ones only a fraction of this (Eyre-Walker 
and Keightley 2007, Sniegowski and Gerrish 2010), and the work here is only 
interested in a subset that will increase host mortality.  Increasing the mutation 
rate should therefore increase the rate at which mutations of interest appear, 
and random mutagenesis has been widely used to improve particular qualities 
of genes or genomes (Labrou 2010).  Working with bacteria rather than higher 
organisms allows for a greater degree of genetic manipulation, through which 
the intrinsic mutation rate of the organism can be altered.  This can be done for 
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the whole genome by altering or removing genes involved in the proofing of 
DNA copying to increase the copy error rate e.g., by silencing the mutS 
mismatch repair gene (Horst, Wu et al. 1999, Packer and Liu 2015).  The 
alternative is to introduce triggers for mutation such as radiation or chemical 
mutagens.  These tend to favour a particular type of mutation depending on the 
mutagen employed e.g., alkylating agents like ethyl methanesulfonate causing 
alkylated guanine to be paired with thymine (Sega 1984). 
Using a mutagen over a mutator strain appears to have a number of 
benefits.  The mutagen concentration, and therefore mutation levels, can be 
calibrated and controlled, while it can be introduced for a limited period during 
the protocol rather than being present throughout.  The problems with 
sporulation in this selective passage suggest that it might be unwise to 
complicate this step further through adding mutagens to it.  Additionally, at the 
end of the passage any isolates of interest can be used as they are, instead of 
fixing mutator genes.  Potential downsides of using mutagens are they will be 
harmful to the experimenter and so might place additional safety constraints on 
experimental procedure, while neither mutation method as described is site-
directed.  The effects of mutation rate on within-host competition and virulence 
evolution have been explored in a similar system with Psedomonas aeruginosa 
in Galleria mellonella waxmoth larvae, which suggested that increased mutation 
rates may favour increased virulence (Racey, Inglis et al. 2010); selective 
passaging could potentially enhance this further. 
 While increasing variation with mutagens is a potential pathogen-focused 
avenue, work by Masri, Branca et al. (2015) with B. thuringiensis BT-679 in 
Caenorhabditis elegans nematodes suggests that changes could also be made 
to how the host is used.  The P. xylostella larvae used here were replaced each 
passage round from the same naïve lab population which excluded any 
opportunities for coevolution.  While the myxoma virus showed that coevolution 
can lead to both attenuated and highly virulent strains (Kerr, Cattadori et al. 
2017), theoretical work suggests that a coevolving pathogen should be under 
extremely high selective pressure from the correspondingly increasing host 
resistance (Woolhouse, Webster et al. 2002, Zaman, Meyer et al. 2014).  When 
restored to a naïve host a coevolving pathogen is freed from the resistance 
mechanisms it has been battling to overcome, giving higher mortality compared 
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to either it in the coevolved host or the ancestral strain in a naïve host.  In the C. 
elegans experiment, BT-679 lineages were more virulent after coevolution than 
pathogen-only evolution and in particular this corresponded to an increase in 
toxin plasmid copy number (Masri, Branca et al. 2015).  For the passage here 
including coevolution was considered a treatment too many above looking for 
effects of within-host relatedness. 
 A final consideration is whether or not aizawai was an appropriate strain 
to use in this passage experiment.  The strain was chosen in part because it is 
a well-known, commercialised strain and because of its limited effectiveness 
compared to kurstaki against Cry1Ac-susceptible larvae; as part of the overall 
project a similar passage was already being carried out with kurstaki in Cry1Ac-
resistant larvae (Dimitriu, Crickmore et al. unpub. data).  It may be the case that 
the current insecticidal activity of aizawai in Cry1Ac-susceptible hosts 
represents a local fitness peak and its toxin suite cannot be made more 
effective in this host background through selection (Orr 2009).  Much of the 
diversity of Cry toxins in B. thuringiensis is thought to have arisen from 
horizontal transfer between strains to give different toxin suites alongside 
domain shuffling between toxins to produce new ones with novel effectiveness 
(Bosch, Schipper et al. 1994, de Maagd, Bravo et al. 2001, Meric, Mageiros et 
al. 2018).  Therefore, even with increasing variation it may not be possible to 
increase the effectiveness of aizawai to the Cry1Ac-susceptible host population 
used here because its toxin suite is too different.  This suggests that future work 
with this protocol might be more effective at restoring insecticidal activity in 
strains that have recently encountered resistance, as the desired fitness peak to 
overcome the resistance mechanism e.g., restoring effective Cry toxin binding, 
could be within reach. 
  Experimental evolution should negate the need for mass screening of 
toxins as a selective regime could produce Cry toxins which are now highly 
effective against the initially resistant host.  Identifying optimal conditions for the 
production of highly virulent strains should allow for a set protocol where, once 
obtained, resistant pests immediately can be used in the protocol to produce a 
strain and ideally a specific Cry toxin that can then be employed successfully in 
the field.  Alternatively, production of Cry toxins could be increased, giving a 
larger dose for a given number of spores.  This can be achieved through 
122 
 
genetic editing such as increasing cry gene copy number or expression of P20 
helper proteins (Arantes and Lereclus 1991, Shao, Liu et al. 2001), but could 
also be an outcome of selecting for higher mortality through passaging, rather 
than specific changes to Cry toxin effectiveness. 
 The selective passage protocol employed here requires further work.  
For certain, the concerns over the particular HCO sporulation medium used 
here need to be resolved before attempting to use it again.  Experimental 
evolution has already been employed successfully for biotechnological aims 
(Van den Bergh, Swings et al. 2018) and there is no reason why further work 
with B. thuringiensis and selective passaging to overcome resistance will not 
ultimately be successful.  Selective passaging has worked for other pathogens 
and there is no obvious reason why it should not for B. thuringiensis in P. 
xylostella.  Maintaining an in vitro growth step may still limit the protocol in terms 
of providing another selective pressure but there does not seem to be a 
practical alternative when working with B. thuringiensis.  However, this can also 
be viewed in a more favourable light as it would be difficult to work with a highly 
insecticidal strain which was also difficult to culture, particularly if it was being 
considered for commercial applications. 
 While the results here are not conclusive, they do suggest that a future 
attempt to adjust this protocol would be better served by increasing variation 
rather than attempting to limit it as here.  The most obvious way to achieve this 
is through increasing the mutation rate, though there are multiple ways of 
achieving this.  
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Experimental evolution has helped highlight which factors can increase 
the rate of evolution.  Understanding these will be highly desirable when trying 
to increase the virulence of biocontrol pathogens, potentially reducing the time 
and cost.  Long-term evolutionary experiments may favour mutators as these 
can generate beneficial mutations at a higher rate.  Coevolution experiments 
appear to increase the rate of evolution compared to one-sided ones as 
selective pressure is maintained on both sides.  These could be combined 
through carrying out coevolution experiments with mutagenesis.  Biocontrol 
pathogens may be used against one or multiple host types so can be 
considered as specialists or generalists.  However, generalists may have lower 
virulence across their range, potentially as a result of antagonistic pleiotropy. 
The entomopathogen Bacillus thuringiensis is used against lepidopterans 
and selective passaging could increase its virulence against emerging resistant 
pests.  It was predicted that passaging B. thuringiensis in coevolution with 
Plutella xylostella larvae will produce a greater virulence increase than repeated 
passaging in naïve larvae.  Additionally, passaging in single larval genotypes is 
expected to result in higher virulence than passaging in multiple ones. 
B. thuringiensis subsp. entomocidus was passaged in either Cry1Ac-
resistant P. xylostella larvae, Cry1Ac-susceptible ones, alternating rounds of 
both or a coevolution treatment.  All treatments included mutagenesis using 
ethyl methanesulfonate.  After passages, lineages were bioassayed alongside 
the ancestor in resistant, susceptible and coevolved larvae to assess changes 
in virulence.  Passage treatments increased virulence in coevolved and 
resistant larvae, and there was no difference between the single and multi-host 
passage treatments.  Together these suggest that, after further refinement, 
coevolution with mutagenesis may be an effective way to produce more virulent 





Experimental evolution is a powerful tool for investigating how particular 
conditions might influence the evolutionary path of an organism.  Bringing 
evolution into a laboratory setting means variables apart from the trait or 
environmental factor of interest can be controlled and evolution directly 
observed (Elena and Lenski 2003, Kawecki, Lenski et al. 2012, Rafaluk, Jansen 
et al. 2015, Schlotterer, Kofler et al. 2015).  As evolution corresponds to change 
over generations it is unsurprising that this area has strongly favoured work with 
bacteria; many generations can be gone through in a manageable time and 
space as exemplified by Lenski’s 30,000+ generation Escherichia coli 
experiment (Cooper and Lenski 2000, Blount, Borland et al. 2008).  The study 
of these experiments has been facilitated by the wider availability of fast, 
affordable whole-genome sequencing (Ensminger 2013, Van den Bergh, 
Swings et al. 2018).  This allows direct tying of phenotypes to genotypes, along 
with easier identification and quantification of the many mutants that might 
appear during experimental culturing (Schlotterer, Kofler et al. 2015). 
The variable(s) in an experimental set up may be abiotic or biotic in 
nature, with biotic systems featuring one or more additional species or 
genotypes along with the focal one.  Biotic experimental systems are appealing 
most obviously because in the field organisms do not live in isolation, with many 
of the influences on their evolution coming through interactions with other 
organisms.  Perhaps as a reflection of their importance, adaptation to biotic 
factors appears to take precedence over abiotic ones in experiments where 
both are varied (Scanlan, Hall et al. 2015, Van den Bergh, Swings et al. 2018).  
A clear example would be the interactions between pathogen and host; this is 
most apparent with the pressure for a host to evolve resistance and the 
pathogen to overcome this (Schulte, Makus et al. 2011).  Better understanding 
of the factors that affect virulence evolution may aid the control of emerging 
pathogens, treatment of infectious disease (Pirofski and Casadevall 2012, 
Rafaluk, Jansen et al. 2015) or (as here) the improvement of biocontrol agents. 
Experimental evolution of pathogens has primarily been done through 
serial passaging (Ebert 1998, Yourth and Schmid-Hempel 2006, Berenos, 
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Schmid-Hempel et al. 2011), with the pathogen repeatedly collected from one 
host or population and then inoculated into a fresh one.  As transfer between 
hosts is often facilitated by an experimenter this generally allows the pathogen 
to evolve higher levels of virulence (Bull and Lauring 2014, Le Clec'h, Dittmer et 
al. 2017).  While this may demonstrate the core truth of the virulence-
transmission trade-off hypothesis (Anderson and May 1982, Alizon, Hurford et 
al. 2009), it gives little further insight into pathogen-host interactions in the real 
world.  Lab populations of pathogens and hosts are often clonal or at least 
homozygous at loci of interest.  This allows for uniformity, removing any 
potential confounding effects of different genetic backgrounds.  However, in the 
field pathogens may not be infecting a single genotype, but multiple ones or 
even multiple species (Woolhouse, Taylor et al. 2001).  They can therefore be 
characterised as either specialists or generalists.  A generalist may experience 
an unpredictable supply of a particular host genotype and so is adapted to 
multiple ones; increased availability of hosts should favour higher virulence 
(Hellgren, Perez-Tris et al. 2009, Leggett, Buckling et al. 2013).  This is 
effectively another example of the virulence-transmission trade-off – a specialist 
should delay killing its host to ensure a new suitable host is available (Pfennig 
2001). 
Conversely, infecting multiple hosts could constrain the virulence of 
generalists (Garamszegi 2006, Yourth and Schmid-Hempel 2006).  A specialist 
can increase its virulence in one host without these adaptations having negative 
consequences elsewhere (Leggett, Buckling et al. 2013), and specialism 
appears to be the normal outcome from passaging (Little, Watt et al. 2006).  A 
generalist may instead experience antagonistic pleiotropy: increasing virulence 
in one host is kept in check by negative selective pressure against the same 
adaptation in another (Ensminger 2013, Kerstes and Martin 2014).  The 
contrasting effects of specialism and generalism on virulence can be explored 
by passaging through single or multiple host backgrounds.  High virulence in a 
generalist would likely be desirable for biopesticide use, so passaging in single 
or multiple host genotypes may help inform how to achieve this. 
The above only considers experimental evolution of the pathogen, with 
naïve hosts introduced for each passage round from a separate population.  
Clearly this is a poor approximation of actual pathogen-host systems as in 
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reality a host should also evolve resistance to its pathogens.  Experimental 
coevolution therefore allows for both sides to adapt during the experiment 
(Kerstes and Martin 2014).  For pathogen-host systems this is achieved by 
allowing any hosts that survive a passage round to breed, using their offspring 
as hosts in the following passage round.  This can make coevolution 
experiments more difficult to carry out as host generation time is likely to be 
significantly longer than the pathogen’s, so waiting for the next host generation 
can extend the time between passage rounds.  There also need to be sufficient 
surviving hosts to produce enough offspring for the next passage round, which 
may constrain the infective doses used. 
When host and pathogen coevolve it is expected that there will be a 
persistent ‘arms race’, where any increase in virulence is met by a 
corresponding increase in resistance and vice versa ad infinitum.  Van Valen 
termed this the Red Queen hypothesis with both agents forever running to stay 
still, resulting in a higher rate of molecular evolution (Van Valen 1974, Paterson, 
Vogwill et al. 2010, Scanlan, Hall et al. 2015).  A potential outcome of this is that 
exposing the evolved form of either to the ancestral version of its antagonist 
should result in improved performance e.g., a coevolved pathogen will have far 
higher virulence in a naïve host than its own ancestor would (Nidelet and Kaltz 
2007, Schulte, Makus et al. 2010).  Coevolution leading to increased virulence 
and resistance has been observed across many pathogen-host systems as well 
as in silico (Buckling and Rainey 2002, Schulte, Makus et al. 2010, Schulte, 
Makus et al. 2011, Masri, Branca et al. 2015, Strauss, Crain et al. 2016), though 
the reverse has also been observed in sexual systems (Berenos, Schmid-
Hempel et al. 2011).  When coevolution is combined with variation in the host 
and pathogen this is expected to lead to negative frequency dependent 
selection (Ebert 2008).  If a particular host genotype is common, a specialist 
pathogen for this genotype should be favoured (Hamilton 1980, Ebert 2008).  
The specialist will in turn lead to selection against the most common host 
genotype, reducing or removing it.  This should continue, cycling between 
different specialist pathogens, or specialists and generalists. 
Any experimental evolution, whether considering host background or 
coevolution, requires sufficient time and variation for observable change.  More 
time, in the form of additional passage rounds, allows for more mutations and 
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additional variation in the host or pathogen population.  It also allows time for 
these mutations to become fixed in the population, with the time taken inversely 
proportional to the benefit (Elena and Lenski 2003).  This may be particularly 
important in clonal populations, which are more common with pathogens, as 
clonal interference may limit the number of beneficial mutations that can be 
fixed in the population at any point; more time means more beneficial mutations 
can build up.  However, dramatic changes in virulence can still occur in only a 
few passage rounds (Woo and Reifman 2014, Rafaluk, Gildenhard et al. 2015, 
Le Clec'h, Dittmer et al. 2017).  Wolbachia evolved from being reasonably 
benign, because of its vertical transmission, to extremely lethal after only a few 
rounds of experimenter-mediated passaging in an isopod host (Le Clec'h, 
Dittmer et al. 2017).  Importantly, while the number of passage rounds or host 
generations may be limited there should still be many rounds of pathogen 
reproduction within each of these.  Additionally, the most beneficial mutations 
are likely to be fixed through selection earlier, resulting in decreasing fitness 
returns as a passage continues (Khan, Dinh et al. 2011). 
If variation is being generated at a low rate then it may be difficult to 
produce observable change in a smaller number of passage rounds.  To 
increase variation in a shorter passage experiment, a non-clonal founding 
population could be used (Rafaluk, Gildenhard et al. 2015).  This has difficulties 
as the pathogen of interest may only be kept as a clonal stock and working with 
a clonal stock makes comparisons back to the ancestor, especially at the 
genetic level, simpler.  Variation can instead be improved by increasing the 
underlying mutation rate during passages.  A raised mutation rate appears to be 
favoured in long-term experimental evolution with mutators emerging and taking 
over populations, as mutator genes can hitchhike along with the additional 
beneficial mutations they have facilitated (Sniegowski, Gerrish et al. 1997, 
Shaver, Dombrowski et al. 2002, Elena and Lenski 2003).  Clearly there is a 
limit to the variation that can be introduced, as above a certain mutation rate 
accumulation of deleterious mutations becomes too high and results in 
extinction (Martin and Gandon 2010, Packer and Liu 2015).  Mutation rates can 
be increased with a mutator strain e.g., with a faulty mutS leading to poor 
mismatch repair (Horst, Wu et al. 1999, Packer and Liu 2015), or by including a 
chemical mutagen like ethyl methanesulfonate (EMS).  EMS (CH3SO3C2H5) is 
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an alkylating agent that has been used as a mutagen in experiments with 
Bacillus cereus amongst other organisms (Necasek, Pikalek et al. 1967, Sega 
1984).  It is primarily thought to generate mutations through alkylation of 
guanine and cytosine residues, causing mismatches with thymine and adenine 
during DNA copying (Labrou 2010). 
 Increasing variation does not necessarily solve the problem of producing 
observable change in a short timeframe.  Additional mutations are still 
constrained by the rate they can spread through the population.  In a clonal 
population there will still be the problem of clonal interference with only the 
fittest mutation being fixed at any one time – any mutations that are beneficial to 
a lesser degree may be pushed aside and lost (Gerrish and Lenski 1998, Imhof 
and Schlotterer 2001).  In bacteria approximately 1-2% of mutations may be 
beneficial, although it is difficult to accurately determine this rate and only a 
subset will be strongly beneficial (Eyre-Walker and Keightley 2007, Perfeito, 
Fernandes et al. 2007, Sniegowski and Gerrish 2010, Zhang, Sehgal et al. 
2012).  However, with a higher mutation rate it is expected beneficial mutations 
will occur more frequently, so even if one is initially lost through clonal 
interference it may still occur again before passage end.  Alternatively, there is 
an increased chance multiple beneficial mutations will occur in the same 
background during fixation, limiting the number lost through clonal interference.  
Passaging of pathogens with raised mutation rates is expected to produce 
higher virulence, provided lethal mutagenesis is avoided. 
 The increase in deleterious mutations could potentially be limited with 
selective passaging.  With pathogens, selection on host mortality can act as a 
proxy for virulence in most experimental situations (Bull 1994, Cressler, McLeod 
et al. 2016).  Using selective passaging deviates from pure experimental 
evolution (Kawecki, Lenski et al. 2012) as the ability to evolve outside the 
desired direction is constrained by selection, though there is not full artificial 
selection on the pathogen as selection occurs at the host level or higher.  This 
still allows insight into the evolution of virulence as comparisons between 
treatments should show which conditions favour evolution of the desired 
virulence level.  Selection can also be employed to produce a pathogen for a 
specific purpose.  Attenuated vaccines were generated by repeated passaging 
of human pathogens in other backgrounds resulting in a loss of human 
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virulence (Plotkin and Plotkin 2011, Kawecki, Lenski et al. 2012), but perhaps 
this could have been accelerated by selecting only pathogen lines that had the 
highest virulence each round.  Selective passaging could also be used to 
overcome emerging resistance in hosts (Kolodny-Hirsch and Van Beek 1997, 
Berling, Blachere-Lopez et al. 2009). 
 Previous work (Chapter III) carried out selective passages on Bacillus 
thuringiensis subsp. aizawai isolated from XenTari® commercial product (Valent 
BioSciences LLC) in Plutella xylostella moth larvae.  These passages had 
treatments that attempted to vary the level of within-host relatedness, as public 
goods models of virulence suggest that higher within-host relatedness should 
favour cooperation and increased virulence (Buckling and Brockhurst 2008, 
Raymond, West et al. 2012).  Relatedness was varied by isolating single 
colonies between passage rounds and growing spores from these for the next 
round (bottlenecking) with the number of bottlenecks varied between 
treatments.  The expectation was that frequent bottlenecking would produce 
lineages with the highest mortality, as these should maintain higher within-host 
relatedness.  However, once bioassayed there were no significant increases in 
virulence from any treatment, including the control treatment with no 
bottlenecking.  While the aizawai strain used did not sporulate reliably during 
the experiment there was still reasonable evidence to suggest varying 
relatedness in this way would not produce higher virulence.  One explanation 
was that there was insufficient variation present.  Extreme bottlenecking could 
act against improved virulence as it removes all heterozygosity and instantly 
fixes a set of mutations in the population, irrespective of whether they are the 
most beneficial ones currently available (Nei, Maruyama et al. 1975).  As 
covered, variation can be increased through mutagenesis which appears to 
favour higher virulence in passages (Racey, Inglis et al. 2010).  Using a 
mutagen rather than a mutator means the window during which increased 
mutation occurs can be controlled, so that mutants with stable phenotypes can 
be produced at the end of experiments.  This seems favourable given the 
difficulties with the sporulation phase of the previous passage experiment 
(Chapter III). 
The main concern with B. thuringiensis as a biocontrol agent, either 
directly or through its Cry toxins in transgenic crops, is the emergence of 
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resistance, notably in the South East Asian populations of P. xylostella (Zhang, 
Zhang et al. 2016) as well as Spodoptera frugiperda & Helicoverpa zea 
(Tabashnik and Carriere 2017).  Selective passaging may provide a route to 
overcome resistance (Berling, Blachere-Lopez et al. 2009) while also gaining 
insight into factors favouring increased virulence.  Host background, generalism 
versus specialism and coevolution could all potentially favour increased 
virulence in P. xylostella.  B. thuringiensis subsp. entomocidus is not currently 
employed as a biocontrol agent and lacks the Cry1Ac toxin commonly used 
commercially (Crickmore, Baum et al. 2018).  It therefore has intermediate 
virulence in both Cry1Ac-susceptible and -resistant P. xylostella larvae (Chapter 
II, figure 2.3).  These two host genotypes provide a convenient system to test 
the effects of host background on pathogen virulence, through separate 
passages in the two genotypes.  P. xylostella resistance to Cry toxins is thought 
to occur principally through modification of receptors such as abcc2 that act to 
prevent toxin binding (Baxter, Zhao et al. 2005, Baxter, Badenes-Perez et al. 
2011).  This means that it is unlikely adaptation to a particular receptor, giving 
an increase in virulence, should also permit increased binding to a different 
receptor in a different host genotype.  Therefore it is hypothesised that selective 
passaging should increase virulence in each host genotype, but this increase 
will not carry over to the other background.  There is already evidence that the 
virulence of B. thuringiensis can be increased through passaging in nematodes 
and that viral P. xylostella pathogens can be improved in this manner (Kolodny-
Hirsch and Van Beek 1997, Schulte, Makus et al. 2010, Masri, Branca et al. 
2015). 
The difference between generalism and specialism can be compared 
between changes in virulence for the above single-host passages and for a two-
background passage.  For this passage, host background can be alternated 
between Cry1Ac-suscpetible and -resistant each passage round.  Using both 
backgrounds in each round would be ineffective in a selective protocol as it 
would likely result in collecting spores only from Cry1Ac-suscpetible cadavers; 
these have higher mortality for a given entomocidus dose (Chapter II, figure 
2.3).  Selecting for increased virulence in both host backgrounds is predicted to 
produce an increase in virulence both genetic backgrounds, unlike the single 
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background passages, but the increase in each background will be less than 
the corresponding single background passage. 
Finally, coevolution effects can be explored by allowing surviving P. 
xylostella larvae to pupate and breed, providing hosts for the next passage 
round.  As explained, coevolution of pathogen and host should push both 
virulence and resistance higher during passaging.  It is therefore hypothesised 
that coevolved B. thuringiensis subsp. entomocidus should produce higher 
virulence than both its ancestor and the other selective passage treatments in 
naïve hosts.  Correspondingly, it should also have higher virulence in the 
coevolved P. xylostella than its ancestor.  Similar comparisons between one-
sided and coevolution are currently limited outside of bacteria-phage systems 
(Masri, Branca et al. 2015).  All four treatments will be conducted with the same 
mutagenesis treatment using EMS.  While it is hoped that increased variation 
will aid the passages, the effects of host background and coevolution on 
producing higher virulence are of more interest.  As well as providing insight into 
which of these factors most favour higher virulence, it is hoped that this work 
may lead to refined selective passage protocols for producing more virulent 






B. thuringiensis subsp. entomocidus (BGSC 4I4) was transformed with 
pHT315 plasmid carrying gfp and eryR for erythromycin resistance.  Wild-type 
entomocidus from stock was cultured overnight at 30oC with 150rpm shaking in 
2% LB broth.  5ml of culture was added to 500ml pre-warmed 2% LB in a conical 
flask and incubated for four hours at 30oC with 150rpm shaking.  67ml of 50% 
glycine was added to give 3% in culture and incubated for an additional hour.  
The culture was transferred to eight 50ml pre-chilled Falcon tubes and these left 
on ice for 5mins.  Tubes were centrifuged at 3,200g and 4oC for 12mins.  Tubes 
were then put on ice and supernatant poured off.  Cell pellets were gently re-
suspended with 10ml ice-cold buffer ‘F’ (272mM sucrose, 0.5mM MgCl2, 0.5mM 
K2HPO4 and 0.5mM KH2PO4 at pH 7.2) (Peng, Luo et al. 2009).  This was 
repeated two further times, final re-suspension done with 500µl of buffer ‘F’ and 
transferred to a pre-chilled Eppendorf.  100µl of electrocompetent cells was 
added to a pre-chilled 0.1cm3 electroporation cuvette with 2µl plasmid DNA and 
electroporated at 1.8kV using a MicroPulser Electroporator (Bio-Rad 
Laboratories, Inc.).  The cells were transferred to 1ml pre-warmed 2% LB and 
incubated at 30oC for one hour.  After, 100µl of culture was spread onto 2% LB 
agar plate containing 10ug/ml erythromycin and 900µl onto another and plates 
incubated at 30oC overnight.  Colonies were re-streaked and viewed under UV 




Bte pHT315-gfp-eryR was inoculated into 40 1ml wells of HCO 
sporulation medium in 24-well plates.  HCO sporulation medium was adapted 
from Lecadet, Blondel et al. (1980) and produced by adding 7g casein 
hydrolysate and 6.8g KH2PO4 in 1l distilled water and adjusting to pH7.2 with 
NaOH.  After autoclaving 1ml 20% MgSO4.7H2O, 1ml 2
% Fe2(SO4)3, 2.2ml 1
% 
ZnSO4.H2O, 2.2ml 1
% CaCl2.2H2O, 440µl 0.5




glucose from sterile stocks along with two tablets of Polymyxin B (50,000 IU per 
tablet, Oxoid Ltd.) and 1ml of 20mg/ml erythromycin stock solution were added.  
Plates were sealed with tape and incubated for six days at 30oC with 150rpm 
shaking.  After incubation, wells were pooled into four 15ml Falcon tubes and 
centrifuged at 3,200g for 6mins.  The supernatant was discarded and spore 
pellets re-suspended in 500µl saline (0.85% NaCl) with 0.05% Triton X surfactant 
and pooled into two Eppendorfs.  These were pasteurised at 65oC for 25mins in 
a heat block.  Spores were then diluted in series to 10-7 with saline and Triton, 
plated out on 20µg/ml erythromycin LB agar plates and incubated overnight at 
30oC to confirm counts.  Spores were diluted to 400cfu/µl for the susceptible 
host passage, 2,000cfu/µl for resistant and 800cfu/µl for coevolution; the 
alternate host passage used the same doses as the susceptible and resistant 
ones, depending on which larvae were used that round.  These were expected 
to give approximately 30% mortality based on existing bioassay data, and plated 
out again to confirm cfu/ml. 
 
Mutagen passaging & treatments (table 4.a) 
The selective passage was split into four treatments.  In the first Bte 
pHT315-gfp-eryR was passaged in Cry1Ac-susceptible Plutella xylostella 
larvae.  The second treatment was in Cry1Ac-resistant larvae.  In the third, host 
background was alternated in successive passage rounds between Cry1Ac-
susceptible and -resistant larvae, with the first round in Cry1Ac-susceptible 
larvae.  For the final treatment an initially mixed population of Cry1Ac-
susceptible and -resistant larvae was coevolved with the passaged Bte 
pHT315-gfp-eryR bacteria.  All treatments had five passage rounds with four 
replicates of ten subpopulations as per the passage protocol in Chapter III, 
though passage rounds were not carried out concurrently as coevolution 












Five rounds of passaging in 
naïve Cry1Ac-susceptible 
larvae 
Increased virulence relative to 




Five rounds of passaging in 
naïve Cry1Ac-resistant 
larvae 
Increased virulence relative to 
ancestor in Cry1Ac-resistant larvae 
Alternate 
hosts 
Five rounds of passaging 
alternating between naïve 
Cry1Ac-susceptible and -
resistant larvae 
Increased virulence relative to 
ancestor in each larvae type, but 
less so than above treatments 
Coevolution 
Five rounds of passaging in 
coevolved partially-Cry1Ac-
resistant larvae 
Increased virulence relative in 
coevolved larvae relative to 
ancestor; increased virulence in 
ancestor larvae relative to coevolved 
ones 
 
Table 4.a: Passage treatments, with basic descriptions and principal predictions 
for each. 
 
In the coevolution treatment each subpopulation of larvae in the first 
passage round had eight Cry1Ac-susceptible and four -resistant larvae.  After 
cadavers had been collected Petri dishes were returned to the incubator at 
24oC and left until all remaining live larvae had pupated.  Pupae from all 
subpopulations across the four coevolution replicates were collected and moved 
into a single breading cage.  Offspring were used in the next passage round in 
the same manner as naïve larvae in the other treatments. 
For all four treatments the passage protocol was carried out as described 
in Chapter III Methodology, with the addition of a mutagen growth phase as 
follows (figure 4.1):  After cadavers were collected 90µl of 2% LB broth was 
added per Eppendorf, cadavers mashed with a sterile toothpick and incubated 
at 30oC with 150rpm shaking for three hours.  After incubation, 10µl of 2% by 
volume ethyl methanesulfonate (EMS) mutagen was added and Eppendorfs 
incubated for a further three hours at 30oC with 150rpm shaking.  Eppendorfs 
were centrifuged at 2,400g for 5mins and supernatant removed.  The pellet was 
re-suspended in 50µl saline and 10µl used to inoculate 1ml of HCO sporulation 




Figure 4.1:  Selective mutagen passage protocol – core steps between 
infection rounds. 
1 In a treatment replicate, the five subpopulations with the highest mortality 
are selected and cadavers from each moved to an Eppendorf. 
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2 Cadavers are mashed in 90µl 2% LB and incubated for three hours at 
30oC; 10µl 2% ethyl methanesulfonate added and incubated for further 
three hours. 
Mutagen removed via centrifuging at 2,400g for 5mins, spore pellet re-
suspended in 50µl saline. 
3 10µl inoculated into 1ml HCO with 20µg/ml erythromycin and incubated 
at 30oC for six days. 
4 2 x 200µl moved into PCR plate wells and centrifuged at 3,200g for 
15mins. 
Spores re-suspended in 80µl saline, diluted in series and plated for 
counts, then dilutions adjusted for desired inocula. 
 
Bioassays 
After passages were completed, bioassays were carried out with 
passaged lineages against the Bte pHT315-gfp-eryR ancestor.  All passage 
treatment bioassays used both Cry1Ac-susceptible and -resistant larvae.  The 
resistant background and coevolution treatment bioassays were repeated in the 
coevolved population of P. xylostella (offspring of larvae that survived the final 
passage).  The spore concentrations used differed depending on larvae being 
bioassayed: 40 to 4,000 cfu/µl in Cry1Ac-susceptible bioassays and 400 to 
10,000cfu/µl in the Cry1Ac-resistant and coevolved bioassays.  For all 
bioassays inocula were diluted from spore stocks recovered from the HCO 
growth phase after the final round of passaging.  Stocks were diluted to give 
bioassay inoculants and plated out on 10µg/ml erythromycin 2% LB agar to 
confirm counts.  In the bioassays, for each treatment replicate the spores from 
the single subpopulation with the highest mortality after the final passage round 
were used.   
 
DNA extraction & sequencing 
After bioassays, CTAB (cetyl trimethylammonium bromide) salt DNA 
extractions were run on a single pooled subpopulation per treatment replicate 
(16 in total across the four treatments), and on one isolated clone per treatment 
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for sequencing, along with the ancestor and one additional clone from the 
susceptible background treatment (for a total of six).  Additionally, any clones 
identified as giving higher mortality also had DNA extracted.  For extraction, 
pools or clones were cultured overnight for 16 hours in 2% LB broth at 30oC with 
150rpm shaking.  Cultures were pelleted by centrifuging at 17,000g for 10mins 
and supernatant removed before being re-suspended in 500µl lysis buffer 
(9.32ml 1mM TE buffer, 100µl 10mg/ml lysozyme, 500µl 10% SDS and 80µl 
25mg/ml proteinase k) and incubated at 30oC for 30mins then 55oC for 20mins.  
2µl of 100mg/ml RNAse A was added and samples vortexed, spun down and 
incubated at 30oC for 30mins.  100µl of 5M NaCl and 80µl of 10% CTAB 0.7M 
NaCl were added, samples vortexed again and incubated at 65oC for 20mins.  
For chloroform extraction, 700µl of chloroform:isoamyl (24:1) was added and 
mixed vigorously then centrifuged at 16,200g for 6mins and 550µl of the top 
aqueous phase moved to a fresh Eppendorf.  This was repeated three times, 
except in the second round phenol:chloroform:isoamyl (25:24:1) was used 
instead.  After chloroform extraction 0.6x sample volume of isopropanol was 
added and incubated at -20oC for 45mins.  These were spun down at 4oC and 
17,950g for 15mins.  The supernatant was removed and DNA pellet washed in 
250µl chilled 70% ethanol before being centrifuged at 4oC and 17,950g for 
10mins and then supernatant removed.  This was repeated and DNA pellets left 
to dry at 22oC for 20mins before re-suspension in 100µl 10mM TE buffer and 
left at 4oC overnight.  DNA quality and yield were assessed by running 4µl of 
each sample with loading dye in a 1.5% agarose gel at 100V for 50mins as well 
as taking Nanodrop (Thermo Fisher Scientific Inc.) and broad-range Qubit 
(Thermo Fisher Scientific Inc.) readings of 10-fold dilutions. 
The DNA is being sequenced via Illumina sequencing with 16 lineage 
pools at 200x coverage and six clones at 50x coverage by Exeter Sequencing 
Service at the University of Exeter.  The ancestral Bte pHT315-gfp-eryR was 
also sent to MicrobesNG at the University of Birmingham, prepared there and 







In bioassay analysis larvae were recorded as either alive or dead, 
meaning mortality could be analysed via GLMs with binomial errors.  To 
account for over-dispersion with a standard binomial distribution a 
quasibinomial one was then used.  This was tested using the F-statistic at the 
overall level against a significance level of p < 0.01, given the noisiness of 
bioassay data, and using the t-statistic for within-treatment tests.  Bioassay 
mortality data were analysed in RStudio 1.1.456 (based on R 3.2.5; R Core 







 All four replicates in each treatment persisted through all five rounds of 
passaging (figure 4.2).  However three replicates did lose subpopulations 
because of either insufficient mortality to select from or occasional failures of 
sporulation.  The Cry1Ac-susceptible host background and alternating host 
background treatments maintained a full set of subpopulations in all replicates.  
The coevolution treatment lost all but two subpopulations in one replicate, while 
the Cry1Ac-resistant host background passage lost two subpopulations in two 
replicates.  Figure 4.2 shows the lineages for each treatment replicate.  The 
improved persistence of subpopulations, with no replicates completely failing, 
suggests that changes made to the production of the HCO sporulation media 
compared to that used in the Chapter III passages were successful.  This was 
principally achieved by adding the majority of required salts and glucose after 
initial autoclaving as detailed in the Methodology.  This was not distinctly tested, 
but after moving to the new HCO formulation for general lab work there were no 
longer cases of completely failed sporulation. 
The ancestry through the selective passages of isolates collected after 
the final passage round is shown in figure 4.2.  In all but two treatment 
replicates (coevolution replicate 3 and resistant host replicate 1) the isolates 
collected at the end were descended from only two of the initial 10 
subpopulations.  The figure also shows that in three treatment replicates the 
number of subpopulations used decreased from ten, primarily because of poor 
spore growth after using cadavers to inoculate HCO sporulation medium.  
Mortality for each treatment passage round was recorded (figure 4.3); 
however there is limited use in analysing this further, as any change in mortality 
for a particular treatment round was compensated for in the next by altering 
spore dose levels, as shown by increases in mean mortality being followed by a 
decrease in the next passage round.  This was to try and maintain a mortality 
rate of 20-30%, so the selection of subpopulations based on differing mortality 




Figure 4.2: Tracking lineages over the five rounds of mutagen selective 
passaging, showing ancestry of end-passage isolates.  Each passage treatment 
is split into its four replicates, with each initial subpopulation a different colour.  
White corresponds to fewer than 10 subpopulations in a passage round, as a 




Figure 4.3: Mean P. xylostella mortality for each passage round in each 
treatment.  Inocula were varied from round to round to try and maintain a 20-
30% mortality rate, so increasing mortality here is not necessarily reflective of an 
actual increase in the individual spores. 
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Bioassays (figure 4.4) 
 There was an overall mortality difference between passage treatments 
and the ancestor when bioassayed in Cry1Ac-susceptible larvae (F3, 69 = 7.25, p 
= 3.02 x 10-4).  This result fits with the prediction that passaging in general 
should increase virulence in naïve hosts.  However, this was only caused by a 
single lineage per treatment diverging from the ancestor in the resistant and 
susceptible passage treatments (t62 = -2.661, p = 9.91 x 10
-3; t62 = -3.74, p = 
4.11 x 10-4) and the alternating host one (t62 = -8.24, p = 1.5x10
-11).  This 
particular alternating host lineage (lineage 3) can clearly be distinguished from 
all other treatment lineages (figure 4.4, highlighted in figure 4.5).  This large 
increase goes against the initial prediction that generalism should give a lower 
increase in virulence than passaging in a single host type. 
In the Cry1Ac-resistant host, again treatments overall produced higher 
mortalities than the ancestor (F4, 115 = 11.2, p = 1.47 x 10
-7) and the same was 
true for the resistant, susceptible and alternating host treatments when 
considered separately (t103 = -5.24, p = 8.56 x 10
-7; t103 = -2.64, p = 9.54 x 10
-3; 
t103 = -3.69, p = 3.55 x 10
-4) though the coevolution passage treatment was not 
significant at the p = 0.01 level (t103 = -2.01, p = 4.66 x 10
-2).  At the lineage 
level, the same alternating host lineage that had significantly higher mortality in 
Cry1Ac-susceptible larvae had significantly lower mortality here (t103 = 4.42, p = 
2.43 x 10-5) (again highlighted in figure 4.5). 
When bioassayed with larvae from the coevolved experimental host 
population, strains from the coevolution and resistant background treatments 
produced higher mortalities overall than the ancestor (F2, 62 = 10.9, p = 1.02 x 
10-4).  All the lineages from the coevolved passages had significantly higher 
mortality than the ancestor (t56 = -2.96, p = 5.23 x 10
-3), though only two of the 
four resistant host treatment lineages gave significantly higher mortalities (t56 = -
3.37, p = 1.35 x 10-3; t56 = -4.41, p = 4.75 x 10
-5).  The small size of the 
coevolved host population meant that only lineages from the resistant 




Figure 4.4: Bioassay mortalities of one lineage per passage treatment replicate 
in Cry1Ac-resistant and -susceptible P. xylostella larvae, as well as in the 




Figure 4.5: Variation between lineages in response to selection in the 
alternating treatment; bioassay mortalities of Cry1Ac-resistant and -susceptible 
P. xylostella larvae for one lineage per treatment replicate of the alternating host 
background passage treatment, alongside the entomocidus ancestor. 
 
Beyond the overall trends described, two lineages can be highlighted, as 
mentioned.  In the alternating host passage one lineage developed significantly 
higher virulence in the Cry1Ac-susceptible larvae compared to all others and 
lower virulence in the resistant host.  Additionally, the lineages passaged 
through Cry1Ac-resistant hosts appeared to produce greater variation in 
mortality when bioassayed against coevolved and Cry1Ac-resistant hosts, with 





 DNA was successfully obtained via CTAB salt extraction from each 
replicate subpopulation used in the bioassays, as well as from a single clone 
taken from the replicate with the highest mortality.  For the alternating host 
treatment, because one clone gave such a significantly different level of 
mortality, a second one was also picked from another replicate.  The ancestral 
Bte pHT315-gfp-eryR was successfully sequenced by MicrobesNG, with the 
DNA extraction done on-site after delivery of the strain to them.  Sequencing of 
the passaged lineages by Exeter Sequencing Service and analysis are ongoing 





Selective passaging in both coevolved and Cry1Ac-resistant P. xylostella 
larvae, combined with an EMS mutagen in vitro growth phase, increased 
virulence in these host populations compared to the B. thuringiensis 
entomocidus ancestor.  However there was not a significant difference when 
passaging in either single- or alternating-host treatments.  This suggests that 
coevolution aided by mutagenesis may be effective in producing B. 
thuringiensis strains with increased virulence to resistant hosts, controlling their 
spread in the field. 
 
 When compared to the ancestor B. thuringiensis subsp. entomocidus, 
the greatest change in host mortality for passaged lineages was observed in the 
larval bioassays with lineages from coevolved and resistant treatments in the 
corresponding P. xylostella populations.  These results suggest that virulence is 
most effectively raised when hosts are more difficult to kill; the similarity 
between resistant and coevolution treatments could be caused by the 
monogenic nature of Cry1Ac-resistance, allowing rapid fixation in the coevolved 
host population.  This appears to fit with the existing body of work showing 
increased rates of evolution under experimental coevolution (Adiba, Huet et al. 
2010, Schulte, Makus et al. 2010), while the Cry1Ac-resistant hosts may 
already possess the resistance mechanism the coevolved population is moving 
towards.  In the coevolved hosts increased virulence was in turn countered by 
the host through increasing resistance.  While coevolved P. xylostella can be 
killed by the two passaged lineages there is reduced mortality against the 
ancestral entomocidus, in accordance with the Red Queen hypothesis (Van 
Valen 1974, Scanlan, Hall et al. 2015).  It has been suggested that this 
ratcheting up should be more apparent in infectivity than virulence (Greischar 
and Koskella 2007, Hoeksema and Forde 2008), though these are difficult to 
disentangle in the obligate killer B. thuringiensis.  Unfortunately there were 
insufficient coevolved larvae for bioassays of all four treatments, and allowing 
further post-passage generations to increase numbers would have tempered 
the selective effects of coevolution.  Using all four passage treatments here 
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might have helped to confirm that increases in virulence were principally 
independent of a particular lineages passage host background, as discussed 
below. 
An increase in virulence compared to the entomocidus ancestor was also 
seen with the bioassays in Cry1Ac-resistant larvae.  As this occurred for 
lineages from all four passage treatments, including the Cry1Ac-susceptible 
passage treatment, it suggests that just the act of passaging in the host may be 
enough to increase virulence (Locher, Witt et al. 2003, Bull and Lauring 2014, 
Le Clec'h, Dittmer et al. 2017).  Increasing virulence is a commonly-found result 
of serial passaging and is generally explained via the virulence-transmission 
trade-off, as experimentally ensuring successful transmission removes the need 
for any prudence on the part of the pathogen (Anderson and May 1982, Ebert 
1998).  This may be less clear-cut for B. thuringiensis as it relies on durable 
endospores (Raymond, Wyres et al. 2010, Narula, Kuchina et al. 2015) for 
transmission rather than vectors or direct transmission.  However, it has still 
been shown that in B. thuringiensis infections spore production is maximised at 
an intermediate time to host death, again suggesting a trade-off between spore 
production and virulence (Raymond, Ellis et al. 2009).  The passaging protocol 
used here also ensured (through pasteurisation) that entomocidus lineages 
needed to maintain successful sporulation to persist through the experiment, 
preventing sporulation investment from potentially being abandoned for even 
higher virulence (Rafaluk, Gildenhard et al. 2015). 
 All passage treatments appear to result in higher mortality in the Cry1Ac-
resistant larvae, as do the two treatments with lineages bioassayed against the 
coevolved larvae.  This could suggest a common mechanism for the universal 
increase in virulence.  It appears unlikely this is caused by a common change in 
Cry toxin binding efficiency – larvae in the susceptible host passage treatment 
have different cell-surface receptors to the resistant ones (causing their differing 
mortalities with Cry1Ac) (Gong, Wang et al. 2010, de Almeida Melo, Soccol et 
al. 2016).  An alternate mechanism could be an upregulation in the production 
of Cry toxins or other virulence factors, which would fit with passaging of any 
sort increasing virulence.  B. thuringiensis bacteria may already produce large 
quantities of Cry toxins, corresponding to up to 25% of spore weight in some 
strains (Agaisse and Lereclus 1995), so other virulence factors might be more 
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likely recipients of any increases in secretion.  Notably, one of the resistant 
background passage lineages had reduced virulence in both the coevolved and 
Cry1Ac-resistant bioassays which could suggest that the increasing resistance 
in the coevolved larvae is underpinned by the same mechanism as in the 
Cry1Ac-resistant ones.  However, the resistant P. xylostella population is 
thought to gain its resistance through a modified abbcc2 receptor that prevents 
Cry1Ac toxin binding (Baxter, Zhao et al. 2005, Baxter, Badenes-Perez et al. 
2011).  B. thuringiensis subsp. entomocidus lacks Cry1Ac, though the same 
receptor might still bind other structurally similar toxins carried by entomocidus 
at a lower rate e.g., Cry1Aa (Crickmore, Baum et al. 2018); as Cry1Ac and 
Cry1Aa both fall into the Cry1A grouping their protein sequences will be at least 
78% identical (Crickmore, Zeigler et al. 1998, de Maagd, Bravo et al. 2001).  In 
any case it appears that the highlighted resistant host passage lineage failed to 
generate or fix the necessary mutation(s) to increase its virulence here. 
 The other replicate lineage showing distinct virulence levels compared to 
all others, whether from the same or different passage treatment, was from the 
alternating host background passage (figure 4.5).  This lineage had a much 
higher mortality in Cry1Ac-susceptible larvae than all other treatments or the 
entomocidus ancestor and a correspondingly lower mortality in Cry1Ac-resistant 
hosts, suggesting antagonistic pleiotropy for the particular mutation(s) it accrued 
(Ensminger 2013).  This was an unexpected result as this apparent Cry1Ac-
susceptible host specialist emerged in the multi-genotype treatment that was 
predicted to favour generalists (Kassen 2002, Elena, Agudelo-Romero et al. 
2009).  For the alternating host passage treatment the final passage round was 
in the Cry1Ac-susceptible background; it could be this specialist mutant was not 
completely selected out in a round with Cry1Ac-resistant larvae before 
increasing in number in the final round.  There are two possible reasons why 
only a single lineage contained this apparent Cry1Ac-susceptible specialist.  
One is that the specialist’s lack of virulence in Cry1Ac-resistant larvae could 
have meant that while the same mutant appeared in other replicates it was 
selected out in those. 
Alternatively, it could be that the observed mutation is particularly rare 
and only appeared once in the experiment – it appears to confer a large fitness 
benefit so should be easily fixed in the population (Lenski, Rose et al. 1991).  
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As this was not the case it suggests that the mutation did not appear in the 
Cry1Ac-susceptible host passage and so is likely to be rare.  Even in larger 
experiments mutation supply may be a limiting factor.  In continuous evolution 
of E. coli it took over 30,000 generations to produce a mutant capable of 
metabolising citrate as a novel carbon source (Blount, Borland et al. 2008).  
Given the underlying mutation rate of E. coli and population size, there were 
enough generations to ensure all possible basic mutations should have been 
experienced (Blount, Borland et al. 2008).  Citrate metabolism could therefore 
depend on stacking of multiple rare mutations or ones that are significantly rarer 
than simple nucleotide substitutions. 
 If the mutation for high virulence specialism is rare it may also explain the 
lack of change in mortality in Cry1Ac-susceptible hosts for all other lineages, as 
on average others were neither significantly different from each other nor the 
ancestor.  Serial passaging is generally expected to increase pathogen 
virulence (Ebert 1998, Locher, Witt et al. 2003, Bull and Lauring 2014) which 
could be achieved through upregulation of virulence factors, though passaging 
may still lead to increased reproduction at the expense of virulence in some 
instances (Shapiro-Ilan and Raymond 2016).  However, the doses needed for 
high mortality in Cry1Ac-susceptible hosts may be sufficiently low already that 
passaging had no observable effect here; roughly 20 times fewer spores of the 
entomocidus ancestor were needed to produce a particular mortality in Cry1Ac-
susceptible larvae compared to resistant ones.  The only way to produce a large 
change might instead be through a significant change in the pathways involved 
which would likely be a rare event.  However once such a beneficial mutation 
appears it should spread rapidly through the experimental population.  Cry 
toxins appear more tolerant of increased mutations only in domain III of their 
three structural domains (Knight, Broadwell et al. 2004, Shan, Zhang et al. 
2011), so if changes in virulence were more linked to the other domains this 
could contribute to their rarity. 
 It is not possible to confirm that the inclusion of the EMS mutagen 
directly improved the virulence outcomes of these selective passages, as this 
was not specifically tested here.  Previous work in the same project suggested 
that mutator strains evolved higher virulence, while the passages in Chapter III 
which specifically limited relatedness and variation were not successful.  
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Increased mutation rates improve the rate at which beneficial mutations are 
generated (Elena and Lenski 2003) and this set of selective passages did 
produce lineages with raised virulence.  The apparently rare occurrence of 
greatly increased virulence in the Cry1Ac-susceptible host presents a potential 
way to confirm the importance of EMS to this selective passage protocol in the 
future.  Knowing that such a mutation and virulence change is possible its 
occurrence rate could be compared between multiple passages in Cry1Ac-
susceptible larvae with and without the EMS mutagen. 
 The specialist (single host background) and generalist (alternating host 
background) passage treatments do not appear to have produced significantly 
different mortality rates overall, as both gave similar results in the Cry1Ac-
susceptible and -resistant bioassays, with the exception of the one lineage 
discussed above.  This result goes against the expectation that serial passage 
in a particular host background should lead to specialisation in it and a greater 
increase in virulence compared to generalists (Little, Watt et al. 2006, Leggett, 
Buckling et al. 2013).  This might be because an increase in virulence factor 
production was selected for in both passage treatments, preventing any obvious 
differentiation.  It might be that the two host backgrounds are not sufficiently 
different to allow for specialisation.  The Cry1Ac-susceptible and -resistant 
larvae should only differ in possession of the Cry1Ac resistance allele (Gong, 
Wang et al. 2010) and entomocidus does not typically possess Cry1Ac 
(Crickmore, Baum et al. 2018).  However, the already highlighted replicate 
lineage (figure 4.5) appears to refute this as it suggests specialisation through 
adaptation to the Cry1Ac-susceptible host at the expense of virulence in the 
resistant one (Little, Watt et al. 2006).  Outside of the entomocidus strain used 
in this work there is also apparent host specialisation through B. thuringiensis 
as a whole (Aronson and Shai 2001, de Almeida Melo, Soccol et al. 2016).  
While this does not appear to occur to the level of individual host species, 
particular strains only produce high mortality in certain subsets of insect orders 
e.g., B. thuringiensis subsp. israelensis specialising in killing mosquitoes 
(Ankarloo, Caugant et al. 2000), while a strain like B. thuringiensis subsp. 
kurstaki is viewed as more of a lepidopteran generalist (making it a favoured 




Although this specificity is principally conferred by Cry toxins and their 
ability to bind to different cell-surface receptors in the midgut e.g., abcc2 
receptors in Plutella and cadherins in Helicoverpa, it is unlikely to be limited to 
them (Baxter, Zhao et al. 2005, Xu, Yu et al. 2005, Baxter, Badenes-Perez et al. 
2011).  If Cry toxin binding restricts particular B. thuringiensis strains to certain 
hosts they might be expected to adapt to haemolymph growing conditions within 
those hosts, though this would assume haemolymphs and toxin receptors are 
similarly varied.  However it does not appear that the within-host fitness of 
particular B. thuringiensis strains across various insect hosts has been widely 
explored elsewhere in the literature, though there is earlier work exploring which 
hosts permit growth (Prasertphon, Areekul et al. 1973, Suzuki, Lereclus et al. 
2004).  This may in part be because the main point of interest in B. thuringiensis 
is deployment of its Cry toxins in transgenic crops (Tabashnik, Brevault et al. 
2013), where growth adaptations of B. thuringiensis to different host species 
likely will be irrelevant. 
 Comparing genome sequencing data (once available) between the 
entomocidus ancestor and passaged lineages should allow for identification of 
any SNPs or deletions, with such a step now being promoted as an intrinsic part 
of any passaging or coevolution experiments (Schlotterer, Kofler et al. 2015).  
The location of these in the genome may determine whether any of the 
observed changes in virulence are the result of changes in cry gene sequences 
(and corresponding structural changes in Cry toxins), other known virulence 
factors or elsewhere.  Without any sequence data, the similar changes in 
virulence across passage treatments observed in the bioassays suggest a more 
general underlying mechanism such as increased production of Cry toxins or 
other virulence factors.  While toxin-rich strains should still be useful 
commercially, such changes would not be of value in the larger market of B. 
thuringiensis transgenics.  The previously highlighted ‘rare’ changes appear 
more likely to be linked to Cry toxins and as discussed further experiments with 
and without mutagenesis could suggest how rare such mutations are in this 
selective passage system.  In either case, it may be that selective passaging 
aided by mutagenesis is not an effective technique if solely attempting to 
produce better-binding Cry toxins, as it is not possible to focus selection onto 
just the Cry toxins. 
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However, the same principals of increasing variation and selection can 
also be applied effectively at the protein level of Cry toxins rather than the 
bacterial level of B. thuringiensis (Packer and Liu 2015).  In simplest terms this 
takes the form of generating a varied library from an initial Cry toxin e.g., 
through error-prone PCR, selecting those variants that produce highest binding 
rate to the receptor of interest and then iterating the process with those 
selected.  Phage-assisted continuous evolution (PACE) is a refined version of 
this idea (Esvelt, Carlson et al. 2011) and has been applied to Cry toxin 
improvement (Badran, Guzov et al. 2016).  Successful Cry toxin-receptor 
binding is required for phage infectivity and proliferation by incorporating Cry 
toxins into the phage and the receptor into the membrane of E. coli, while 
mutagenesis is provided by faulty polymerase in the host cells.  This technique 
was able to produce a 300-fold increase in mortality for Cry1Ac in Cry1Ac-
resistant Trichoplusia ni moths after 500 phage generations (Badran and Liu 
2015, Badran, Guzov et al. 2016).  This system also could easily be adapted to 
other Cry toxins and/or hosts with known Cry toxin receptors. 
 The work here with B. thuringiensis subsp. entomocidus appears to 
confirm that mutagenesis in combination with selective passaging can increase 
the virulence of B. thuringiensis.  Based on previous passage failures, it 
appears that any subsequent attempts to refine the selective passage protocol 
or use it to explore other aspects of virulence evolution should continue to use 
an EMS mutagenesis step.  In particular, overall virulence appeared to be most 
successfully increased when B. thuringiensis was selectively passaged in more 
resistant hosts.  This falls in line with existing theories and experimental work on 
the race between virulence and resistance, and the increasing selective 
pressures they exert upon each other.  Overall the passage treatments and 
bioassays fit with existing patterns, but show them in a pathogen-host system 
that has been rarely utilised in this manner, despite its economic importance 
and relative ease of use; much of the coevolution and passaging work with B. 
thuringiensis so far has been with nematodes (Schulte, Makus et al. 2011, 
Masri, Branca et al. 2015, Shapiro-Ilan and Raymond 2016).  With pest control 
in mind, it does not appear that even the resistant or coevolution treatment 
passage sufficiently increased virulence compared to alternatives – a roughly 
three-fold increase was achieved over a few months here, whilst PACE could 
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achieve a 300-fold increase in what is assumed to be a shorter timespan given 
the 500 phage generations it required (Badran, Guzov et al. 2016).  While the 
selective passage protocol could be refined further, the amount of time required 
for significant increases in virulence would be difficult to reduce to a level that 
could compete with PACE. 
However, even if Cry toxins produced by PACE or similar methods can 
have their genes transformed back into B. thuringiensis to improve 
biopesticides, full passages may still be viable for increasing the virulence of 
commercialised strains.  Working only with the Cry toxin divorces it from other 
aspects of B. thuringiensis biology that are needed for successful infections and 
might also be improved through selective passaging.  While transgenics 
dominate the agricultural uses of B. thuringiensis and its Cry toxins, spore-
based biopesticides will still be required, in particular for organic farming where 
genetic modification may still be viewed with suspicion (Wickson, Binimelis et al. 










Moving to the post-genomic age has made constructing phylogenies or 
linking phenotypic change over time to underlying mutations common-place.  
However, a possible disconnect remains between this new wealth of genomic 
data and organisms’ precise modi vivendi.  This is most apparent with 
sequences found in environmental sampling that cannot be tied to culturable 
organisms, but the same can be true for supposedly far better characterised 
ones (Rappe and Giovannoni 2003, Ungerer, Johnson et al. 2008).  The 
evolution of genomes also cannot be fully understood without also 
understanding the ecology and selective pressures that shape them. 
The entomopathogen Bacillus thuringiensis has been used as 
commercial biopesticide for over 50 years (Lambert and Peferoen 1992), yet its 
ecology and that of its sister species in the Bacillus cereus group are still not 
fully understood.  This produces problems for ongoing B. thuringiensis use, in 
terms of whether it continues to be viewed as safe (EFSA 2016) and how its 
effectiveness can be maintained against spreading resistance in pest species 
(Tabashnik, Brevault et al. 2013, Tabashnik and Carriere 2017).  This thesis 
has shown that the B. thuringiensis strains used in agriculture are distinct 
ecologically as well as genetically from the majority of B. cereus.  Within hosts it 
appears that the outcomes of B. thuringiensis co-infections are strongly 
dependent on the relative frequencies of strains, likely because of the shared 
nature of virulence factors.  Experimental evolution can be used to tie ecological 
interactions to phenotypic (and ultimately genetic) change.  The selective 
passages used here suggest that virulence of B. thuringiensis can be best 
maintained or increased through passaging with resistant hosts; despite 
predictions to the contrary, high relatedness does not appear to favour high 
virulence, perhaps because its effects were outweighed by local competition 




Safety & Regulation of Bacillus thuringiensis 
 
Concerns over the safety risks of B. thuringiensis ultimately appear borne 
out of confusion over what this name actually describes and covers.  Ideally the 
B. thuringiensis species should be realigned to only bacteria found in clade 2 of 
the Bacillus cereus species group, based on ecological differences between 
clade 2 and others, combined with the growing reinforcement of genetic divides 
(Didelot, Barker et al. 2009, Meric, Mageiros et al. 2018).  Both areas suggest a 
clear separation between commercialised B. thuringiensis strains and medically 
significant strains of emetic B. cereus or even B. anthracis.  Even without this 
growing data, the European Food Safety Authority’s (EFSA) newly apparent 
apprehensions over human consumption of B. thuringiensis – “levels of B. 
cereus that can be considered as a risk for consumers are also valid for B. 
thuringiensis” – appear misguided (EFSA 2016, Raymond and Federici 2017).  
Given the historic and widespread use of B. thuringiensis spores on food crops 
(Lambert and Peferoen 1992, Siegel 2001) it would be expected that any 
negative effects of their consumption would have been felt, but there have been 
no definitive cases (Raymond and Federici 2017).  The EFSA highlighted a 
case of food poisoning, but other microbes, including B. cereus, are far more 
plausible culprits (EFSA 2016, Raymond and Federici 2017).  Safety concerns 
may also extend to the Cry toxins, which could be ingested separately 
depending on biopesticide formulations or within transgenic crops.  Certain Cry 
toxins (e.g., Cry31Aa1) have been identified that can bind to receptors on 
human cell lines (Mizuki, Park et al. 2000).  It is not impossible that Cry toxins 
exist that can bind to and kill healthy human gut cells, resulting in similar illness 
to emetic forms of B. cereus.  Again though, the strains used in agriculture are 
well characterised along with their Cry toxins.  There is clear evidence that 
consuming Cry toxins or B. thuringiensis spores in amounts larger than would 
be found with crops has no negative effects (Mendelsohn, Kough et al. 2003, 
Koch, Ward et al. 2015).  In all, it seems somewhat misguided for the EFSA to 
publish concerns over limited data despite the clear opposing evidence. 
Worries over B. thuringiensis pesticide use and transgenic crops in 
general, which are already under heavy European regulation (Davison 2010), 
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have impacts beyond human health.  Insect-resistant crops and biopesticides, 
both markets dominated by B. thuringiensis-related products (Bailey, Boyetchko 
et al. 2010), mean far fewer crops are lost to herbivory, including in 
neighbouring non-transgenic fields (Cattaneo, Yafuso et al. 2006, Dively, 
Venugopal et al. 2018).  Higher yields in turn mean that smaller areas of land 
can be used to produce the necessary amounts of food or cotton.  Turning land 
over to farming is a principal cause of habitat loss (Curtis, Slay et al. 2018), so 
maximising crop production from a given area is highly desirable.  B. 
thuringiensis is already a valuable tool for achieving this (Whalon and Wingerd 
2003, Tabashnik, Brevault et al. 2013) and its importance is only likely to grow: 
global food demands are expected to increase until 2050 (Godfray, Beddington 
et al. 2010) whilst running up against environmental concerns, including 
opposition to chemical pesticides.  Increasing control of B. thuringiensis use 
when there is currently no clear need would therefore prevent full advantage 
being taken of it in the search for more sustainable food production. 
 
Passaging versus Protein Evolution 
 
Regulations aside, the role of B. thuringiensis in a more sustainable 
future will only be realised if it remains effective at controlling crop pests.  
Farming management strategies and pyramided transgenics combining multiple 
Cry toxins are currently used in an attempt to limit the emergence and spread of 
resistance to existing commercial Cry toxins (Zhao, Cao et al. 2005, Tabashnik, 
Brevault et al. 2013).  However, resistance has readily occurred to common 
toxins like Cry1Ac in a number of species, in part because of lax enforcement of 
resistance management (Storer, Kubiszak et al. 2012, Tabashnik and Carriere 
2017).  It is hoped that emerging resistance can be overcome by finding or 
generating new B. thuringiensis strains and toxins to restore high mortality in 
resistant pests (Roh, Choi et al. 2007).  The growing number of sequenced 
isolates means that discovering new toxins is increasingly efficient (Ye, Zhu et 
al. 2012), but this only provides what is already available in nature; it is possible 
that the most useful Cry toxins have already been identified, while discovery is 
mainly limited to homologs of existing toxins.  In the laboratory, engineering or 
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directed evolution of proteins provides an alternative means of producing Cry 
(or other) toxins that might never be found in wild-type isolates e.g., by 
combining domains from Cry toxins isolated on opposite sides of the globe.  
Random mutagenesis, domain shuffling or even chimeric combinations using 
proteins outside the Cry family can all be employed (Bravo, Gomez et al. 2013, 
Deist, Rausch et al. 2014) e.g., combining Cry3Aa with a chymotrypsin 
proteolytic site to increase mortality in Diabrotica virgifera (corn rootworm) on 
transgenic maize (Walters, Stacy et al. 2008, Hibbard, Frank et al. 2011). 
In particular, directed in vivo methods like phage assisted continuous 
evolution (PACE) can produce rapid increases in mortality over the starting 
toxin (Esvelt, Carlson et al. 2011, Badran and Liu 2015, Badran, Guzov et al. 
2016).  These techniques have the potential to rapidly restore toxin 
effectiveness in resistant pests, but also have limitations as they normally rely 
on knowledge of the particular toxin-receptor relationship involved.  If a potential 
receptor is not known then it cannot be engineered into the membrane of 
Escherichia coli as required for PACE to work.  If Cry resistance does occur 
through conformational changes to a single receptor, then the receptor could 
presumably be identified through crosses of susceptible and resistant 
homozygous hosts.  PACE would then be ideal for reshaping toxins to restore 
their binding and overcome resistance.  However, even in major global pests 
like Plutella xylostella the receptors involved in Cry toxin binding have only 
recently been fully identified e.g., abcc2 for Cry1Ac (Baxter, Badenes-Perez et 
al. 2011).  There are still competing models for how Cry toxins bind to receptors 
and ultimately trigger cell death (Bravo, Gomez et al. 2013, de Almeida Melo, 
Soccol et al. 2016).  While this may not be crucial to engineering new Cry 
toxins, as shown by the existing progress with PACE, clearer knowledge might 
further guide toxin development.  Additionally, resistant insects with receptor 
deletion rather than moderation present additional challenges which may not be 
easily addressed solely by PACE and similar techniques. 
The selective passage technique used and refined here does not require 
any foreknowledge of toxin-receptor interactions; it only requires a strain that 
can grow in vivo and produce some level of mortality on which to then select 
individual hosts or subpopulations.  This is an important strength compared to 
protein-level work, though it would appear to come with the trade-off of slower 
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virulence improvement.  This lack of understanding is not just limited to P. 
xylostella; to fully take advantage of PACE would require full characterisation of 
Cry toxins and potential receptors across many pest species.  Additionally, 
toxins or receptors might be identified that cannot be easily expressed by the 
phage or E. coli.  Plutella are far from the only insect crop pests and selective 
passaging could just as easily be applied against other Cry-resistant 
lepidopteran pests e.g., Spodoptera or Helicoverpa (Herrero, Bel et al. 2016, 
Tabashnik and Carriere 2017), or even against coleopterans and dipterans.  
More broadly, there is no reason why selective passaging could not be applied 
to pathogens other than B. thuringiensis, whether bacterial, fungal or viral.  
Increasing pathogen mutation rates and passaging with resistant hosts may be 
the best ways to achieve the desired increases in virulence, and evidence in 
support of them promoting higher virulence is widespread.  Therefore these 
conditions were predicted to have the same effects on B. thuringiensis when 
selectively passaged in P. xylostella.  If these conditions are taken to be 
universal drivers of increased evolutionary rate they should have the same 
effect when used to improve virulence in other pathogen systems.  Fungal 
pathogens including Beauveria bassiana are already used to control aphids or 
other insects and these could be another target for improvement through 
selective passaging. 
Directed evolution of Cry toxins or other proteins only allows for iterative 
changes to that particular target’s structure.  However, Cry toxins are only a part 
of the virulence factors carried by B. thuringiensis.  Selective passaging should 
allow for the mutations that have the greatest beneficial fitness effects to 
surface – here mutations that increase host mortality.  It may be the case that 
there is little room for improvement via Cry toxins as local fitness peaks have 
already been reached.  Any increases in virulence might instead be achieved 
through other virulence factors such as vegetative insecticidal proteins, or 
changing regulation of toxin production.  This appears particularly relevant if 
transforming B. thuringiensis with previously modified toxin sequences, as the 
strain may not produce the desired quantities of toxin, while any toxin mortality 
could be bolstered by within-host replication and septicaemia.  If B. 
thuringiensis spores also rely on attached Cry toxins for germination (Du and 
Nickerson 1996) it may be that modified toxins can no longer bind in this way, 
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as this selection pressure would be removed in a protein-only system.  While 
PACE produced more virulent Cry1Ac toxins, they also had reduced stability 
(Badran, Guzov et al. 2016).  These improvements could all be achieved 
through within-host passaging, with no specific target needed. 
Decreasing virulence might also be desirable in certain situations.  While 
there is no current applied need to do this for B. thuringiensis or its toxins, it 
may be the case for other pathogens.  PACE and similar protein techniques 
cannot currently be configured to specifically favour decreased binding, though 
PACE can be altered to avoid selection of a particular trait (Carlson, Badran et 
al. 2014), leaving only repeated screening of mutant protein libraries for 
reduced binding efficiencies.  Selective passaging could allow for selection of 
strains with reduced virulence, which potentially could be useful for attenuated 
vaccines.  For B. thuringiensis or other pathogens with shared virulence factors 
such selection might be more likely to result in cheats than anything else.  It 
would be interesting to see if repeated selection for reduced virulence could 
reduce B. thuringiensis to a more commensal or symbiotic role, as has 
tentatively been achieved in some other systems (Marchetti, Jauneau et al. 
2014, King, Brockhurst et al. 2016), although it lacks a means of attaching to 
the host (though there is possible evidence for this in B. cereus (Margulis, 
Jorgensen et al. 1998)).  This could depend on B. thuringiensis maintaining 
some Cry toxin production to access the haemolymph, but heavily modulating 
its growth there to prevent septicaemia and host death.  However, if sufficient 
Cry-null cheats were selected for then this resource would be barred and B. 
thuringiensis might lack the means to establish itself against existing 
commensals in the insect gut. 
Away from applied factors, selective passaging has one final, important 
mark in its favour.  Experimental manipulation of proteins may be efficient, but it 
does not appear to shed light on anything new.  In fact, as discussed above, it 
requires pre-existing knowledge of receptors involved for it to be carried out 
effectively.  A selective passaging system can produce strains with increased 
mortality while at the same time identifying which conditions favour higher 
virulence.  These findings might reflect conditions that favour higher virulence 
everywhere, though there is the caveat that this experimental system used 
artificial selection at the host level rather than allowing unrestricted evolution.  
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Coevolution should favour increased virulence (Buckling and Rainey 2002, 
Schulte, Makus et al. 2010, Masri, Branca et al. 2015) and using it in passages 
appears to have additional outcomes beyond just improving the rate of virulence 
evolution.  Allowing the host population to coevolve should also increase its 
resistance.  In P. xylostella this could be caused by a number of things e.g., 
changing gut conditions (Forcada, Alcacer et al. 1996), but it could also be 
caused by changes to midgut epithelial receptors.  Comparisons with the 
ancestral host population could then allow for easier identification of the 
receptor(s) of interest, providing an obvious target to investigate for PACE or 
similar.  If an improved Cry toxin is developed, trying to predict how pest 
populations might evolve resistance in response to exposure would likely be 
welcomed.  Coevolution passages could then be carried out to determine the 
possible routes resistance could emerge through, with repeat experiments 
highlighting the most likely.  This in turn might affect toxin use or allow for a 
head start on developing different toxins for when resistance does emerge in 
field populations. 
In the same manner, selective passaging for decreased virulence could 
help identify factors that favour this decrease.  It could be assumed that these 
factors will be the opposite of those favouring high virulence e.g., limiting 
variation, but this might just maintain virulence at its initial level rather than 
actually decreasing it.  While B. thuringiensis is a pathogen that has been 
commercialised there are obviously many others that cause agricultural damage 
or are medically significant.  Understanding the conditions that favour lower 
virulence during selective passaging could then inform farming or treatment 
practices in an attempt to replicate any decreases in the field.  Similarly, factors 
that favour host resistance could be explored, while any resistant phenotypes 
generated could be searched for alleles to transfer into field populations.  
Alternatively, a wide range of Bacillus species are used in commercial 
microbiology (Schallmey, Singh et al. 2004); if protein secretion is important in 





Bacillus weihenstephanensis  
 
 To take full advantage of any evolved strains and toxin proteins 
produced, the difference between highly insecticidal strains of B. thuringiensis 
and dangerous strains of B. cereus needs to be understood.  However, the 
alignment of species within the B. cereus group is also important for 
fundamental reasons.  Genetic separation should reflect ecological separation 
and this appears to be the case for clade 2 B. thuringiensis against B. cereus 
sensu stricto, with the former identified as specialised invertebrate pathogens.  
However, less attention has been paid to the other significant member of the 
group (in terms of abundance, if not human impact (Raymond, Wyres et al. 
2010)): Bacillus weihenstephanensis, in clade 3 (Didelot, Barker et al. 2009, 
Zheng, Gao et al. 2017).  While the B. cereus group in general is often 
characterised as being soil dwelling, the majority of isolates from soil may in fact 
be B. weihenstephanensis (Raymond, Wyres et al. 2010).  B. 
weihenstephanensis is characterised as being psychrotrophic or 
psychrotolerant (growing at 7oC but not 43oC) but this gives little indication as to 
what it actually does while active at colder temperatures (Soufiane and Cote 
2010).  B. weihenstephanensis appears no better able to grow on soil nutrients 
or simulated root extract than B. cereus or B. thuringiensis, though these had 
previously been suggested as potential niches.  However, B. 
weihenstephanensis would grow on animal-based protein media, and given that 
other members of the B. cereus species group have niches built around animal 
protein this is not surprising.  Therefore B. weihenstephanensis may have a 
similar or the same niche as the others, except at lower temperatures.  For 
example, it might be that both B. weihenstephanensis and B. thuringiensis are 
adapted to growth in insect haemolymph, except across different temperature 
ranges. 
The spatial structuring of B. thuringiensis spores on plant leaves suggest 
that insects generally ingest one strain (Collier, Elliot et al. 2005, Raymond, 
West et al. 2012), resulting in single-strain infections.  Yet B. thuringiensis also 
possesses a wide suite of bacteriocins (Cherif, Rezgui et al. 2008, Raymond, 
Johnston et al. 2010, Garbutt, Bonsall et al. 2011), meaning it should regularly 
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be in competition with closely related strains or species.  The high likelihood of 
initially single-strain infections could instead mean that these bacteriocins are 
employed against B. weihenstephanensis attempting to colonise cadavers that 
have fallen from leaves to the soil.  At intermediate temperatures both species 
can grow, so bacteriocins may be required to drive home any slight advantage 
one species gains in growth rate from a cadaver’s temperature.  This appears 
plausible, and could seemingly be tested in a straightforward manner.  Taking 
the in vivo competitions in Chapter I as a template, a marked competitor strain 
of B. thuringiensis could be competed against a set of B. weihenstephanensis 
strains across a range of temperatures.  The clear prediction would be that the 
relative fitness of B. weihenstephanensis would be negatively correlated with 
temperature, and would only be higher than B. thuringiensis at lower 
temperatures e.g., below 10oC. 
 Notably, a number of strains initially classified as B. thuringiensis, 
including vazensis and navarrensis, have been proposed for reclassification as 
B. weihenstephanensis (Soufiane and Cote 2010); they are still listed as B. 
thuringiensis in the Bacillus Genetic Stock Centre.  It is assumed that they were 
originally identified based on the possession of Cry toxins, though there is the 
strong possibility that contamination or similar issues resulted in 
misclassification.  However, they are psychrotolerant and carry the two specific 
sequences indicative of B. weihenstephanensis in the 16S rRNA and cspA 
genes (Mayr, Kaplan et al. 1996, Lechner, Mayr et al. 1998).  Furthermore, in 
full-genome phylogenies they group with the rest of B. weihenstephanensis 
strains in clade 3 (Priest, Barker et al. 2004, Didelot, Barker et al. 2009, Zheng, 
Gao et al. 2017).  If these strains do actually possess Cry toxins it would fit with 
above hypothesis that B. weihenstephanensis has a similar niche to B. 
thuringiensis, but at colder temperatures, hence their possible need for Cry 
toxins.  While it has previously been suggested that Cry toxins might have a role 
in bacteria-plant associations (Aronson and Shai 2001), the overwhelming 
evidence is that they are virulence factors that allow for invertebrate infections.  
There is limited evidence for B. weihenstephanensis carrying Cry toxins; 
alternatively some B. thuringiensis strains have been found with cold shock 
proteins which they could have acquired subsequently (Bartoszewicz, Bideshi et 
al. 2009), although an exact order of acquisition is difficult to infer without full 
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genotyping.  The consensus is that the majority of known B. 
weihenstephanensis strains do not carry Cry toxins, as otherwise they too 
would have been previously classified as B. thuringiensis, but it does not seem 
impossible for some to possess them.  There could potentially be a similar story 
to that proposed for ‘B. thuringiensis’ strains in clade 1 (Didelot, Barker et al. 
2009) with toxins being horizontally transferred into clade 1 B. cereus strains 
more recently.  It could be the case that while the majority B. 
weihenstephanensis focus on invertebrate cadavers some have adapted, 
assisted by Cry toxin acquisition, to a more actively entomopathogenic lifestyle, 
albeit at lower temperatures than B. thuringiensis. 
This of course presupposes that most B. weihenstephanensis strains do 
lack Cry toxins.  While B. thuringiensis was first identified over a century ago, B. 
weihenstephanensis was only described 20 years ago on the basis of two 
genetic markers common to psychrotolerant Bacillus isolates (Lechner, Mayr et 
al. 1998) and subsequently confirmed in whole-genome phylogenies (Didelot, 
Barker et al. 2009).  As any Bacillus spore carrying Cry toxins would have been 
automatically labelled B. thuringiensis this could mean there are further Cry-
carrying isolates that when fully sequenced will fall into clade 3.  The recent 
phylogenies for the Bacillus species group appear to have only found 
misclassified B. thuringiensis in clade 1 (Didelot, Barker et al. 2009), but this 
obviously does not rule out any other misidentified clade 3 strains existing 
among the many B. thuringiensis isolates held around the world. 
 
Population structure in Experimental Evolution 
 
 The majority of experimental evolution studies have used bacteria 
evolved in serial transfers or chemostats (Elena and Lenski 2003).  These 
methods ensure a replenishing supply of nutrients and prevent the build-up of 
potentially harmful waste products.  Serial transfer and chemostat systems have 
provided insights into many aspects of evolution, which have also informed the 
selective passages carried out here e.g., the impact raised mutation rates have 
on the accumulation of beneficial or desired mutations (Elena and Lenski 2003).  
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However, there is a major flaw with such experiments when it comes drawing 
real-world inferences from them; the very factors that make these long-term 
bacterial cultures feasible also make them unrealistic.  Using a liquid culture 
means that samples can easily be taken for storage, analysis or to inoculate the 
next batch; it also means the culture can be easily mixed to ensure food is 
distributed to all bacteria within, while conditions can be easily adjusted through 
the addition of chemicals or organisms from other cultures.  Mixing also means 
that the culture will be homogenous throughout.  At the within-host level, many 
(if not all) interactions between bacteria are influenced by community structure 
and this is likely also the case for all levels of ecological interaction 
(Stubbendieck, Vargas-Bautista et al. 2016).  Patch structure can play an 
important role in determining the success of particular strategies, most 
obviously through allowing frequency dependent phenotypes to persist even 
when rare in the overall population.  In a mixed, unstructured environment these 
phenotypes would be unable to invade from rare, so they would not be 
expected to emerge in the long-term cultures described. 
 Frequency-dependent traits in bacteria are common; 30% of E. coli 
strains produce colicins for intraspecific competition (Levin 1988, Gordon and 
Riley 1999).  In an unstructured environment bacteriocin-producing strains are 
not expected to invade from rare.  Once mixed through the culture, the small 
volume of bacteriocins produced would not remove sufficient competition by 
non-producers to compensate for any differences in basic growth rate.  
Conversely, when producers are common susceptible strains should not invade 
from rare because large quantities of bacteriocin will be spread throughout the 
mixed culture (Chao and Levin 1981).  Structured populations allow frequency-
dependent strains to achieve persistence at the local level from where they may 
spread to further patches, eventually becoming common across the whole 
population.  Structured populations are likely to be common in nature e.g., 
biofilms only permitting bacteria to interact with their neighbours (Costerton, 
Lewandowski et al. 1995, Kolter and Greenberg 2006).  When bacterial 
densities are low patchiness should also occur, simply because there are 
insufficient bacteria to uniformly fill the total available niche.  Clearly, frequently 
or continuously mixed experimental populations would not allow for any 
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structuring – their advantage is only that they allow larger populations to be 
maintained over potentially many thousands of generations. 
 Structuring could be introduced into these systems by removing mixing 
or growing on a solid matrix, though it may be difficult to maintain structuring 
during replacement of nutrients e.g., transferring a previously unmixed culture to 
fresh media.  While levels of local and global competition can be controlled in 
bacterial multi-culture systems (Griffin, West et al. 2004), in vivo passaging of 
pathogens not only allows for a structured population but also better 
approaches real-world conditions and permits a greater range of selective 
forces than artificial liquid media in flasks e.g., comparing local and global 
competition in vivo (Shapiro-Ilan and Raymond 2016).  Inoculating the initial 
pathogen population automatically creates patchiness, as pathogens are 
partitioned between hosts.  The overall structure of the passage experiment can 
then determine how sharply these patches are defined.  If infected hosts are in 
a larger population then pathogens can be transmitted on to susceptible hosts.  
This would likely generate new patches with a mix of the members of existing 
ones, as pathogens from multiple hosts may be transmitted to a single new one.  
Alternatively, hosts could be kept separate, and transmission limited to one-to-
one, potentially done by the experimenter.  Earlier experiments in this project 
compared global and local competition (Dimitriu, Crickmore et al. unpub. data). 
In the former, all B. thuringiensis spores collected from a passage round were 
then grown up together before being used to infect the next round.  This was 
contrasted against splitting hosts into subpopulations and only pooling collected 
spores within these.  Structuring the population into subpopulations removed 
global competition and produced lineages with higher virulence than found in 
those exposed to global competition. 
Long-term experimental evolution in bacterial cultures has provided 
support for a number of hypotheses, but it must be remembered that such 
systems are only approximations of natural ones, and crude ones at that.  In an 
ideal world insect-pathogen passages could be continued for decades too, and 
while these would not reach 10,000 generations or more in this time, it is 
conceivable that they could reach hundreds.  The P. xylostella and B. 
thuringiensis system used here may not be ideal for longer-term experiments; 
experience suggests it is difficult to ensure cadaver spores are ingested by 
167 
 
subsequent generations without experimenter intervention, while mould is also 
a concern. However, systems using the red flour beetle Tribolium castaneum 
and microsporidium Nosema whitei may be more useful for long-term 
experiments (Berenos, Schmid-Hempel et al. 2011, Kerstes and Martin 2014).  
Microsporidian spores can more easily disperse through the experimental 
environment and flour-based food can be easily replenished.  Over the last 
decade T. castaneum has been used in a number of longer coevolution 
experiments which have provided further evidence in favour of the Red Queen 
hypothesis, amongst others (Van Valen 1974, Salathe, Kouyos et al. 2008, 
Kerstes and Martin 2014).  While such experiments do not approach the 
hundreds of generations suggested above, they do reach into the tens, which is 
more than has been achieved so far with P. xylostella.  Whatever the system 
used, efforts should be made carry out longer experiments in a variety of 
systems more complex than bacterial liquid cultures.  Bringing experimental 
systems closer in line with real-world situations may generate more applied 
knowledge, but this would come at the expense of the tractability available with 




This thesis has clear applied potential as it aimed to produce a within-
host passaging protocol that could raise the virulence of B. thuringiensis strains 
in the crop pest P. xylostella.  While there is not yet a finalised protocol, this 
work has highlighted key areas that should be focused on, namely increasing 
the mutation rate, targeting resistant hosts and avoiding unnecessary within-
host competition.  These findings also fit with existing theoretical and 
experimental work on the evolution of pathogen virulence, but demonstrate 
them in a novel, economically important pathogen-host system.  Along with this, 
it is hoped that the work demonstrating the differing ecologies of clade 1 and 2 
B. thuringiensis strains will permit a reconsideration of the classification of B. 
thuringiensis.  Ideally this will be to strains only in clade 2, irrespective of their 
possession of Cry toxins, as classifying in this way best combines the available 
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